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Summary 
In the course of this work two main projects comprising the development and implementation 
of analytical tools for proteomic applications were realized. Both projects included 
methodology development and methodology optimization of specific enrichment methods to 
facilitate target proteome identification by liquid chromatography (LC) – tandem mass 
spectrometry (MS/MS).  Optimized protocols were then used for biological applications. 
In the first part tin dioxide (SnO2) was examined for the use as enrichment material for 
selective phosphopeptide enrichment. Tin dioxide was provided in the form of porous 
microspheres, which were manufactured by the nanocast process [Smått, 2007]. Initially, a 
prescreening of different surface treated tin dioxide materials was performed. The most 
suitable material was chosen for method optimization, which comprised optimization of the 
loading and elution buffer composition, including variations of the pH, the ion strength and 
the percentage of organic solvent, as well as the evaluation of possible buffer additives to 
increase selectivity and phosphopeptide recovery rates. The applicability of the optimized 
protocol was demonstrated by the LC-MS/MS analysis of a tryptic digest of a mix of 
phosphorylated and nonphosphorylated model proteins [see Appendix Publication no. 1]. 
Beneficial features of the new method were a simple loading buffer composition and good 
practicability. Furthermore, different nanocast TiO2 materials, with variations in diameter, 
pore size, and surface treatment were examined for material dependent parameter 
optimization. Whereas variations in pore size yielded comparable results, the largest 
differences in terms of selectivity and recovery rates were achieved by surface treatment with 
acid (HF or HCl) or base (NaOH) [see Appendix Publication no. 2]. Finally the 
phosphoproteome of HeLa cells was analyzed using nanocast tin dioxide and titanium 
dioxide (TiO2) and a commercial TiO2 material (Sachtopore) For the enrichment with the 
titania materials an enrichment protocol of Sugiyama et al. [Sugiyama, 2007] was used. In 
sum 1595 unique phosphopeptide were identified, combining the results from all 3 methods. 
Using the new stannia material 619 unique phosphopeptides were found and 140 peptides 
were exclusively identified using this material. By combining both nanocast materials in one 
experiment 1137 identified phosphopeptides could be identified, providing a complementary 
coverage of the given proteome [see Appendix Publication no. 3]. The highest rate of 
unspecific binding was observed using the stannia material, but the simple loading buffer 
composition (no additives in high concentrations) makes this material ideal for a 2-
dimensional setup (e.g. strong cation exchange fractionation followed by SnO2 enrichment). 
In this case the lower selectivity would be less of a concern. The second project included the 
conception, synthesis and biological application of a chemically cleavable linker for targeted 
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protein pull down experiments. Parts of this project were carried out in cooperation with the 
Center of Molecular Medicine (CeMM) of the medical university of Vienna. Based on 
previous work of the group [Foettinger, 2007], an indolylacetic acid – malondialdehyde 
derivative was synthesized, which could be selectively cleaved at the indolyl nitrogen by 
treatment with pyrrolidine or hydrazine. The linker construct was further attached to 
hydrazide functionalized agarose- or acrylamide beads. For a biological application the 
kinase inhibitor bosutinib, a drug used for the therapy of chronic myeloid leukemia (CML), 
was coupled onto beads via this linker system for enrichment of known and potential 
interaction partners. The protein pull down experiment was realized at the CeMM using a 
K562 cell lysate for affinity purification. The successful application of the concept could be 
demonstrated by immunoblot and LC-MS/MS protein analysis [see Appendix Manuscript no. 
1]. 
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Zusammenfassung 
 
 Die Doktorarbeit umfasste die wissenschaftliche Bearbeitung von 2 Hauptprojekten auf dem 
Gebiet der Proteomanalytik. Beide Projekte beinhalteten im wesentlichen 
Methodenentwicklung und Methodenoptimierung von spezifischen Anreicherungsverfahren 
zur Erleichterung der jeweiligen Ziel-Proteomidentifizierung (Proteomics) mittels 
Flüssigkeitschromatographie (LC) – Tandem-Massenspektrometrie (MS/MS). Im weiteren 
Verlauf der Arbeit wurde, basierend auf den jeweils optimierten Protokollen, die biologische 
Anwendbarkeit untersucht.  
Im Zuge des ersten Projekts wurde Zinnoxid (SnO2) im Berich der Metalloxid – 
Affinitätschromatographie als Material zur Phosphopeptidanreicherung untersucht. Zinnoxid 
wurde dabei in Form von porösen Mikropartikeln, welche nach dem Nanocasting-Verfahren 
hergestellt wurden [Smått, 2007], verwendet. Anhand einer Mischung aus phosphorylierten 
und nicht phosphorylierten Peptiden wurde ein Vorabscreen von unterschiedlich 
oberflächenbehandelten Zinnoxidmaterialien durchgeführt. Mit dem bestgeeigneten Material 
wurde eine Methodenoptimierung vorgenommen. Dies beinhaltete die Optimierung der Lade- 
und Elutionspufferzusammensetzung durch Variation des pH-Werts, der Ionenstärke und des 
Anteils an organischem Lösungsmittel, sowie die Evaluierung von etwaigen Pufferzusätzen 
zur Verbesserung der Selektivität und der Phosphopeptid-Wiederfindungsrate.  
Anhand eines tryptischen Verdaus von Modellproteinen wurde die Anwendbarkeit des 
optimierten Protokolls gezeigt [siehe Appendix Publikation Nr. 1]. Das optimierte Protokoll 
zeichnete sich insbesondere durch eine einfache Ladepufferzusammensetzung und einfache 
Durchführbarkeit aus. Weiterführend wurden Zinnoxidmaterialien unterschiedlichen 
Durchmessers, unterschiedlicher Porengrösse und unterschiedlicher Oberflächen-
behandlung untersucht, um eine materialseitige Parameteroptimierung zu erhalten. Während 
unterschiedliche Porengrössen vergleichbare Ergebnisse lieferten, hatte die 
Oberflächenbehandlung mit Säure (HF, HCl) oder Base (NaOH) den größten Einfluß auf 
Selektivität und Wiederfindungsrate von Phosphopeptiden [siehe Appendix Publikation Nr. 
2]. Zum Abschluss des Projekts wurde ein Phosphoproteomikexperiment eines HeLa-
Zelllysatverdaus mit Nanocast-Zinnoxid (optimiertes Protokoll), Nanocast-Titanoxid (TiO2) 
und einem kommerziellen TiO2-Material (Sachtopore) durchgeführt. Die 
Phosphopeptidanreicherung mit Titanoxid  wurde nach einem Protokoll von Sugiyama et al. 
durchgeführt [Sugiyama, 2007]. Insgesamt konnten 1595 unterschiedliche Phosphopeptide 
mit Hilfe aller drei Anreicherungsmaterialien identifiziert werden. Allein 619 Phosphopeptide 
wurden durch SnO2 identifiziert und davon 140 exklusiv durch SnO2 nachgewiesen [siehe 
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Appendix Publikation Nr. 3]. Durch Kombination beider Nanocast-Materialien in einem 
Experiment wurden 1137 Phosphopeptide identifiziert, was eine komplementäre Abdeckung 
des HeLa-Zellproteoms ermöglichte. Zwar war der Anteil an unspezifischer Bindung bei 
Zinnoxid am höchsten, die einfache Ladepufferzusammensetzung (keine hochkonzentrierten 
Additive) erlaubt jedoch eine einfache Durchführung eines 2-dimensionalen 
Anreicherungsverfahrens (Fraktionierung mittels starkem Kationenaustauscher gefolgt von 
einer Anreicherung mit SnO2), wobei die geringere Spezifität eine untergeordnete Rolle 
spielen würde.  
Das zweite Projekt umfasste die Konzeption, Synthese und praktische Anwendung eines 
chemisch spaltbaren Linkers für Protein-„pull-down“-Experimente. Bereiche dieses Projekts 
wurden in Kooperation mit dem Center of Molecular Medicine (CeMM) der Medizinischen 
Universität Wien durchgeführt. Basierend auf Arbeiten aus unserer Arbeitsgruppe [Foettinger 
2007] wurde ein Indolessigsäure-Malondialdehydderivat synthetisiert, welches selektiv durch 
Pyrrolidin oder Hydrazin am Indolstickstoff gespalten werden kann. Dieses Derivat wurde an 
Hydrazid-funktionalisierte Agarose- oder Acrylamidbeads gekoppelt.  Zur biologischen 
Evaluierung dieses Systems wurde der Kinaseinhibitor Bosutinib, ein Wirkstoff zur Therapie 
der chronischen myeloiden Leukämie, an den Linker gekoppelt, um potentielle 
Interaktionspartner des Wirkstoffs selektiv für die Identifizierung mittels -Gelelektrophorese 
und LC-MS/MS  anzureichern. Der Pulldown wurde an einem K562-Zelllysat am CeMM 
durchgeführt. Die erfolgreiche Durchführung konnte mit Immunoblotanalyse und LC-MS/MS-
Proteomanalyse gezeigt werden [siehe Appendix Manuscript Nr. 1]. 
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1 Aim 
Analysing the proteome is a challenging task due to the plethora of possible analytes. Mass 
spectrometry is the  technique of choice when analyzing the (human) proteome. Although 
capable of determining thousands of analytes in a single run, certain analytes are present in 
substoichiometric amounts and may not be detected without specific purification steps. Both 
topics of my thesis were based on the development and implementation of specific affinity 
purification tools to enrich for a certain class of proteins to facilitate their mass spectrometric 
identification. 
Accordingly a review about purification tools for phosphoproteomics was chosen as the 
introduction part of the thesis. Therein the theoretical background of one dissertation project 
is fully described and separation tools and mass spectrometric technologies for proteomic 
purposes are discussed in detail. 
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2 Tools for analysing the phosphoproteome and other 
phosphorylated biocompounds 
 
The enrichment, separation and analysis of phosphate group containing biomolecules plays 
an ever increasing role in recent separation science. Starting from the preparative 
enrichment of phospholipids for biotechnological purposes, the separation and purification of 
pDNA or mRNA, to the specific preconcentration of phosphoproteins and peptides and 
carbohydrates to ease their later identification by mass spectrometry, many new methods 
and materials were therefore developed. Most improvements in this field were triggered by 
the need of phosphopeptide enrichment technology for the analysis of cellular protein 
phosphorylation in the proteomics field with the help of liquid chromatography - mass 
spectrometry instrumentation. 
The high sensitivity and the possibility to combine mass spectrometry with different liquid 
chromatography separation techniques with the accessibility for high throughput online 
analysis make mass spectrometry to the instrument of choice for proteome analysis. 
Suppression effects and low quality fragment spectra of phosphopeptides in mass 
spectrometry interfere with the identification of phosphoproteins. Recent developments in 
phosphopeptide enrichment and fragmentation technologies successfully help to overcome 
these limitations.   
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1 Introduction 
 
Phosphate groups are a very common functional group in a variety of different biological 
compounds. They form the hydrophilic backbone of DNA or RNA poly- and oligomers and 
represent the hydrophilic group in many amphiphilic membrane lipids. Reversible protein 
phosphorylation works as a molecular switch which allows the regulation of metabolism and 
signal transduction in cells [1]. Phosphorylation marks the activation of sugars for 
metabolism, and the triphosphate nucleotide ATP serves as the main energy carrier and 
phosphate group donor in all organisms. The phosphate group is capable to carry two 
negative charges depending on the pH of the solvent. Typical pKa values are 2.2 for the 
singly charged and 7.2 for the doubly charged free phosphate [2]. These values can vary 
depending on the specific chemical environment. Phosphate groups are basically tetrahedral, 
with a symmetry depending on the number of substituents on the O-atoms [3].  
Most enrichment methods take advantage of the ionic and Lewis base character of the 
phosphate group for interaction. Therefore, methods based on ion exchange mechanisms 
are generally suitable for the analysis of phosphates. Additionally the Lewis base properties 
allow coordinative binding to positively charged iron or gallium central atoms in a chelating 
matrix, a concept called immobilized metal affinity chromatography (IMAC), and recently new 
metal oxide materials like TiO2, ZrO2 or SnO2 which are said to possess Lewis acid and ion 
exchange properties are frequently used for selective phosphopeptide enrichment [4]. In 
addition to the methods mentioned above, there are different chemical phosphosite tagging 
techniques, and of course phosphosite- and/or phosphoamino acid-specific antibodies are 
available and are widely used.  
The majority of enrichment and separation strategies were developed as a result of the need 
for the selective enrichment of phosphopeptides to facilitate their identification by mass 
spectrometry.  
Reversible protein phosphorylation is the most widespread post translational protein 
modification (PTM) in (eukaryotic) cells, and it is the main chemical protein modification in 
cellular signalling, metabolism, protein transport or cell division and apoptosis, when proteins 
interact with each other [5]. Recent proteomic research revealed that the onset of many 
severe diseases, especially many cancer types, is influenced by the activity of tyrosine 
kinases in certain regulation/signal transduction pathways [6]. Recently developed anticancer 
drugs like imatinib, desatinib or bosutinib act as direct inhibitors of the respective protein 
tyrosine kinases in cancer specific signalling networks [7-9]. New proteins in protein 
interaction pathways could successfully be inferred by LC-MS/MS identification coupled with 
phosphopeptide enrichment methods [10-13]. These achievements show that 
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phosphoprotein identification and phosphorylation site determination is of high clinical and 
research interest. O-phosphorylation is the most common type of protein phosphorylation. It 
occurs mainly on the hydroxyl-containing amino acids serine, threonine and tyrosine in a 
distribution of approximately 1800:200:1 [14], and far less frequently abundance as N-, S- 
and acyl-phosphorylation on histidine, lysine, cysteine and aspartic or glutamic acid residues 
[15]. The covalent attachment of the phosphate group to the respective amino acid residues 
is catalyzed by a class of enzymes called kinases which use the energy of adenosine 
triphosphate (ATP) or guanine triphosphate (GTP) hydrolysis for the transfer of the 
phosphate group onto the substrate protein [16, 17]. This leads to a conformational change 
and thus alteration of the activity of the respective substrate proteins or attracts 
phosphospecific binding domains from other proteins constituting a protein interaction [18].  
Although some proteins remain phosphorylated, the larger amount, especially those involved 
in signalling pathways show a highly dynamic and regulated interaction between kinases and 
phosphatases, which rapidly dephosphorylate the proteins after a phosphorylation event, 
resembling an on/off mechanism. Even though phosphoproteins account for approximately 
30% of the eukaryotic proteome, the ratio of the phosphorylated to unphosphorylated form of 
the protein is rather small, so that the phosphoproteins will be present in substoichiometric 
concentrations [19]. A couple of years ago researchers believed that the sensitivity and 
dynamic range of mass spectrometry analysers would increase in a few years so much that it 
would be possible to identify even low abundance proteins of complex samples like body 
fluids of cell lysates in a single run (“shotgun” proteomics) without the need of any further 
enrichment or separation technique. But like many dreams, this dream did not come true. 
Even with the availability of more powerful mass analysers (with improved selectivity, 
sensitivity, resolution power paired with a high dynamic range) like the linear ion trap (LIT), 
the Orbitrap or Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR-MS) 
that were designed for proteomics applications, there is still the need for an efficient and 
selective separation of peptides before mass spectrometry analysis, able to identify even low 
abundant protein species from a complex biological sample. A typical (phospho) proteomic 
experiment workflow is shown in Figure 1. Depending on the requirements one might start 
with a more or less specific prefractionation for the proteins of interest. This comprises 
methods like targeted protein pull downs (affinity purification of protein complexes), 1D or 2D 
gel electrophoresis or other common protein fractionation techniques.  
After separation or fractionation on the protein level, proteins are typically digested with site 
specific enzymes to obtain smaller peptide fragments, which are accessible to a wider range 
of separation techniques and mass analysers, show higher ionisation efficiency and give a 
more predictable fragmentation pattern compared to whole proteins when using MS/MS 
fragmentation techniques. After protein digestion, peptides are injected onto a micro or nano 
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high performance liquid chromatography (nanoHPLC) system which is in most cases coupled 
online to the mass analyser. A digest of a phosphorylated protein will result in an excess of 
nonphosphorylated peptides. In a biological sample like cell extracts or body fluids, which 
consists of several thousand different proteins and phosphorylated proteins present in low 
abundances, the ratio between nonphosphorylated to phosphorylated peptides will be much 
higher. So even when using high performance liquid chromatography separation techniques, 
coelution of peptides will be unavoidable. It has been shown that phosphopeptides are more 
difficult to detect in complex mixtures than their unphosphorylated analogs. This is either 
attributed to lower ionization efficiency of phosphopeptides compared to unphosphorylated 
peptides [20], or to their sub stoichiometric occurrence [21]; the reports on this are 
contradictory. In any case, an enrichment step for phosphopeptides prior to reversed phase 
separation will help to overcome this limitation. Many different phosphopeptide enrichment 
strategies were therefore developed and are in permanent improvement. Nowadays a 
combination of phosphoselective prefractionation and enrichment is most widely used to 
obtain an increase in selectivity and to achieve better orthogonality for the following reversed 
phase separation. Figure 2 gives an overview about present enrichment methods. In 
following chapters methods are discussed in detail. 
Here it is important to mention that some of these techniques, primarily developed for 
phosphoproteomic purposes, may also be applied to other classes of phosphorylated 
biomolecules. Due to the fact that there is an increased interest of academic researchers, but 
also from the pharmaceutical industry for the selective enrichment and separation of 
phospholipids, DNA (plasmids), or phosphorylated metabolites, a short comment about 
recent applications and developments will be included in this review.  
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2 Starting an experiment 
 
When starting a proteomic experiment, a careful and elaborate sample preparation is 
necessary. Therefore, all sample preparation steps should be carried out at low temperature, 
and when working with cells or body fluids, protease inhibitors have to be added in an early 
stage to avoid protein artefacts which may lead to false positive identification. Phosphatase 
inhibitors have also to be added to avoid cleavage of the phosphate group upon cell lysis. 
The molecules of interest should exist in their native state, which means that all possible 
degradation during the preparation steps should be minimized. When analysing biological 
samples like tissue, cells or body fluids, one needs to remove interfering sample constituents 
such as DNA or RNA and cell debris. Therefore crude pretreatment steps such as 
centrifugation, precipitation, protein extraction, or protein pull downs, or some 
chromatographic steps are necessary. The resulting protein lysates are in most cases 
treated with site specific proteolytic enzymes like trypsin or Lys-c to obtain smaller fragments, 
for which LC-MS analysis can be realized more easily than when working with whole 
proteins. Peptides are then separated by liquid chromatography -mass spectrometry. The 
obtained peptide- and fragment mass data allows the identification of proteins from protein or 
genome databases.  
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3 Immunoaffinity chromatography 
 
Affinity chromatography or immunoprecipitation are widely used enrichment strategies in 
biochemistry. Antibodies are known to have a high affinity and selectivity for their target 
epitopes. Commonly used for trapping whole proteins, they are even used for enrichment of 
smaller molecules like peptides or amino acids, although the generation of good working 
antibodies for smaller molecules is more elaborate.  
In a traditional experiment to analyse protein phosphorylation the setup was focused on one 
phosphoprotein of interest. For detection and purification specific antibodies directed against 
the phospho-epitopes had to be generated. The production and validation of proper 
antibodies is a time consuming and expensive process taking up to one year to generate and 
validate an effective antibody [22]. 
Antibodies used for phosphopeptide or phosphoprotein enrichment on a proteomic scale 
should therefore be directed against the phosphosite solely, so they should have the same or 
similar affinity and selectivity for all the phosphopeptides or proteins in a biological sample to 
obtain a balanced enrichment of all phosphorylated members. However the proximity of 
phosphate groups in peptides is affected by surrounding amino acids so it is very difficult to 
generate adequate antibodies. Although there are antibodies against most common 
phosphosites like phosphoserine (pS), phosphothreonine (pT) and phosphotyrosine (pY) 
available, their use is limited by the specificity of the antibodies [14, 23]. Highly specific pY 
antibodies exist and are predominantely used. Because phosphorylation on Serine, threonine 
and tyrosine occurs in a ratio of 1800:200:1, so the occurrence of phosphotyrosine compared 
to the other common phosphorylation sites is rather low. Tyrosine kinases play an important 
role in human cancer, taking part in oncogenic signalling for cellular proliferation and survival. 
Therefore an unregulated tyrosine kinase activity can lead to malignancy and tumor 
formation [24]. In a global phosphoproteomic approach the number of identifications of 
phosphotyrosine containing peptides would be rather small because of its low abundance. 
Repetition! Pandey et al.[23] used immunoprecipitation of tyrosine phosphorylated molecules 
of EGF stimulated HeLa cells in an LC-MS based proteomic approach. They used a mix of 
different anti phosphotyrosine antibodies for enrichment followed by a 1D electrophoresis 
and in gel digestion before LC-MS analysis. This approach led to the identification of nine 
signalling molecules, seven of it had previously been implicated in EGFR signalling. For 
example Vav-2, STAM and Odin could be identified from epidermal growth factor stimulated 
HeLa cells. 
A more comprehensive proteomic study of tyrosine phosphorylation from Jurkat cells was 
done by Rush et al.[24]. Phosphotyrosine containing peptides from a cell digest of 
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pervanadate treated Jurkat cells were immunoprecipitated with P-Tyr-100, a phosphotyrosine 
specific antibody noncovalently coupled to protein G agarose. Pervanadate was used as a 
specific inhibitor of tyrosine phosphatases. The enriched peptides were later on analysed by 
conventional reversed phase chromatography – tandem massspectrometry.  Using this 
strategy 688 phosphotyrosine containing peptides and 628 phosphotyrosine sites could be 
identified.  The same strategy was used by Rukova et al. for a large scale analysis of 
tyrosine kinase activity in non-small cell lung cancer (NSCLC) cells lines [25]. Known tyrosine 
kinases such as EGFR and c-Met as well as new oncogenic tyrosine kinases not known to 
play a role in lung cancer were identified. In summary over 50 different tyrosine kinases and 
over 2500 downstream substrates were identified by this approach  After elution an 
additional enrichment of phosphorylated species on the peptide level with less phosphosite 
specific enrichment or separation methods like immobilized metal affinity chromatography 
may be performed [26, 27].  
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4 Immobilized Metal Affinity Chromatography 
 
Cysteines and Histidines are known to form stable complexes with zinc and copper ions in an 
aqueous solution [28]. This effect was used for selective enrichment of proteins via certain 
transition metals trapped in a chelating matrix. The concept, termed immobilized metal 
affinity chromatography, is a sort of pseudo affinity chromatography. The materials show 
affinity to a motif like a certain amino acid or functional group and not to a specific epitope 
like in biospecific affinity chromatography. The IMAC technique is widely used for the 
enrichment of recombinant histidine-tagged proteins for biotechnological purposes. A string 
of six His residues is genetically attached to the C- or N-terminus of proteins of interest and 
the high affinity of histidine to covalently fixed Ni2+ is used for enrichment of the tagged 
protein. The concept was expanded for enrichment of phosphorylated proteins by Andersson 
and Porath in the year 1986 [29]. In their experiments they used Fe3+ bound via iminodiacetic 
acid (IDA) to a sepharose matrix. Phosphorylated amino acids like phosphoserine, 
phosphothreonine or phosphotyrosine were retained by the chromatographic material 
whereas nonphosphorylated amino acids were not, or in some cases, like aspartic acid or 
glutamic acid, were only weakly bound. A separation of ovalbumin phosphoisoforms, carrying 
different numbers of phosphates, succeeded using this technology [49]. An advantage of the 
method was that all steps could be carried out in water or buffer and no protein denaturing 
components were needed. 
The affinities of phosphorylated amino acids, peptides, and proteins to Fe3+ ions was 
characterised by Muzynska et al.[30]. The binding and release of analysed compounds were 
observed to be strongly pH dependent. The release of phosphorylated compounds occurred 
at higher pH than their nonphosphorylated counterparts. An improved application of the 
technique was reported by Scanff et al. [31] who did a phosphopeptide enrichment of a 
tryptic digest of the phosphoprotein casein with Fe3+-IDA-Superose-beads. 
Neville et al. [22, 32] observed an increase in selectivity towards phosphorylated peptides 
when using the tetradentate ligand nitrilotriacetic acid (NTA) instead of the tridentate ligand 
IDA for fixing the iron ion in the chromatographic matrix when analysing the phosphorylation 
sites of the cystic fibrose transmembrane conductance regulator (CFTCR). The 
phosphopeptides were identified using MALDI-MS2.  Meanwhile IMAC is the most frequently 
used method for enrichment of phosphopeptides also due to the fact that commercial kits are 
available from different suppliers. However, the high level of unspecific binding of acidic 
peptides via their carboxylic residues remains a challenging problem. A method to 
circumvent unspecific binding of acidic peptides was introduced by Ficarro et al. [33]. In his 
approach a tryptic digest of a yeast whole cell lysate was analysed and carboxylic residues 
16 
 
on peptides were chemically derivatised by O-methyl esterification with methanolic HCl 
before Fe3+-IMAC enrichment. The esterification led to an elimination of unspecifically bound 
peptides without loss in sensitivity. Using this method the authors could identify 200 
phosphopeptides from S. cerevisiae.  
This technology increased the selectivity of IMAC phosphopeptide enrichment considerably 
and was used in numerous publications [26, 27, 33-38]. 
However, authors reported that the chemical derivatisation reaction does not have a 100% 
turnover, so some carboxylic residues remain unmethylated. This led to an increase in 
sample complexity originating from peptides with different degrees of O-methylation [39].  
Other authors reported sample loss when performing methyl esterification before IMAC 
enrichment [36, 37]. Additionally this chemical modification is time consuming especially 
when one has to deal with many samples.  
Another way to increase selectivity of the IMAC method towards phosphorylated peptides is 
to adjust the pH of the loading buffer. Acidifying the sample with strong acids like TFA, formic 
acid or acetic acid before enrichment protonates the carboxylic residues on peptides and will 
therefore reduce non specific binding. The pKa value of phosphate residues from peptides is 
significantly lower than that of carboxylic ones, roughly 1-2 units [40]. So the pH of the 
loading buffer has to be adjusted to a value where the carboxylic residues are protonated 
and the phosphate residues remain ionized to keep their affinity to the IMAC resin. Kokubu 
used 50% acetonitrile 0.1% TFA as loading buffer for Fe3+- IMAC enrichment when analysing 
a tryptic digest of a mouse brain protein extract [41]. With TFA, a selective protonation of 
carboxylic residues on peptides was reported. Additionally the high acetonitrile content 
alleviated hydrophobic interaction between peptides and the IMAC resin. Using this loading 
buffer a reduction of nonspecific binding of acidic peptides was obtained. Just 96 
nonphosphopeptides and 1654 phosphopeptides were identified using Mascot interpretation. 
After manual validation 166 phosphosites on 135 different proteins were identified using this 
approach. Although iron is used as central ion in most IMAC methods, other metal ions have 
been evaluated for selective phosphate affinity. Posewitz tested different metal ions like Ga, 
Sn, Ge, Fe, and others for their applicability in IMAC phosphopeptide enrichment [42]. With 
Ga3+ a better selectivity compared to conventional Fe3+–IMAC was reported when analysing 
a tryptic digest of phosphoproteins. An interesting approach was reported from the group of 
Zou [43, 44]. They used a phosphate polymer to coordinatively bind Ti4+ or Zr4+ ions. The 
resulting IMAC resin was used for phosphopeptide enrichment and compared to Fe3+-IMAC, 
TiO2 and ZrO2 enrichment methods. For the preparation of the IMAC resin they used a 
special chemistry to attach the phosphate groups to the matrix via a linker. The binding of the 
metal ions via phosphonate groups provides a beneficial structural orientation for the 
selective binding of phosphorylated biomolecules. Additionally phosphates form a stable 
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MO6 octahedron structure with Ti and Zr ions. So the metal ions stably bound to the 
phosphonate groups form an interface on the surface of the resin which is very attractive for 
phosphate ions to form a stable double layer. A mix of a standard phosphoprotein digest and 
BSA digest as nonphosphoprotein in a ratio of 1 to 500 was anaylsed. Further the method 
was applied to the phosphoproteome analysis of mouse liver. The method was reported to 
outperform conventional metal oxide enrichment (see following chapter) and Fe3+-IMAC in 
terms of efficacy and selectivity, even when using optimized conditions for the respective 
methods and a bias of Ti4+-IMAC towards monophosphorylated peptides and of Zr4+-IMAC 
towards multiply phosphorylated peptides was reported. The results of the new methods 
were ascribed on one hand to the highly specific interaction between the Ti and Zr ions and 
the phosphate groups on peptides and on the other hand to the novel resin design which is 
composed of phosphonate- immobilized titanium or zirconium ions with a flexible spacer arm 
linked to polymer beads. Another way to increase the specifity and efficiacy of the IMAC 
technology is to combine it with other enrichment or fractionation methods. In most cases 
ione exchange chromatography (IEX) or hydrophilic interaction liquid chromatography 
(HILIC) chromatography is used for prefractionation before a specific enrichment for 
phosphopeptides with IMAC [39, 45-47] or metal oxides is performed. A detailed discussion 
is given in the chapter combination of methods. 
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5 Metal Oxide Affinity Chromatography 
 
From the beginning of the 1990s TiO2 and ZrO2 was increasingly used as a new 
chromatographic material for high performance liquid chromatography in normal phase 
mode. The advantages of this material included large adsorption capacities, chemical 
stability when used under extreme pH ranges, mechanical stability and unique amphoteric 
ion exchange properties [48-53]. Phosphates are known to bind to metal oxide materials [3] 
and in 1990 Matsuda et al. [51] reported the selective adsorption of organic phosphates to 
ceramic TiO2 material. Henceforward several studies concerning enrichment of phosphate 
containing biomolecules with metal oxide materials emerged [49, 51], but not a lot was 
known about the surface chemistry and binding properties of these materials. Connor et al. 
[3] investigated the phosphate adsorption onto TiO2 from aqueous solutions with infrared 
spectroscopy. They proposed a pH dependent bidentate binding of monosubstituted 
phosphate groups to TiO2 sol gel films. In another work, the surface chemistry of metal oxide 
materials was characterized by their acidity and basicity which are from Lewis and Bronsted 
base type [4]. Alumina, TiO2 and ZrO2 possess strong Lewis acid properties with increasing 
Lewis acidity from aluminia to ZrO2. In addition, the high coordination numbers of Ti-O and 
Zr-O are responsible for strong complexation properties of these oxides. Both the Lewis acid 
and the strong complexation properties may be a possible explanation for the affinity of some 
metal oxides for phosphate molecules.  
Tani et al.[54] characterized the chromatographic properties in terms of ion exchange and 
ligand exchange behaviour of different calcinated TiO2. TiO2 was calcinated in an oven from 
200 to 800° C and a strong temperature dependence of the ion - and ligand exchange 
behaviour could be observed. At 700° C TiO2 is completely converted from anatase to rultile 
form and no ion-exchange or ligand-exchange behaviour could be detected any more. The 
authors ascribed the absence of these properties to the loss of the surface hydroxyl groups 
and coodinatively bonded water by calcination at high temperatures. In another experiment 
Tani et al.[55] compared the chromatographic behaviour of TiO2 and ZrO2 with hydroxyl and 
other substituent aliphatic carboxylic acids. The highest retention times were achieved with 
alpha hydroxyl carboxylic acid because they can form a stable five-membered ring between 
metal ion and acid. Alpha hydroxy acids were later used as additives to avoid unspecific 
binding of carboxylic acid containing peptides to TiO2 when used for selective 
phosphopeptide enrichment [56]. The stable ring formation can be a possible explanation 
why alpha hydroxyl acids are able to displace acidic peptides from TiO2 or ZrO2. A work with 
a focus to screen differently treated metal oxide materials for their phosphate affinity was 
done by Leitner et al. [57]. They compared different surface treated tin dioxide microspheres, 
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an alternative metal oxide used for phosphopeptide enrichment, for phosphopeptide affinity 
and selectivity purposes. The results gave evidence that parameters like calcination 
temperature, acid or base surface treatment can differently affect the surface chemistry and 
morphology of metal oxide materials, which will affect the affinity and selectivity of the 
materials to phosphates, respectively.  
The first proteomic application of TiO2 for phosphopeptide enrichment was done by Pinkse et 
al.[58] In his work a novel automated method for the enrichment of phosphopeptides from 
complex mixtures with TiO2 was developed. A two dimensional chromatographic setup with 
titanium dioxide-based solid-phase material (Titansphere) as the first dimension and 
reversed-phase material as the second dimension was employed. Phosphorylated peptides 
were separated from nonphosphorylated peptides in the first dimension by trapping them 
under acidic conditions on the TiO2 precolumn (0,1M acetic acid). Nonphosphopeptides were 
not retained in the first dimension but trapped in the second dimension precolumn before 
they were analysed by nanoflow LC-ESI-MS/MS. The phosphopeptides were eluted from the 
column under alkaline condition (ammonium bicarbonate pH 9.0), concentrated on the 
second dimension and analysed on nanoflow LC-ESI-MS/MS. 125 fmol of a phosphopeptide 
in a 1:1 mixture of the phosphorylated to unphosphorylated form could be successfully 
identified with a recovery rate of above 90 %.  Additionally from a digest of the cGMP 
dependent protein kinase a novel autophosphorylation target could be identified. A drawback 
of this strategy was the high level of unspecific binding of acidic non-phosphorylated peptides 
to TiO2 under these conditions which were reported to be in a comparable level to the IMAC 
method. This may be attributed to the relatively high pH in the binding step. The authors 
recommended O-methyl esterification [33] to reduce unspecific binding. Larsen[59] used 2,5-
dihydroxy benzoic acid (DHB), a matrix component used in MALDI mass spectrometry, to 
increase selectivity without a reduction in phosphopeptide recovery. In this procedure, 
peptides from a tryptic digest of the phosphoproteins ovalbumin and α-and β- casein were 
used for phosphopeptide enrichment with TiO2 columns. Peptides were loaded onto TiO2 
columns with different concentrations of DHB (0-200 mg/ml in 80% acetonitrile, 0.1% TFA) in 
the loading buffer. The column was washed with 20 mg/ml DHB in 50% acetonitrile and 
subsequently with an 80% acetonitrile 0.1% TFA solution. Bound peptides were eluted with 
NH4OH pH 10.5. With increasing concentrations of DHB in the loading buffer the number of 
non-phosphorylated peptides bound to the column decreased dramatically with no 
unspecifically bound peptides observed at 200 mg/ml DHB. When using very complex 
samples the author recommended the use of high concentrations of DHB, up to 400 mg/ml, 
to effectively exclude unspecific binding of non-phosphorylated peptides. A possible reason 
why DHB is able to avoid unspecific binding of acidic non-phosphorylated peptides without 
reducing phosphopeptide binding was explained by different binding properties of these 
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molecules to TiO2. DHB binds to TiO2 via a chelating bidentate geometry whereas a 
phosphate group binds in a bridging bidentate way, so the two molecules target different 
binding sites on the TiO2 surface and DHB is directly competing with carboxylic residues from 
acidic peptides. One big disadvantage of this protocol is that one has to get rid of the DHB 
before LC-MS analysis, because the high amount of DHB would interfere with the reversed 
phase separation and the ionisation. Meanwhile several attempts to increase selectivity 
without decrease in sensitivity were done by screening different loading buffer additives to 
suppress unspecific binding [56, 60]. Mazanek [60] and co workers claimed that the high 
concentration of DHB used in the enrichment protocol from Larsen et al. [59] could be 
problematic with the following LC-MS analysis. Although washing with high organic content is 
performed, the remaining DHB causes a high background in MS. They suggested using a 
mix of DHB and octanesulfonic acid (OSA), an ion pairing agent used for improved peptide 
separation in reversed phase chromatography, to reduce unspecific binding. The additives 
were used in lower concentration and should therefore be less problematic with the following 
analysis. Additionally OSA as ion pairing reagent should improve the quality of the reversed 
phase separation. The quality of the protocol was shown with a mix of phosphorylated and 
non-phosphorylated peptides and the applicability of the protocol to more complex samples 
like a tryptic HeLa digest was demonstrated. More recently, this method was further 
optimized in terms of selectivity using slightly increased concentrations of DHB and OSA, 
and with the addition of heptafluorobutyric acid (HFBA) [61]. The optimized protocol allowed 
improved recovery of phosphorylated peptides and a reduction of unspecific binding from a 
trypsinized bovine serum albumin matrix, when compared to a previous protocol [60].  The 
new method was applicable to both titania and zirconia enrichment. The applicability to 
complex samples was demonstrated by the identification of in vivo phosphorylation sites of 
the affinity enriched anaphase promoting complex (APC/C) and the mitotic complex, 
condensin-I. Sugiyama et al screened different hydroxyl carboxylic acids as alternative 
displacement additives in TiO2 and ZrO2 enrichment. The best results in terms of selectivity 
were achieved when using lactic acid in a concentration of 300 mg/ml in 80% acetonitrile 
0.1% TFA for TiO2 and 100 mg/ml β-hydroxpropanoic acid in 80% ACN 0.1% TFA for ZrO2 
enrichment . Again the applicability to complex samples was successfully demonstrated by 
analysing a tryptic HeLa sample [56]. Lactic acid modified TiO2 gave the highest selectivity 
as well the largest number of identified phosphopeptides. In total, 1100 phosphopeptides 
could be identified by four replicated experiments using TiO2 and ZrO2 enrichment. An 
alternative to optimizing the loading buffer composition for TiO2 enrichment would be to test 
out other metal oxide materials for phosphopeptied enrichment purposes. At the same time 
when TiO2 was tested as affinity chromatography material ZrO2 was also evaluated due to 
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structural, chemical and physical similarities but phosphopeptide enrichment with ZrO2 did 
not offer noteworthy alternatives or improvements to TiO2 enrichment. Al(OH)3 was reported 
as a cheap and robust alternative to TiO2 or IMAC enrichment. In a work of Wolschin et 
al.[62], phosphoprotein enrichment was performed with Al(OH)3 and two commercial 
available Phosphoprotein enrichment kits (BD, QIAGEN) were used as benchmark. 
Additionally phosphopeptide enrichment was done with a tryptic digest of the phosphoprotein 
α-casein. To increase selectivity 0.2 M sodium glutamate and 0.2 M potassium aspartate 
was used in the loading buffer, which again will not allow coupling online to LC-MS. Although 
the authors succeeded to outperform the commercial kits, not a lot of further applications 
were published using this protocol since then. Porous tin dioxide microspheres, a new 
material for phosphopeptide enrichment, were tested in our group as novel phosphoaffinity 
chromatographic material [19]. The spheres were manufactured by the nanocasting process 
[63] which allows  the fine tuning of material properties like particle size, morphology and 
pore size of different metal oxide materials. Using a tryptic digest of 10 proteins with 
ovalbumin as the only phosphorylated protein, phosphopeptide enrichment with SnO2 and a 
simple loading buffer composition without additives performed on the same level to TiO2 with 
the use of 300 mg/ml lactic acid as additive [56] which was used as benchmark protocol for 
all experiments in this approach. Later, a tryptic digest of a HeLa cell lysate was analysed on 
a FT-ICR mass spectrometer. With both protocols  similar numbers of peptides were 
identified, although the SnO2 protocol provided lower phospho-specifity. The overall specifity 
of SnO2 with around 70% phosphopeptides in the eluent is however comparable to IMAC 
enrichment.  
Recently, several authors reported the preparation of magnetic iron oxide (Fe3O4) / metal 
oxide - core/ shell particles for the enrichment of phosphopeptides [64-69]. The focus of this 
work was to facilitate the enrichment procedure by the fact that coated beads could be easily 
captured when applying a magnet to the sample vials during enrichment process, so that 
incubation and washing steps can be performed with a minimum of sample loss. Members 
from the Zhang group used known and novel metal oxide shell material for phosphopeptide 
enrichment [65, 66, 68, 69]. For example Dawei and colleagues coated the magnetic core 
particles with a tin oxide layer [69] and got comparable results to TiO2 coated beads from a 
previous work without the use of high concentrated additives in the loading buffer. Also novel 
oxide materials like Nb2O5 [70] or Ta2O5 [68] were analysed for phosphopepetide enrichment 
application. Both materials in the near vicinity to TiO2 and ZrO2 in the periodic table of 
elements gave comparable performance to the benchmark material TiO2 using common 
protocols, but were also able to reveal a useful degree of divergence in peptides selectivity 
between the compared materials.  
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Summing up, no other enrichment material can provide such a plethora of benefits for 
phosphopeptide enrichment than metal oxides. Different types metal oxide materials have 
proven their quality for selective phosphopeptide enrichment, with every material displaying 
its own (characteristic) bias, giving the possibility of enriching a wide range of differently 
phosphorylated peptides or other phosphorylated species. The materials have a high 
phosphate affinity, exhibit chemical and physical stability and can be manufactured in 
different morphologies and sizes, like porous microspheres [19, 63] or magnetic nanobeads 
[64, 67]. Additionally, MeOAC has shown to be more tolerant against buffer additives like 
salts, detergents and denaturing components than IMAC enrichment. These unique 
properties make metal oxides the ideal materials when an automated online enrichment/ LC-
MS analysis is performed which would allow faster and more reproducible proteomic data 
acquisition [1, 71].  
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6 Ion exchange chromatography 
 
In early proteomic approaches proteins were separated by their size and pI by 2D-PAGE 
before they were in gel digested and analysed by reversed phase liquid chromatography and 
mass spectrometry. The gel-electrophoresis step was reported to be tedious and time 
consuming, and portions of proteomes such as proteins with high molecular weight, extreme 
pI and low abundance proteins as well as hydrophobic proteins were rarely found in a 2D-
PAGE study [72, 73]. Non gel based chromatographic systems for proteomic investigation 
were developed [72, 74] and it was found that ion exchange chromatography as an 
orthogonal resolving system to reversed phase separation performed sufficiently well 
especially when working with complex protein/ peptide samples. Multidimensional protein 
identification technology (MudPIT) used strong cation exchange chromatography in the first 
chromatographic dimension to separate peptides depending to their solution charge state, 
and reversed phase chromatography in the second dimension where analytes are separated 
by their hydrophobicity, which provided an unbiased chromatographic tool for proteome 
analysis [72]. The MudPIT technology was introduced to obtain a higher resolving power of 
the chromatographic system which was necessary for the analysis of complex protein 
samples. Beausoleil et al. used MudPIT in a phosphoproteomic approach [10] when 
analysing a tryptic digest of a HeLa cell lysate. For loading of peptides to the SCX, peptides 
were acidified to a pH of 2.7 and bound peptides were eluted with increasing salt and pH. At 
the pH 2.7 Lys, Arg, His and the amino-terminus of peptides are charged. Tryptic proteolysis 
produces peptides with an Arg or Lys on the C-terminus. Consequently, tryptic peptides 
should carry a solution charge of 2+ and because phosphate groups retain their negative 
charge at this pH, the net charge state of phosphopeptides should be 1+. Thus the 
phosphopeptides tend to elute earlier from the SCX column. The phosphopeptide containing 
fractions were analysed by LC-MS2 and additional data dependent MS3 for improved 
phosphopeptide identification was performed. This chromatographic setup combined with 
elaborate mass spectrometric identification allowed the determination of 2002 
phosphorylation sites on 967 phosphoproteins. But the combination of SCX with RP 
chromatography also revealed some difficulties, especially when both columns were coupled 
online. For example, the interaction of peptides with the SCX resin is proposed to be (mainly) 
of electrostatic and (partially) of hydrophobic character, arising from the hydrophobic 
character of the sufonyl polymer backbone, so that structurally similar peptides with the same 
net charge may be separated. For the increase of peptide recovery from the SCX column, 
the use of organic modifier is recommended [75], which can on other hand interfere with the 
following RP separation. As a consequence both dimensions cannot be optimized 
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independently [76]. On the other hand, when using strong anion exchange chromatography 
(SAX) instead of SCX, phosphopeptides are typically more retained than non phosphorylated 
ones. Uridine monophosphate, uridine diphosphate, uridine triphosphate, and their 
unphosphorylated uridine were baseline separated on an anion-exchanging solid-phase 
extraction (SPE) column by a four step elution with a gradient of salt concentration and pH 
values in an approach from Zhang et al. [77]. Zhang et al. also demonstrated the applicability 
of anion exchange chromatography (AEC) for selective phosphopeptide enrichment when 
analysing a tryptic digest of the standard phosphoprotein β-casein. SAX was used for the 
enrichment and separation of phosphopetides from a digest of human liver cancer tissue 
from Han and co-workers [78]. In contrast to SCX chromatography, the authors claimed that 
not only phosphopeptide enrichment, but also fractionation according to the number of 
phosphate groups was possible. This was demonstrated when analysing tryptic a digest of 
the standard phosphoproteins α- and β-casein. For separation of bound phosphopeptides a 
salt gradient of NH4Cl was used and the pH of the solvent was set to a value of 4. At this pH 
phosphopeptides which are more acidic than nonphosphorylated ones and should therefore 
remain ionized and hence are able to interact with the SAX resin via their phosphate groups. 
Consequently, multiply phosphorylated peptides should show a higher affinity to the SAX 
resin than singly phosphorylated ones. The performance of the technology was compared to 
a Fe3+-IMAC enrichment with POROS 20 MC beads with a commonly used protocol. For 
comparison of the two methods only one fraction (5-28 minutes retention time) of retained 
peptides was collected from the SCX column due to the assumption that 
nonphosphopeptides would not be retained by the SCX column and will therefore elute with 
the flow through.  A higher number of unique phosphopeptides, 47 to 24 with IMAC, could be 
identified using the SAX method and an overlap of 12 unique phosphopeptides was identified 
with both methods. Although both methods suffer from unspecific binding, the 
nonphosphopeptides identified with SAX were mainly acidic peptides whereas IMAC 
enriched peptides were reported to be more heterogeneous (histidine binding to IMAC). 
Additionally the ability for fractionating phosphopeptides was investigated. Two minutes 
fractions from the liver digest were taken and analysed by MALDI-MS. This led to the 
identification of 274 phosphorylation sites from 305 unique phosphopeptides corresponding 
to 168 proteins at FDR of 0.96%. A disadvantage arising from this method is that the 
solvents used in SAX chromatography are not optimal for online LC-MSMS coupling because 
the weak acidic to neutral pH and the aqueous buffer lowers the ionisation efficiency when 
LC-ESI-MS is used.  
An anion-cation (ACE) -mixed bed system for shotgun proteome analysis was introduced by 
the Yates group [76]. They used self assembled columns filled with C-18 (upstream) and 
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SCX material or a mixture of SCX and WAX material. Increased recovery of peptides from 
the SCX resin and a better orthogonality of the 2D system were reported when using the 
anion-exchange-SCX mixed bed material. The “Donnan” effect [reference] was used to 
explain the beneficial behaviour of this novel chromatographic setup for proteome analysis. 
The opposite charges of the mixed bed material would lead to a separation of the salt ions 
used for elution. Salt cations were repelled from the anion exchange resin whereas the salt 
anions were attracted, resulting in a increased reflux of salt cations in the SCX proximity [76] 
improving elution efficacy. Beyond partitioning by charge state, HILIC provides an additional 
orthogonal separation tool to reversed phase chromatography for proteomic applications. In 
contrast to SCX, which is the standard first dimension in proteomic applications, in HILIC 
analytes are separated according to their polarity. HILIC is a special form of normal phase 
chromatography run using mobile phases that are 10-40% aqueous solutions. In HILIC, the 
interaction occurs via hydrogen-bonding of the analytes to a neutral hydrophilic resin within a 
small aqueous film at the interface between the stationary phase and the highly organic 
eluent. So the more polar the eluent becomes the more elution strength it has. Typical 
starting conditions for HILIC separations are up to 90% organic solvent.  HILIC as part of a 
multidimensional peptide separation strategy was used for the phosphoproteomic analysis of 
a tryptic HeLa cell digest [79]. Phosphopeptides with the highly polar phosphate group 
should therefore be strongly retained on the HILIC stationary phase. IMAC phosphopeptide 
enrichment was added before or after HILIC chromatography to increase selectivity of the 
setup. Nearly 100% selectivity for phosphopeptides was achieved when IMAC enrichment 
was performed after HILIC chromatography, and over 1000 phosphorylation sites on 914 
peptides were identified, demonstrating HILIC chromatography as a powerful prefractionation 
tool before selective phosphopeptide enrichment is done. Additionally phosphopeptides elute 
at a buffer composition of 70-50% ACN containing 0,1% TFA which is asserted to be the 
optimal loading buffer composition for IMAC phosphopeptide loading [41]. 
Somewhat similar to HILIC, electrostatic repulsion - hydrophilic interaction liquid 
chromatography (ERLIC) uses electrostatic repulsion as an additional chromatographic 
property to adjust selectivity in HILIC chromatography, as introduced by Alpert et al. [80]. 
Superimposing the properties of ion exchange and HILIC chromatography, selectivity can be 
adjusted by changing the organic content or the pH of the solvent and additionally by using a 
salt gradient. Using a weak anion exchange column and a solvent with a pH of 2(because 
carboxylic residues of acids peptides are not ionized at this pH) tryptic peptides are repelled 
from the stationary phase into the mobile phase via their N-termini and basic amino acids at 
their C-terminus. On the other hand the phosphate groups on phosphopeptides remain 
ionized and are retained by the WAX resin. A high organic content in the mobile phase will 
therefore trap these peptides on the stationary phase increasing the retention. With 
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decreasing organic content in the mobile phase nonphosphorylated peptides will elute 
whereas phosphopeptides remain trapped. Applying a salt gradient will elute remaining 
phosphopeptides. With this setup phosphopeptide separation and  fractionation in a single 
step is possible [46]. In an elaborate comparative study, ERLIC chromatography was 
compared to SCX and SCX-IMAC for phosphopeptide enrichment purposes by Gan et al. In 
their approach human epithelial carcinoma cell line A431 cells were analysed leading to a 
total identification of 2058 unique phosphopeptides of which 1801 were identified by only one 
of the methods. Of these phosphopetides, ERLIC accounted for 38%, SCX-IMAC for 57% 
and SCX alone for 5%. The overlap between ERLIC and SCX-IMAC identified 
phosphopeptides was 12% showing that for a comprehensive phosphoproteome analysis a 
combination of different enrichment strategies is sometimes necessary. Currently most LC-
based methods described in this chapter are used for crude phosphopeptide prefractionation 
before more selective enrichment with IMAC or MOAC is done (see also chapter 2.10).  In 
this way superior selectivity up to 99% is archieved. 
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7 Chemical modification based methods 
 
In addition to chromatography based methods, tagging phosphate species with certain 
compounds using a specific chemical derivatisation reaction is another strategy for 
phosphopeptide enrichment. Site specific modification of phosphoseryl and phosphothreonyl 
residues using a combination of β-elimination and Michael addition is a way to introduce 
phosphosite specific tagging. Oda and co-workers used this technology to introduce a biotin 
tag for biotin/ avidin enrichment [81]. Under strongly alkaline conditions the phosphate moiety 
from phosphoserine or phosphothreonine undergoes β-elimination to form a dehydroalanyl or 
β-methyldehydroalanyl residue, respectively. These α,β-unsaturated residues are Michael 
acceptors, which can react with nucleophiles like ethandithiole, which is further coupled to 
biotin. The benefits for this method are that one can selectively enrich via different types of 
tags available, and the tags can be isotope labelled for quantification purposes [81] or carry 
functional groups to increase ionization efficiacy or to facilitate phosphorylation site 
determination [82]. However, there were some drawbacks reported from the authors. The 
high concentration of hydroxyl ions, necessary for efficient β-elimination, can cause some 
proteine / peptide degradation, also the reactivity of free cysteine residues can lead to 
unwanted derivatisation. In addition, O-glycosylated serines could be converted to 
dehydroalanine as well. These drawbacks can be avoided by additional protecting reactions 
[81] or method modifications [83] but this may head to a more complicated realisation and 
potential sample losses, respectively. Besides only phosphoserine and phosphothreonine 
containing peptides can be enriched using β-elimination/ Michael addition because tyrosine 
is not able to form an α,β-unsaturated bond and additionally β-elimination on free serines 
were observed as well [84]. Aebersold and co-workers used a carbodiimide catalyzed 
reaction for a reversible capturing of phosphate groups on phosphopeptides [85]. A six step 
protocol was developed. First, the free amino groups had to be protected by t-Boc chemistry 
to avoid intra – and intermolecular condensation in the following steps. The main reaction 
used carbodiimide to catalyze the condensation reaction between the peptides and excess 
amine to derivatize phosphate and carboxylate groups. The phosphoamidate bonds had to 
be cleaved off again by a brief acid hydrolysis and the carbodiimide catalyzed condensation 
reaction had to be repeated with cysteamine as condensating agent. The newly introduced 
thiol groups were covalently bound to immobilized iodoacetyl groups. Phosphopeptides were 
released from the resin by acidic hydrolysis revealing the native phosphate form. The 
applicability of this method for complex samples was proven by analysing the 
phosphoproteome of a yeast cell lysate. Although no low abundance phosphoproteins were 
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identified using the method, this was referred to an inadequate post enrichment separation 
[85]. Because the six step strategy seems to be time consuming and prone to sample losses, 
this method was further refined to a more simplified realization and the implementation of 
quantitation by introduction of isotope labelling [86].  
The resulting three step strategy includes the protecting of free carboxylate groups by 
methylation with methanolic HCl which also offers the possibility for the introduction of 
deuterium labelled methyl groups, the coupling of the methylated peptides to a dendrimer via 
their phosphate groups, catalyzed by imidazole and carbodiimide in a one pot reaction, and 
the release of the peptides by acidic hydrolysis with 10% TFA. Using a tandem purification 
protocol with anti phosphotyrosine immunoprecipitation followed by phosphoserine and 
threonine enrichment by implementing the above stated protocol, 80 serine and threonine 
phosphorylation sites on 97 tyrosine phosphoproteins from Jurkat T cells could be identified. 
A recent application of a similar protocol was reported by Bodenmiller et al. when performing 
an elaborate phosphosite assignment of D. melanogaster KC167 cells [84]. 
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8 Ca2+-Precipitation 
 
In the year 1994 Reynolds et al. used an excess of Ca2+ (20 mol/ mol protein) in 50% ethanol 
for precipitating phosphopeptides from a tryptic casein hydrolysate. At lower pH, only 
peptides containing multiple phosphoserines were enriched. At a pH of 8 all 
phosphopeptides except two monophosphorylated could be found in the precipitate [87]. 
Calcium phosphate – calcium-phosphopetide–coprecipitation in combination with two 
subsequent IMAC enrichment steps were used when analysing the phosphoproteome of rice 
embryonic cells. Peptides were mixed with disodium phosphate (Na2HPO4) and ammonia 
solution (NH3 x H2O) followed by the addition of calcium chloride (CaCl2) at a pH of 10. In 
total 242 phosphopeptides, representing 125 phosphoproteins could be identified [88]. 
Although no tyrosine phosphorylated peptide was detected in this study, this was attributed 
to the low abundance of these in rice, rather than lacking selectivity for it. A similar method 
was recently used for the phosphoproteomic analysis of human brain by Xia et al. allowing 
the identification of 551 phosphopeptides with 466 unique phosphorylation sites [89]. Again, 
no phosphotyrosine containing peptides could be found. 
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9  Combination of methods 
 
On the one hand, a combination of methods can be employed to combine different 
enrichment methods in parallel to obtain a more comprehensive view of the 
phosphoproteome, on the other hand it is possible to combine them in a serial workflow to 
maximise selectivity. For example, several groups reported that using TiO2 enrichment 
preferably singly phosphorylated peptides are isolated, whereas IMAC enrichment shows a 
bias towards multiply, predominantly doubly phosphorylated peptides [1, 88, 90]. This may 
be explained by the different binding properties and /or some microstructural preferences, 
but also by the different peptide to resin ratios of both materials [91]. In most recent 
phosphoproteome studies TiO2 and IMAC enrichment are carried out in parallel [11, 91, 92] 
utilizing the different preferences of the methods. A comprehensive comparison of TiO2, 
PAC and IMAC enrichment was carried out by Bodenmiller et al. In their experiments they 
obtained good reproducibility within the same method when analysing repeated isolates but 
the overlaps of peptide identification, generated between different methods were rather low 
(around 30% between all methods) [91]. In a recent work from our group the 
phosphoproteome of HeLa cells was screened by combining different metal oxide protocols 
(nanocast SnO2 and TiO2, commercial TiO2) in a parallel setup [93]. In sum 1595 unique 
phosphopeptides were identified. The overlap of identifications between the methods was 
less than one third, almost 140 phosphopeptides were identified by SnO2 solely, but more 
surprisingly both titania materials isolated exclusively for more than 20% of the total 
identifications. These results are indicating that for a complementary coverage of the 
phosphoproteome, a combined approach may be necessary. 
LC based methods are used preliminary in the first dimension and fractions are collected 
according to resolving power of the respective method used. One has to pay attention that 
the elution conditions used for the first dimension do not interfere with the following 
enrichment step. Primarily high salt concentration or low pH elution conditions, which may be 
used to elute peptides from prefractionation columns, can cause some problems with 
following enrichment methods. Therefore a desalting step or other sample buffer adjustment 
may be required to allow further phosphopeptide enrichment.  Trinidad et al. analysed the 
postsynaptic density (PSD), a part of the mammalian central nervous system using SCX or 
SCX-IMAC phosphopeptide enrichment. 88 SCX fractions were collected and subjected 
either direct to LC-MS analysis or to further IMAC enrichment (for fractions 24 to 88). In the 
early fractions the highest amount of phosphopeptides were found, but phosphopeptides 
were identified throughout the whole fractions. Thus 311 phosphopetides were identified with 
SCX alone and with the addition of IMAC chromatography a 3 fold increase of identification 
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could be achieved summing up to a total of 998 unique phosphopeptide identifications on 
287 phosphoproteins out of 1263 proteins which were identified in total with this approach. 
Using SILAC peptide labeling in combination with SCX-IMAC phosphopeptide enrichment 
and high accuracy mass spectrometry with MS3 peptide sequencing, double auxotroph yeast 
strains were analyzed for pheromone response by the Jensen group. More than 700 
phosphopeptides could be identified of whom 18% were regulated by pheromone response. 
Another comprehensive phosphoproteomic approach using SILAC-quantification, but using 
SCX-TiO2 enrichment and high resolution mass spectrometry with multistage activation 
peptide sequencing [94] for accurate phosphopeptide identification was done by Olsen et al. 
[13]. Analysing EGF treated HeLa cells, more than 99% confidence of phosphopeptide 
identification could be achieved by combining high precursor mass accuracy information  and 
two stage fragmentation of peptides losing a phosphate group and 6600 phosphorylation 
sites on a total of 2244 proteins could be identified, 14% of identified phosphorylation sites 
were modulated more than two fold upon EGF stimulation.  
SCX fractionation and a combination of IMAC and TiO2 enrichment with high mass accuracy 
peptide identification and SILAC quantification was used for the analysis of the 
phosphorylation dependent cell cycle regulation of HeLa cells [11]. Cells were arrested in the 
G1 or M-phase of the cell cycle and –grown in media supplemented with differently isotope 
labeled amino acids to be able to distinguish between the different cell cycle phases. After 
SCX chromatography, fractions were split into halves and equally enriched with either TiO2 
or IMAC. Differently enriched fractions were pooled again and analysed by mass 
spectrometry. The combined setup allowed the identification of over 14.000 sites of 
phosphorylation on 3682 proteins with over 1000 proteins being upregulated phosphorylation 
during mitosis. The authors reported nearly one order of magnitude increased number of 
sites identified from nocodazole arrested HeLa cells compared to previous work [10].  
Studies have shown that IMAC shows a bias towards multiply phosphorylated peptides 
whereas preferentially singly phosphorylated peptides elute from TiO2 [1, 33]. Utilizing this 
behavior, Thingholm developed a strategy for sequential separation of monophosphorylated 
peptides and multiplyphosphorylated peptides. The strategy named sequential elution from 
IMAC (SIMAC) uses IMAC in the first dimension and TiO2 for secondary enrichment of IMAC 
flow through and mild condition elutes. Peptides were therefore eluted from IMAC under 
acidic conditions (1% TFA, pH 1.0) when preferably monophosphorylated peptides should 
elute followed by TiO2 enrichment to remove remaining nonphosphorylated peptides which 
may coelute from IMAC under these conditions, respectively. Subsequently basic elution with 
ammonium hydroxide solution (pH 11.3) is applied to IMAC to recover remaining multiply 
phsophorylated peptides. Combining the advantages of IMAC and TiO2 it was possible to 
identify 306 monophosphorylated peptides, 186 multiply phosphorylated peptides and 716 
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unique phosphosites of a tryptic digest of human mesenchymal stem cells. These numbers 
were in contrast to 232 monophosphorylated and just 54 multiphosphorylated peptides and 
350 unique sites when using an optimized TiO2 protocol alone.  
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10 Application to other biological phosphocompounds 
 
As already mentioned in the Introduction, other phosphorylated biocompounds such as 
phosopholipids (PL), DNA or RNA, and phosphorylated metabolites play an important role in 
biological and pharmaceutical research as well. 
Phospholipids are the main constituent of the cellular membrane bilayer but also play an 
important role in cellular signalling [95]. Lipidomics provides analytical strategies for the 
analysis of lipid metabolism and lipid mediated signalling processes [96].  
Mass spectrometry is currently the method of choice for straightforward lipidomic analysis 
[references], however, elaborate separation or specific enrichment is also in this case 
essential for efficient MS identification.  
Analytical tools such as gas chromatography-mass spectrometry (GC-MS) and thin layer 
chromatography (TLC) with MALDI-TOF-MS can be used [97] but HPLC-ESI-MS is currently 
the most preferred combination for lipidomic analysis [95-97]. 
Therefore, in general, total lipids are extracted from biological samples like cells or tissue 
according to the Bligh-Dyer or the Folch method [98, 99] and extracts are separated by 
normal phase or reversed phase chromatography using diol, C-18 or amino- phase columns 
before mass spectrometric identification [97]. A more phosphospecific method was first 
introduced by Ikeguchi and co workers. In their approach they used TiO2 for selective 
enrichment of PLs from egg yolk prior to LC analysis. Recovery rates up to 70 % for diverse 
PLs could be achieved and the method was also effective for removement of fatty acids and 
neutral lipids [49]. A further refinement of the method was done by Calvano et al. [100]. TiO2 
was packet into frits allowing a fast and uncomplicated SPE enrichment of PLs from dairy 
products. Similar to the protocol of Larsen for phosphopeptide enrichment they used DHB to 
reduce unspecific binding from nonphosphorylated lipids. Only PLs could be identified in the 
elution fraction, proving the high selectivity for PLs of the method. In a recent work from our 
group, ZrO2 packed into SPE cartridges were used to selectively isolate phosphatidylcholines 
(PCs) from natural samples like milk, or human or mouse plasma [101]. Recovery rates up to 
100% were achieved using an optimized extraction, incubation and elution protocol. Using 
the protocol optimized for ZrO2, TiO2 and SnO2 were also tested for PC enrichment, whereas 
ZrO2 performed superior compared to other materials tested 
The negatively charged phosphate diester backbone of DNA can also serve as ligand for 
purification with phosphoaffine enrichment materials. 
Due to the advancements of gene therapy and genetic vaccines during the last decade, the 
demand for highly purified plasmid DNA is still increasing [102]. pDNAs are mainly produced 
by recombinant E.coli fermentation.  So, for research and clinical applications pDNA has to 
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be purified and separated from genomic DNA, RNA, remaining proteins and endotoxins. 
Secondly, only the super coiled conformation of pDNA (sc pDNA) is biologically active and 
hence has to be separated from other isoforms [103]. Therefore chromatographic methods 
such as size exclusion (SEC), hydrophobic interaction (HIC), hydroxyapatite (HA), reversed 
phase (RP), or thiophilic adsorption and affinity chromatography (AC) mostly in combination 
with ion exchange chromatography (IEX) as the second dimension is used [104]. To date, no 
phosphatespecific method for pDNA purification was reported, although Sousa et al. reported 
the complete separation of sc pDNA and open circular pDNA by arginine affinity 
chromatography. The specific recognition was described to be the result of multiple 
interactions between arginine and pDNA, including electrostatic interaction with the pDNA 
phosphate backbone and also some degree of biorecognition of nucleotide bases by the 
arginine ligand [105]. 
The highly active antiretroviral therapy (HAART) is currently the common treatment for 
human immunodeficiency virus (HIV)-infected patients. HAART is a combination of different 
antiretroviral drugs and one of its main constituents are nucleoside reverse transcriptase 
inhibitors (NRTIs). The active form of NRTIs is not the drug itself but its triphosphorylated 
metabolites in the cytosol. Analysis of NRTIs and their phosphorylated metabolites is needed 
to prove individual effectiveness of therapy. In a recent review by Jiaping Lai [106] analysis 
methods of HAART drugs constituents and their phosphorylated metabolites are discussed. 
The chromatographic methods range from SPE, GC to RP-LC with either spectroscopic or 
mass spectrometric detection. For triphosphorylated NRTIs (tp NRTIs), nano or micro RP-LC 
combined with triple quad MS in multiple reaction monitoring mode (MRM) was 
recommended due to the high selectivity and sensitivity of the method, but is still suffering 
from some serious problems. Ion pairing reagents (IPRs) are necessary to reach sufficient 
separation of the highly polar tp NRTIs, but IPRs lead to high signal background and reduced 
ionization efficiency during the ESI-MS analysis. Even though no work on phosphate specific 
enrichment of phosphorylated metabolites was published to date, according to the authors, 
more sensitive and selective methods for the trace analysis of tp NRTIs in biological samples 
need to be developed [106]. 
Summing up, the most important property of phosphorylated biomolecules is their low 
concentration in a complex biological matrix. Therefore, specific enrichment methods for 
phosphorylated biomolecules, that were initially developed for phosphoproteome analysis 
may help to overcome limitations which currently hamper effective LC-MS analysis.  
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11  Mass spectrometry based protein analysis 
 
Before the introduction of mass spectrometry for (phospho-) proteome analysis, phosphosite 
specific antibodies or the incorporation of (32P) orthophosphate into proteins with later 
detection on electrophoresis gels were the traditional methods for the detection of 
phosphoproteins. Phosphorylation site determination was accomplished using Edman 
degradation of 32P- labelled peptides. These methods were robust and well established, but 
showed limitations when analysing complex samples and were labour extensive and prone to 
sample losses, so a lot of sample material was needed [107-110]. With the introduction of 
mass spectrometry for proteome analysis, the possibilities increased dramatically. Mass 
spectrometers provided accurate, fast, sensitive and selective instruments for peptide or 
protein mass determination. Depending on the type of mass spectrometer, data-dependent 
fragmentation [111] of measured peptides(tandem mass spectrometry) delivered additional 
peptide sequence information and/or allowed the identification of post-translational 
modification sites. During data dependent acquisition, the most abundant peptides from a 
survey scan are selected for further fragmentation. Depending on the analytical 
requirements, different types of mass analysators are available ranging from cheap and 
robust low resolution analysers like quadrupole, (linear) ion trap, or time of flight (TOF) mass 
spectrometers with higher resolving power, to highly accurate and sensitive, high resolution 
mass spectrometers like Orbitrap or Fourier transform ion cyclotron resonance (FT-ICR) 
mass analysers. The application of the different analysers also depends on the budget of the 
laboratories. Nowadays most instruments are combinations of different analysers (“hybrid” 
instruments). Here, the first part is used for precursor selection or accumulation and highly 
sensitive, high resolution detection is accomplished in the second part of the instrument. 
Recent mass spectrometers used in proteomic studies are listed in Table 1 with their pros 
and cons and types of application. 
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12 Technologies for peptide sequencing by mass spectrometry 
 
With the introduction of soft ionization techniques like electrospray ionization (ESI) or matrix 
assisted laser desorption / ionization (MALDI) analytes can be ionized in the gas phase, 
mostly in the positive mode by protonation, without inducing fragmentation. This allowed the 
introduction of the intact peptide or protein into the analysator.  
After an enzymatic protein digest by site specific proteases, peptides are either analysed 
direcly without additional separation, e.g. by MALDI-TOF-MS, or using liquid 
chromatographic separation coupled to ESI-MS, and determined peptide masses are then 
compared to predicted peptide masses from genomic or proteomic databases. This 
technology called peptide mass fingerprinting is a useful tool when proteomic samples are 
not too complex or only mass spectrometers without fragmentation capabilities are available. 
Nevertheless this identification tool has its limitations when more complex protein samples 
like body fluids or cell lysates have to be analysed. There is a much higher risk of false 
positive identifications in comparison with methods that rely on MS/MS information as well 
[112]. Protein identification and peptide sequencing using tandem mass spectrometry 
revealed additional sequence specific data which allowed a higher identification confidence. 
Using this technique, precursors (peptides) are fragmented by colliding peptides with an inert 
gas (collision induced fragmentation, CID), or by capture of low energy electrons (electron 
capture dissociation, ECD) or by reduction with anions in the gas phase (electron transfer 
dissociation, ETD). These techniques predominantly induce fragmentation of the peptide 
backbone and sequence informative fragments designated as a, b, c and their 
complementary counterparts, x, y, z ions are generated [figure 3].  
Each fragmentation technique produces a distinct series of ions (y and b for CID, c and z for 
ECD and ETD respectively). By determining the mass differences of ions of one ion series, a 
particular amino acid can be assigned to the next larger fragment and sequence 
determination can be realized.  
For protein identification by database search, search programs need a predictable 
fragmentation pattern for generating possible ions out of DNA or protein databases [113-
116]. Therefore an understanding of the mechanisms underlying this fragmentation pattern is 
necessary. The mobile proton model gives a good explanation of peptide fragmentation 
behaviour in CID experiments [117]. Briefly, the protons for ionisation need to move along 
the peptide backbone and the cleavage is initiated at the site where the proton is located at 
the time point of collision. The energy necessary for fragmentation depends on the sequence 
of the peptide and on the charge state. In the case of CID fragmentation, basic residues like 
lysine or arginine can attract or sequester protons required for fragmentation, and additional 
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energy is needed to move (“mobilize”) the protons from the residue to the backbone. If a 
second proton is available less activation energy is necessary because the most basic site is 
already occupied. Side-chains from acidic residues like aspartic acid, glumatic acid or 
protonated histidine can favour a cleavage in their proximity by providing additional protons. 
Collision induced fragmentation  
With Collision induced dissociation (CID), also called collision activated dissociation (CAD), 
peptide ions in the mass spectrometer are accelerated by applying additional kinetic energy 
and fragmented by collision with an inert gas such as nitrogen or helium.  
Thereby imparted translational energy is converted into vibrational energy which is rapidly 
dispersed over the whole molecule where the weakest bonds are cleaved. 
With CID, mainly sequence informative b and/or y fragment ions are generated, which 
contain the N- and C-terminus, respectively [figure 4]. In addition, neutral loss of water, 
ammonia, carbon dioxide and - in the case of phosphopeptides - phosphoric acid can occur 
[94, 118]. The phosphate group on serine or threonine is the energetically most labile bond 
on phosphorylated peptides. Frequently, a neutral loss of phosphoric acid (H3PO4 (98 Da)) is 
induced upon CID fragmentation and dehydroalanine or dehydroaminobutyric acid is 
generated due to an internal β-elimination reaction in the gas phase. A neutral loss of a 
phosphate group on phosphotyrosine can also occur (HPO3 (80 Da)) but is less common 
[119]. Using the neutral loss as indicator to selectively target for phosphopeptides, a 
precursor ion scan or a neutral loss scan (on triple quadrupole mass spectrometers) can be 
used to specifically detect phosphorylated peptides [94, 120-123].  
When a phosphopeptide is selected for fragmentation and a neutral loss is detected, the ion 
originating from the neutral loss can be selected for further fragmentation by MS3 [10]. MS3 
provides a more sequence specific fragmentation spectra of the product ion of the neutral 
loss. In addition, phosphorylation site identification is enabled, for example by the detection 
of dehydroalanine instead of pSer. As a disadvantage, the authors [10] stated that this 
technology only worked well when relatively abundant phosphopeptides were selected, 
whereas low abundant phosphopeptides did not provide evaluable MS3 spectra. This was 
attributed to insufficient trapping of ions over several MS stages. An alternative to MS3, called 
pseudo MS3 or multistage activation (MSA), to circumvent several trapping stages was 
introduced by Schroeder et al. Here, peptides and possible (multiple) neutral loss products 
are activated for fragmentation during one MS stage. Hence a composite spectrum 
containing fragments from precursor (MS2) and the possible neutral loss products (MS3) are 
generated and the analysis time per peptide is reduced. A comprehensive comparison of 
MS2-only, MS2/MS3 and MSA workflows was carried out by Ulintz et al. When analysing the 
phosphoproteome of yeast and fruit fly, the MSA method showed the highest number of 
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identifiable peaks and the obtained spectra had the highest information content compared to 
the other methods used in the study [124]. 
Electron capture dissociation  
In 1998 Zubarev introduced electron capture dissociation as a more gentle fragmentation 
method compared to CID. ECD rarely causes loss of labile groups such as post-translational 
modifications. In the static magnetic field of an FT-ICR mass spectrometer peptides are 
trapped and irradiated with a beam of thermal electrons. The absorption of the electron is a 
non-ergodic process and the intra-molecular energy dispersion by atomic vibration and 
rearrangements is slower than the bond cleavage mechanism [125]. Via ECD mainly c and z 
fragments are generated [figure 4], which results from the cleavage of the N-Cα amine 
backbone bond [126]. As a consequence of the electron capture and the ensuing charge 
state reduction, peptide ions have to be multiply protonated for fragmentation. In general, 
ECD generates a more randomized fragmentation pattern than CID and is less affected by 
acidic or basic side-chains. Only N-Cα cleavage N-terminal to proline residues is not 
observed due to the tertiary nature of the amide nitrogen. Disulfide bonds are reduced due to 
their high affinity towards radicals [125].  
Electron transfer dissociation 
Due to the fact that ECD is limited to FT-ICR mass spectrometers a further development of 
ECD, which can be applied to more accessible instruments like linear ion traps or ion trap 
hybrid mass spectrometers was developed by Syka and co- workers [126]. In a static radio-
frequency field, like it is present in quadrupoles or ion traps, thermal electrons cannot be 
trapped [126]. Using anions with low electron affinities like anthracene as one electron donor, 
electron transfer to protonated peptides occurs and initiates the same non-ergodic 
fragmentation process like ECD. The anion beam is generated by a chemical ionization 
source and guided via octopole lenses to the ion trap where fragmentation occurs. With ETD, 
thermal electron triggered fragmentation is accessible to cheaper mass spectrometers like 
3D-ion traps (IT) or linear ion traps (LTQ). The disadvantage of these analysers is the lower 
mass accuracy compared to FT-ICR mass spectrometers. With the 
introduction/commercialization of the LTQ-Orbitrap mass analyser, a cheaper and more 
robust mass spectrometer with similar mass accuracy and superior sensitivity compared to 
FT-ICR is available, which can use either CID or ETD fragmentation. 
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13 Quantitation Methods 
 
Measuring the proteomic response of cells to certain stimuli like drug treatment, changes in 
the environment, or disease, changes can be determined by differences in the amount of 
affected proteins. Mass spectrometry offers a wide range of applications for differential 
quantitative proteomics. In contrast to non mass spectrometry based quantification tools like  
staining of gels or western blots, mass spectrometry analysis delivers both, identification and 
quantitative  information. For the determination of cellular phosphorylation dynamics 
phosphospecific enrichment is in most cases required before quantitation can be realized 
[127]. So the phosphorylation dynamics can be inferred from the respective number of 
phosphorylated peptides. Taking into account that the mass spectrometric response of 
peptides can depend on their size, charge or the hydrophobicity, it is necessary to compare 
each individual peptide during analysis. In general this can be accomplished by introducing a 
stable isotope label for the respective peptides. Isotopes used for this task are 2H, 13C, 18O, 
or 15N and can be introduced as internal standard during cell culture (SILAC, labelled amino 
acids), using enzymes (incorporation of 18O during digestion),chemical tagging (iTRAQ, 
ICAT) or by spiking samples with known amounts of synthetic peptides as external standard 
(absolute quantification, AQUA). Isotopically labelled peptides are chemically identical to 
their native counterparts and exhibit the same chromatographic (with the exception of 
deuterium, which might lead to small shifts in retention time) and mass spectrometric 
properties. Thereby “light” and “heavy” phosphopeptide species can be distinguished in the 
spectra by a distinct mass difference and quantitation can be accomplished by comparing 
signal intensities [128].  
In general it is recommended to pool sample and reference in the earliest stages of sample 
preparation. Thus, from the time point of combination, both samples are treated identically 
and errors in quantitation resulting from variations during sample preparation can be 
compensated for. Metabolic labeling allows the combination of samples in early stages right 
after cell harvesting. For SILAC, cells are grown in amino acid depleted media in which 
labelled essential amino acids are substituted. In most cases 13C and 15N labelled arginine 
and lysine are used, generating singly labelled peptides after trypic protein digestion 
ensuring a defined mass difference between peptides. SILAC quantification provides 
probably the most accurate quantitation method and applications are numerous [13, 129-
134]. The disadvantages of SILAC are that the method is expensive and limited to cell 
culture.  
Enzymatic and chemical tagging allows the integration of stable isotopes on the protein or 
peptide level. 18O can be incorporated into peptides during protein digestion with proteolytic 
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enzymes [135]. For example trypsin and Glu-C introduce two oxygens per peptide which 
provides a mass shift of 4 Da, which is also sufficient for discrimination of isotopomers with 
higher charge states.  
Reactive side chains offer a possibility to attach isotopic mass tags to peptides or proteins 
via a chemical reaction. Isotope coded affinity tags (ICAT) use iodoacetamide functional 
groups to selectively bind to the sulfhydryl group of cysteines [136]. The tag consists of the 
reactive group, a linker which can be isotopically labelled, and a biotin group for affinity 
purification of labelled peptides. Taking into consideration that cysteine is a rare amino acid, 
this method is not suitable when analysing proteins with low numbers of cysteines or for 
analysing post-translational modifications like phosphorylation [128]. The N-terminus of 
peptides and the epsilon amino group of lysines can be used to introduce an isobaric tag by 
specific N-hydroxysuccinimide (NHS) chemistry, a method called isotope tags for relative and 
absolute quantification (iTRAQ). During analysis, iTRAQ tagged peptides behave identical 
until CID fragmentation is initiated. During fragmentation, the tag loses its balancer group 
and peptide abundances can be determined by the ratio of the generated reporter ions [137]. 
Methyl esterification of carboxyl residues with deuterated alcohols can also be used to 
introduce isotopic tags. This modification is additionally attractive for phosphopetide 
enrichment, because it reduces unspecific binding to IMAC resins. As well as direct tagging 
of phosphorylated amino acids by using β-elimination/Michael addition reaction with 
deuterated nucleophiles is possible [138, 139]. However, a variety of additional chemical 
reaction for selectively tagging certain amino acids exist which can be used to introduce 
stable isotope labels [140-147]. 
Absolute protein quantification is generally used when only one or a few proteins are in 
focus, e.g. for analysis and validation of biomarkers in a large number of clinical samples 
[148]. In its simplest case, synthetic peptides in known amounts are added to a protein digest 
and quantities are determined by comparing signal intensities (absolute quantification by 
adding isotope-labelled peptides, AQUA) [149, 150]. 
More recently label free quantitation proved a straightforward technique for screening 
experiments, because no extra sample preparation or specific growth media are required. 
Label free quantitation uses global standards instead of peptide specific standards and 
quantitative information can be acquired by either counting the frequency of acquired MS2 
spectra [151] or by comparing the signal intensities of each peptide [150, 152], respectively . 
More recently, liquid chromatography coupled with inductive coupled plasma mass 
spectrometry (LC-ICP-MS) was introduced for specific phosphopeptide quantification [153-
156]. With ICP-MS, heteroatoms like metals and semimetals but also biochemically important 
non-metals like sulphur, phosphorous, and iodine on biomolecules can be selectively 
detected. ICP-MS delivers no sequence information and thus no discrimination between 
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different phosphopeptides is possible. Therefore one has to ensure that phosphopeptides are 
sufficiently separated into discrete peaks by chromatography. Secondly, decreasing 
ionization efficacy due to increasing organic solvent has to be considered. With the help of 
ICP-MS, relative and absolute specific phosphopeptide quantification is possible. The 
phosphorylation degree of proteins can be determined using the sulphur signal from cysteine 
or methionine as a probe to quantify both, the phosphorylated and the nonphosphorylated 
form of the protein [155]. 
This chapter describes only a brief and generalized comment on recent quantification 
methods. For further information the reader is referred to recent reviews [127, 128]. 
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Conclusion 
Phosphospecific enrichment combined with liquid chromatography – mass spectrometry 
analysis has enabled a more comprehensive proteome-wide view of cellular phosphorylation 
networks. But the analysis of the phosphoproteome is still a challenging task due to high 
phosphorylation dynamics and abundance differences between analytes and matrix 
components, respectively. Therefore, the utilization of new materials as well as 
improvements of protocols and strategies are offering solutions which may help to overcome 
these limitations. The combination of ion exchange chromatography with specific 
phosphopeptide enrichment enabled a large increase in phosphopeptide selectivity. On the 
other hand, the parallel implementation of different enrichment methods allowed a more 
complementary coverage of the phosphoproteome. Improvements in MS-instrumentation 
offer increased resolution and dynamic range, high mass accuracy and sensitivity with fast 
scan speeds, enabling the identification of thousands of analytes in a single run. The 
additional implementation of new fragmentation tools such as neutral loss-triggeredMS3, 
MSA, ECD and ETD allow a more specific phosphopeptide identification and a more detailed 
sequencing of phosphopeptides for accurate phosphorylation site identification. 
A major protocol improvement for metal oxide-based phosphopeptide enrichment was 
achieved by the addition of specific buffer additives which allowed higher selectivity and 
better recovery rates of phosphopeptides. For further optimization, a fine tuning of material 
properties which may influence phosphopeptide binding and selectivity may be necessary. 
First attempts were already made in our group by screening different enrichment materials 
for material properties like surface area, surface treatment, or manufacturing process in 
terms of phosphopeptide affinity and selectivity, but there is still more information needed to 
allow a dedicated rational material design. 
As a future perspective, a robust and automated phosphoproteome analysis for clinical 
application  is intended. Therefore both physically and chemically robust enrichment 
materials are necessary which may be packed into chromatographic columns for online 
analysis. By the nanocast process metal oxides can be manufactured in different diameters 
and pore sizes. Especially porous tin dioxide, which can be used without the use of highly 
concentrated additives, may be a suitable material for this purpose.  
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Figure 1. A general workflow of an MS based phosphoproteomic experiment is depicted. 
Phosphorylated species can be fractionated (SCX, HILIC) or specifically enriched (IMAC, MeOAC), 
furthermore p-Tyr containing peptides/proteins may be enriched by specific antibodies. 
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Figure 2. Overview about most common enrichment strategies for specific phosphopeptide 
enrichment. A combination of methods increases the amount of possible unique phosphosite 
identifications. By the use of prefractionation before specific enrichment a marked increase in 
selectivity can be achieved. 
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Figure 3. ( A) Nomenclature of peptide fragmentation patterns with (B) predicted ion structures 
commonly induced by CID-type fragmentation (b and y ions) or ECD/ETD fragmentation (c and z ions) 
[157].  
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Figure 4.  Only poor sequence information can be obtained from CID spectra of many 
phosphopeptides, because CID preferably induces dissociation of the most labile bonds. Predominant 
signals are caused by neutral loss of phosphoric acid (H3PO4), from the cleavage of the labile O-
phosphate bond and by site specific fragmentation of the amide bond c-terminal to proline. Mainly y 
and b ions are generated. (B) Cleavage energy is dispersed more randomly on peptide backbone 
during ETD fragmentation, leading to a more sequence informative fragment spectra. Notably, only z 
and c ions are generated. Commonly no neutral losses of H3PO4 are induced by ETD. Neutral losses 
observeable in this spectrum are caused by a higher activation energy during fragmentation to 
increase signal intensity. Reprinted from [158] with permission of Annual Reviews of Pharmacology 
and Toxicology.  
47 
 
 
Type of analyzer Pros Cons Supplier Applications 
Triple Quadrupole 
instruments (QqQ) 
moderately expensive 
instrument,  robust; 
Ion filtering,  
MS2, CID 
fragmentation 
high dynamic range, 
very high sensitivity 
when used in MRM 
(SRM) mode – good 
for quantitation 
Low scan speeds, 
Low sensitivity in scan 
mode,  
low resolution (unit 
resolution), only CID 
fragmentation 
AB Sciex, Thermo 
Scientific, Agilent, 
Waters, Varian 
Good  for quantitation 
(SRM/ MRM) , 
 but also peptide 
sequencing possible  
(Linear) Ion Trap (L)IT 
Mass spectrometers 
moderately expensive,  
robust; 
Ion selection, 
MSn, CID & ETD 
fragmentation 
possible, 
Fast scan speeds, 
high sensitivity 
 
relatively low (typically 
~unit) resolution, 
higher scan 
speeds,sensitivity and 
enhanced resolution 
mode with latest 
generation 
instruments   
Thermo Scientific, 
Bruker, Agilent, Varian 
Peptide (protein) 
sequencing, 
quantification 
Time of flight (TOF) 
Mass spectrometers 
cheap 
High resolution, high 
sensitivity, wide mass 
range  
Low dynamic range, 
no fragmentation, 
generally not 
applicable for 
quantitation purposes 
Shimadzu, Bruker, 
Waters, Agilent 
Peptide mass 
fingerprinting. 
Mainly provided with 
MALDI-ionization 
TOF-TOF High resolution and  
high sensitivity,  
high energy (20keV) 
CID, MS2 
 
Low dynamic range, 
minor application for 
quantitation  
Bruker, AB Sciex, 
Shimadzu  
Peptide sequencing, 
accurate peptide and 
fragment ion mass 
determination. 
Mainly provided with 
MALDI-ionization 
Q-TOF High resolution, high 
sensitivity (TOF), 
Ion filtering (Q) 
MS2 (CID) 
Quantification 
 AB Sciex, Bruker, 
Waters, Agilent 
Accurate mass 
determination (TOF). 
Peptide sequencing, 
quantification. 
Combines qualities of 
quadruplole and TOF 
MS 
LIT-TOF High resolution (TOF), 
CID fragmentation, 
high scan speeds, 
MSn (LIT) 
 Shimadzu Protein and peptide 
sequencing, 
quantification (LIT), 
Accurate mass 
determination (TOF) 
LTQ (LIT)-Orbitrap Very high resolution 
and sensitivity with 
Orbitrap 
High dynamic range 
Fast scan speeds, 
expensive Thermo Scientific Peptide and protein 
sequencing in LIT, 
quantification 
combines fast scan 
speeds (MSn) of LIT 
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multiple  fragmentation 
MSn, CID & ETD 
fragmentation with 
LTQ 
with high resolution 
and sensitivity of 
Qrbitrap 
FT-ICR  Delivers highest 
resolution of all mass 
spectrometers, ECD 
fragmentation 
Slow scan speeds, 
Low sensitivity, 
Very expensive, costly 
in operation (needs 
liquid He for cooling)  
 Accurate mass 
determination. 
Peptide and protein 
sequencing with ECD. 
Exclusively provided 
as hybrid instrument 
(Qq-FTMS, QqQ-
FTMS, LTQ-FT-ICR) 
LTQ-FT-ICR-MS High resolution (FT-
ICR) 
High scan speeds 
(LTQ) 
MSn 
CID, and ECD 
fragmentation possible 
Expensive, sensible, 
costly 
Thermo Scientific Peptide and protein 
sequencing, 
quantification. 
Combines fast scan 
speeds (MSn) of LIT 
with high resolution of 
FT-ICR 
 
Qq(Q)-FTMS High resolution (FT-
ICR-MS) 
Ion filtering, SRM 
High dynamic range 
CID, ETD, ECD 
fragmentation possible 
 
Expensive, sensible, 
costly 
Bruker, Varian Peptide and protein 
sequencing, 
quantification. 
Combines the power 
of QqQ and FT-ICR 
 
Table 1. Overview about recent MS technologies used in proteomic experiments. Their pros and cons, 
types of application and suppliers are listed. Abreviations: FT-ICR-MS Fourier transform-ion 
cyclotron resonance-MS; SRM selected reaction  monitoring; MRM multiple reaction monitoring 
(same technology, differently named by supplier); CID collision induced fragmentation;  
ECD electron capture dissociation; ETD electron transfer dissociation. 
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3  A Chemically Cleavable Linker Concept 
 
Aim 
During the second project the development and evaluation of a new method for affinity 
purification of target proteins was realized. Therefore a new linker chemistry was designed, 
which allows the release of bait – target complexes via specific chemical linker cleavage. 
In the field of chemical proteomics, targeted protein pull-downs are generally used to 
selectively enrich for specific bait interactors, enabling their identification by liquid 
chromatography – (tandem) mass spectrometry. Commonly, baits are coupled to beads via 
different linker chemistries, allowing the isolation of target proteins from matrix components. 
Elution is generally performed by the use of denaturing buffers. However, this may also elute 
proteins which are unspecifically bound to the bead matrix, increasing the risk of false 
positive identifications. By elution-independent affinity chromatography, intact target–bait 
complexes can be eluted, commonly by specific linker cleavage. In our group a cleavable 
core structure, based on an indoleacetic acid-malondialdehyde derivative, was designed, 
which can be selectively cleaved at the indole nitrogen by incubation with pyrrolidine. This 
derivative was coupled to hydrazide functionalized agarose or acrylamide beads via the 
reactive allylaldehyde group of the derivative. As bait we used bosutinib, a drug recently 
used in the therapy of chronic myeloid leukemia, which was available in its amino 
functionalized form. Bosutinib was coupled to the linker via an amidation reaction with the 
help of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM) as 
coupling reagent. A protein pull down was performed on a K562 cell lysate and isolated 
interaction partners were identified by immunoblot and LC-MS/MS analysis. 
 
Synthesis and results of this work can be found in the manuscript “A New Chemically 
Cleavable Linker of an Immobilized Bait for Target Protein Pull-down Concept” to be 
submitted (see Appendix Manuscript no. 1). 
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RTin Dioxide Microspheres as a Promising Material
for Phosphopeptide Enrichment Prior to Liquid
Chromatography-(Tandem) Mass Spectrometry Analysis**
By Martin Sturm, Alexander Leitner,* Jan-Henrik Sma˚tt, Mika Linde´n, and Wolfgang Lindner*Functional materials are frequently used to identify and characterize proteins and their modifications in complex biological
samples throughout the analytical workflow. Protein phosphorylation is a highly important post-translational modification that is
being examined with the help of diverse materials that exhibit affinity towards the phosphate group of phosphoamino acids.
Titanium dioxide and zirconium dioxide particles are increasingly used to enrich phosphopeptides from proteolytic digests of
protein mixtures, although specificity and recovery still leave room for improvement. Here, we present tin dioxide (SnO2,
stannia)microspheres as a new type ofmetal oxidematerial for phosphopeptide enrichment. Themicrospheres are produced by a
nanocasting process, starting from silica particles as a template, which allows the tuning of material properties such as particle
diameter and porosity of themicrospheres in a straightforwardmanner. For the first time, we are able to show that tin dioxide can
be used to enrich phosphopeptides from mixtures such as enzymatic digests of proteins, followed by analysis by liquid
chromatography-mass spectrometry (LC-MS). For optimization of the enrichment protocol, we use synthetic phosphorylated
and nonphosphorylated peptides, and test different solvent compositions for loading and washing steps to enhance the selectivity
of the material without compromising phosphopeptide recovery. Furthermore, the selectivity and phosphopeptide binding
properties of tin dioxide are compared to the established metal oxide materials, titanium dioxide and zirconium dioxide, using
mixtures of model proteins. Even without the use of additional additives such as a-hydroxy acids, which have been used to
enhance the specificity of TiO2-based enrichment, we show that a comparably good performance can be achieved for the SnO2
spheres.1. Introduction
Proteomics, as a scientific discipline, aims to characterize the
protein complement – the ‘‘proteome’’ – of a cell, a body fluid
or another complex biological sample. It is estimated that the
human proteome consists of approximately 30 000 genes, each
gene coding for a specific protein. But the number of different
proteins present in an organism at any given time could rise
over one million, and this is mainly the result of splice variants
and posttranslational modifications (PTMs). These PTMs
comprise chemical modifications ranging from the formation
of disulfide bonds via oxidation of the thiol groups from[*] Dr. A. Leitner, Prof. Dr. W. Lindner, M. Sturm
Department of Analytical Chemistry and Food Chemistry, University
of Vienna
Waehringer Strasse 38, 1090 Vienna (Austria)
E-mail: alexander.leitner@univie.ac.at; wolfgang.lindner@univie.ac.at
Dr. J.-H. Sma˚tt, Dr. M. Linde´n
Center for Functional Materials, Department of Physical Chemistry,
A˚bo Akademi University
Porthansgatan 3-5, 20500 Turku (Finland)
[**] The authors would like to acknowledge Karl Mechtler (Institute for
Molecular Pathology, Vienna, Austria) for providing the phosphopep-
tides for this study. This work was financially supported by the GEN-AU
framework program ‘‘Austrian Proteomics Platform II’’ funded by the
Austrian Federal Ministry of Science and Research.
Adv. Funct. Mater. 2008, 18, 2381–2389  2008 WILEY-VCH Verlagcysteines during protein folding, to phosphorylation, glycosy-
lation and other covalent modifications when the protein is
already folded.[1] Protein phosphorylation is known to be a key
event in intracellular signaling and other important cellular
processes such as metabolism, transcription and apoptosis.
Thus, the identification and localization of phosphorylation
sites in proteins is very important to get insights in the
regulation of cellular signaling cascades and other biological
networks. It is estimated that phosphoproteins account for
more than 30% of the proteome,[2] but on the level of a
particular protein, phosphorylation is typically transient and
only present in substoichiometric amounts. Mass spectrometry
(MS) is the technique of choice for proteome analysis due to its
ability to not only identify a large number of proteins, mostly
from their corresponding peptides, but also to identify,
characterize and locate post-translational modifications.[1]
In a typical ‘‘bottom-up’’ analysis, single proteins or more
complex samples like whole cell lysates or plasma are
enzymatically digested into peptides, because they are more
amenable to mass spectrometric analysis. Peptide mixtures
are thenmost commonly separated by one- or two-dimensional
high performance liquid chromatography (HPLC) prior to MS
analysis. However, after the digestion step, phosphopeptides
are usually present in an overwhelming excess of unpho-
sphorylated peptides, which usually have higher ionizationGmbH & Co. KGaA, Weinheim 2381
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2382efficiencies and are preferentially selected for peptide
sequencing by tandem mass spectrometry (MS/MS) in so-
called ‘‘data-dependent’’ experiments. For this reason it is
necessary to develop efficient and selective phosphopeptide
enrichment methods to reduce the complexity of the peptide
mixture to ease later analysis and allow the identification of
phosphorylation sites. Different affinity-based preseparation
strategies have been used with varying degrees of success.[3]
These include immunoprecipitation, immobilized metal affi-
nity chromatography (IMAC), strong cation exchange chro-
matography, metal oxide affinity chromatography and chemi-
cal modifications like b-elimination. Some of these methods
have recently allowed the identification of several hundred and
up to thousands of phosphoproteins in large-scale phospho-
proteomics studies.[4]
While IMAC continues to be widely used in phosphopro-
teomics, studies on different metal oxide materials such as
titanium dioxide (TiO2, titania),
[5] zirconium dioxide (ZrO2,
zirconia)[6] and aluminum oxides,[7] which are said to enrich
phosphopeptides due to their Lewis acid properties have
shown promising results, and frequently outperform the IMAC
materials. The number of studies that have used metal oxide-
based phosphopeptide enrichment has increased rapidly as a
result of these initial reports. Beside the use of commercially
available particles, several groups have also reported the
preparation of different types of metal oxide materials and
morphologies (nanoparticles, magnetic beads, surfaces and
membranes) and their application to phosphopeptide enrich-
ment. TiO2,
[8] ZrO2,
[8d,9] Al2O3,
[10] and, most recently,
Ga2O3
[11] have been demonstrated to bind phosphopeptides
with varying degrees of specificity, although in most cases, the
materials were only evaluated with samples of limited
complexity (single proteins or mixtures of two to three
proteins).
Unfortunately, at present little is known about the exact
binding characteristics of the phosphate groups to these metal
oxide materials. It is known that under acidic conditions,
titania shows amphoteric ion-exchange properties depending
on the pH-value of the solvent[12] and the adsorption of soluble
phosphate to titania presumably occurs in a bidentate
manner.[13] Different material properties may arise from
variations of the manufacturing process of the oxides, such as
the use of different calcination temperatures. This may in turn
affect the binding properties, as exemplified by the different
performance of commercially available TiO2 materials com-
pared in a recent study by Yates and co-workers.[14]
Calcination of commercial TiO2 spheres – thereby changing
its crystalline properties – was recently found to increase the
specificity of phosphopeptide enrichment on titania as
reported by Ishihama and co-workers.[15] But even with these
newly introduced metal oxide materials sufficient selectivity
for the analysis of complex samples may not always be
achievable and was found to be highly dependent on the
solvents used for loading of the sample and during washing
steps. Larsen et al.[5c] and Mazanek et al.[16] added dihydroxy-
benzoic acid (DHB) or DHB in combination with octane-www.afm-journal.de  2008 WILEY-VCH Verlag GmbHsulfonic acid to the loading buffer and achieved a remarkable
gain in chemoselectivity, but these additives may complicate
direct LC-MS analysis because residual DHB interferes with
peptide detection. Less interference can be expected with the
use of different aliphatic hydroxy acids as first reported by
Sugiyama et al.[17]
Phosphate groups have been shown to have high affinity
towards a number of metal oxides,[13] so it is desirable to test
new porous metal oxide materials that may show even better
chemoselectivity and phosphate binding properties at less
stringent binding and release conditions. For this purpose, we
evaluated porous tin oxide (SnO2, stannia) as a novel oxide
material for phosphopeptide enrichment. SnO2, for example,
has a different, slightly lower surface isoelectric point than the
presently used oxides and may also differ in other properties
that may influence phosphate affinity. In our experiments we
used SnO2 microspheres that are manufactured in a so called
‘‘nanocasting’’ (replication) process[18] allowing the conveni-
ent preparation of dedicatedmaterials and tailoring of material
properties like shape, particle diameter and pore size.
Previously, the nanocasting method has successfully been
used to prepare a series of mesoporous metal oxide
powders,[19] and it is easier to control the morphology/porosity
of the material with this technique than with the coacervation
(polymer-induced colloid aggregation) process commonly used
for the preparation of TiO2
[20] and ZrO2.
[21] Starting from
porous silica particles as a ‘‘negative’’ template, the particles
are first soaked in a metal salt solution, and metal oxides are
formed in situ by evaporation of the solvent followed by the
thermal decomposition of the metal salt and a calcination step.
In the final step, the silica portion is leached from the particles
by treatment with HF or NaOH solution. Nanocast stannia
material obtained by the above-mentioned procedure was
evaluated for its suitability for phosphopeptide enrichment,
using a set of model peptides and protein digests. Our results
demonstrated that SnO2 is a promising phosphopeptide affinity
material that can complement existing sorbents in the study of
the phosphoproteome.2. Results and Discussion
2.1. Structural and Chemical Properties of the Nanocast
SnO2 Spheres
A scanning electron microscopy (SEM) image of SnO2
spheres replicated from 10mm silica spheres is shown in
Figure 1a. The spheres have a uniform shape and a narrow size
distribution similar to the starting silica spheres (results not
shown). For comparison, a SEM image of commercial TiO2
spheres (Sachtopore NP), which is used as reference, is shown
in Figure 1b. For the latter, we observed a slightly broader size
distribution compared to the SnO2 spheres. Furthermore, we
have used the nitrogen physisorption technique to evaluate the
intra-particular porosity of the spheres and the adsorption
isotherms of the SnO2 and TiO2 microspheres are plotted in& Co. KGaA, Weinheim Adv. Funct. Mater. 2008, 18, 2381–2389
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Figure 1. SEM images of a) tin dioxide microspheres prepared from 10mm silica as starting
material and b) Sachtopore TiO2 spheres for comparison.
Figure 2. Nitrogen physisorption isotherms of the SnO2 replica spheres
(squares) and the Sachtopore TiO2 spheres (triangles). Inset: The corre-
sponding BJH pore size distribution plots derived from the desorption
branch.Figure 2. From the inset in Figure 2 it is evident that the SnO2
replica spheres have a bimodal pore structure, while the
Sachtopore TiO2 spheres have a sharp monomodal mesopore
size distribution. The data on the textural properties of
the spheres obtained from the nitrogen physisorption mea-
surements is summarized in Table 1. The SnO2 spheres have a
specific surface area of 55.9m2 g1 and a pore volume of
0.19 cm3 g1, which is lower than for the starting silica template
(374m2 g1 and 1.21 cm3 g1, respectively). For comparison,
these values are 23.5m2 g1 and 0.19 cm3 g1 for the commer-Table 1. Textural properties of the spheres obtained from the nitrogen physisorption measuremen
electrokinetic titrations.
Sample BET surface area [m2 g1] Pore volume [cm g1]
SiO2 374.0 1.205
SnO2 55.9 0.188
TiO2 23.5 0.193
Adv. Funct. Mater. 2008, 18, 2381–2389  2008 WILEY-VCH Verlag GmbH & Co. KGaA,cial TiO2 spheres. While the SiO2 and the
TiO2 spheres have monomodal pore size
distributions (centered around 10.7 nm and
32.1 nm, respectively), the SnO2 replica
spheres have a bimodal distribution of pores
centered around 50.8 nm and 5.0 nm, and
which comprise of about 73% and 23%of the
total mesopore volume, respectively. The
larger pore region consists of inter-aggregate
pores and the smaller pore region is an
inverse pore structure of the silica meso-
pores. A more complete structural study of
the SnO2 spheres has been published ear-
lier.[18b] Electrokinetic titrations were con-ducted to shed some light on the differences in the surface
chemistry of the various metal oxides used in this study and the
results are presented in Figure 3. The isoelectric point (IEP),
defined as the point at which the electrokinetic potential (z-
potential) equals zero, is a measure of the acidity of the metal
oxide. The IEP values (listed in Table 1) determined for the
three oxides are 3.2 for SiO2, 4.1 for SnO2, and 5.0 for TiO2,
confirming the higher acidity of tin dioxide compared to
titanium dioxide as reported previously.[22]2.2. Optimizing a Phosphopeptide Enrichment Procedure
for SnO2 with Standard Peptides
The binding properties of tin dioxide as an affinity material
were unknown. Thus, as a first step it was necessary to set up an
enrichment protocol using a set of synthetic peptides with a
focus on the optimization of loading solvent conditions
(binding pH, organic solvent content, type of acid used) in
order to obtain a method for the chemoselective binding of
phosphopeptides in the presence of nonphosphorylated
peptides. Throughout the study, enrichment experiments were
performed in ‘‘batch-mode’’ by mixing the sample solutions
with the metal oxide spheres in microcentrifuge tubes (Fig. 4).
Unbound fractions were combined with the supernatants from
washing steps to constitute the ‘‘binding/washing’’ fraction.
Peptides bound to the material were eluted by a combination
of high pH (10.5, adjusted with NH4OH) and addition of
inorganic phosphate ((NH4)2HPO4) as a competitor for
phosphate binding sites. These elution conditions even allowed
the recovery of multiply phosphorylated peptides in high yield.
Liquid chromatographic separation in combination with
electrospray ionization mass spectrometry was then used asts together with the isoelectric points obtained from
Pore diameter [nm] IEP [pH]
10.7 3.2
5.0; 50.8 4.1
32.1 5.0
Weinheim www.afm-journal.de 2383
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Figure 3. Electrokinetic titration curves for the starting SiO2 spheres (squares), the SnO2 replica
spheres (circles), and for the Sachtopore TiO2 spheres (triangles). The metal oxide spheres were
titrated from their native pH to a pH value around 2.
Figure 4. Workflow of the phosphopeptide enrichment protocol. Model peptides or protein digests
were applied to the oxide materials in loading buffer, mixed for 30min, washed twice with the same
solvent and supernatants of the binding and washing steps were pooled. Bound phosphopeptides
were eluted twice with elution buffer, and supernatant fractions were again pooled. Final analysis of
the collected fractions was performed by LC-MS or -MS/MS as described in the Experimental Section.
Table 2. Amino acid sequences (in one-letter code) of the synthetic
phospho- and nonphosphopeptides used in this study. Phosphorylated
serine (pS), threonine (pT) and tyrosine (pY) residues are highlighted in
bold.
Abbreviation Sequence Mr
PP1 NpSVEQGRRL 1137.5
PP2 SVENLPEAGIpTHEQR 1758.8
PP3 LIEDNEpYTAR 1302.5
PP4 QLGEPEKpSQDSSPVLpSELK 2230.0
PP5 QLGEPEKpSQDpSSPVLpSELK 2310.0
PP6 KFLpSLASNPELLNLPSpSVIK 2329.2
NPP1 RPPGFS (internal standard) 659.6
NPP2 WAGGDASGE 848.8
NPP3 RNIAEIIKDI 1184.4
NPP4 PTHIKWGD 953.1
NPP5 EGVNDNEEGFFSAR 1569.7
2384an analysis platform to allow the sensitive and specific
detection of the peptides.
2.2.1. Influence of pH and Content of Organic Solvent in the
Loading Buffer on Selectivity and Recovery
As a first step towards optimizing a protocol for phospho-
peptide enrichment with SnO2 we chose a ‘‘mild’’ loading
buffer composition to better allow the monitoring of possible
differences in binding properties of peptides to SnO2 and other
metal oxides. For this reason we used formic acid in different
concentrations.
Selected synthetic peptides (Table 2) were dissolved in
various solvents differing in their pH and content of organic
solvent (acetonitrile, ACN) and loaded onto the tin oxide
material. The results show a strong pH-dependency of the
binding properties of phosphopeptides to tin oxide, as already
an increase from 0.1% to 0.5% formic acid noticeably reduced
the binding of phosphopeptides to the metal oxide material.
The influence of content of organic solvent was found to be less
significant, but 50% acetonitrile showed the best compromise
in selectivity and phosphopeptide recovery. Therefore we
chose a solvent containing 50% ACN and 0.1% formic acid
(FA) for further experiments.www.afm-journal.de  2008 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimTo prove the competitiveness of the tin
oxide material compared to already
established metal oxide materials used
for phosphopeptide enrichment and for
the selection for a representative control
during optimization, we evaluated tita-
nium oxide and zirconium oxide in terms
of their binding properties for selected
phospho- and nonphosphopeptides (data
not shown). Titanium oxide achieved
better results than zirconia and was used
as a control to compare selectivity and
recovery rates for further experiments.
Synthetic peptides (Table 2) were
applied to tin oxide and titanium oxide
with the optimized solvent system and
the enrichment procedure was performed
as described in the Experimental section.
The nonphosphorylated peptides chosen
in this study deliberately represented
‘‘sticky’’ peptides with one or more acidic
residues that should exhibit particularly
strong nonspecific binding. Results
showed a reduced tendency of certain
very acidic nonphosphorylated peptides
to bind to tin oxide compared to titanium
oxide (the recovery rates of ‘‘acidic’’
unphosphorylated peptides in the elution
fraction were lower by up to 50%)
whereas the phosphopeptide recoveries
were slightly reduced (around 10% lower
compared to titania) in the case of tin
oxide. These results allow the assumptionthat titania possesses a higher affinity to Lewis bases (i.e., in
this case the phosphopeptides) than tin oxide, which might be
an advantage because of higher recovery rates achievable for
phosphopeptides, but also a disadvantage in the case of lower
selectivities in the presence of acidic peptides.Adv. Funct. Mater. 2008, 18, 2381–2389
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Figure 5. Recovery rates (relative to an unprocessed sample) of nonpho-
sphorylated (NPP) and phosphorylated (PP) peptides after the phospho-
peptide enrichment procedure with SnO2 and different loading buffer
compositions. ACN¼ acetonitrile, FA¼ formic acid, TFA¼ trifluoroacetic
acid.
Figure 6. Recovery rates (relative to an unprocessed sample) of selected
peptides after phosphopeptide enrichment using optimized procedures for
SnO2 and TiO2. ACN¼ acetonitrile, TFA¼ trifluoroacetic acid, LA¼ lactic
acid.Nonetheless, we observed that a complete removal of
nonphosphorylated peptides in the elution fraction was not
attainable with this simple experimental setup for both stannia
and titania. Thus, the selectivity achieved in this first
optimization step may not be adequate for more complex
samples such as protein digests or cell extracts. The problem
could be that the high abundance of nonphosphorylated
peptides in such samples will prevent binding of phosphory-
lated peptides if the selectivity of the enrichment material is
not good enough. Several groups have reported the effective-
ness of hydroxy acids to reduce unspecific binding of acidic
peptides to titanium oxide. In our study, we tested some a-
hydroxy acids (lactic acid, tartaric acid, malic acid in a
concentration of 300mgml1; according to Ref. [17a]) and 2,5-
dihydroxybenzoic acid (300mgml1; Ref. [5c]) for both tin
oxide and titanium oxide. Both protocols were previously
optimized for a different TiO2 material and reevaluation for
the present titania spheres was necessary. The best selectivity
and phosphopeptide recovery were obtained by titania with
0.1% trifluoroacetic acid (TFA) and 300mgml1 of lactic acid
(LA), in line with data reported by Sugiyama et al.,[17a] while
for the SnO2material the use of hydroxy acids was not found to
further improve specificity.
2.2.2. Influence of pH and Type of Acid in the Solvent for
Binding Properties of Enrichment Materials
Despite favorable binding of phosphopeptides to SnO2 even
at relatively high pH, the lack of specificity led us to investigate
the influence of the acidity of the loading solvent in more
detail. It was expected that working at a lower pH would
improve the discrimination between phosphopeptides and
unphosphorylated, acidic peptides when the pH is lower than
the pKa of the carboxyl groups (4). Thus, in accordance with
results previously observed for other oxides, carboxylic acids
should be present in protonated form to a large degree and not
compete with phosphopeptides for binding.
In the next experiment we therefore compared the
selectivity achieved by the use of different acids in varying
concentrations for the tin oxide material. Figure 5 shows the
recovery rates of unphosphorylated (NPP2-NPP5) and phos-
phorylated peptides (PP1-PP4, see Table 2) in the elution
fraction after enrichment using tin oxide and different
compositions of the loading solution. Solvents used were
50% ACN with 0.05% TFA, 0.1% TFA or 0.1% FA. It is
evident that there is no sufficient selectivity achievable for a
satisfactory phosphopeptide enrichment with formic acid,
particularly for complex samples where the excess of acidic
peptides is much higher than in this case: up to 80% of the
unphosphorylated controls were retained under these condi-
tions. The lowest recovery rates for nonphosphopeptides in the
elution fraction (i.e., less than 3% of nonspecific binding) were
obtained with 0.1% TFA. Considering the fact that in complex
samples the excess of acidic peptides will be much higher than
in this experiment, we decided to use 0.1% TFA in the loading
solution instead of 0.05% TFA for further experiments,
although higher phosphopeptide recovery rates would beAdv. Funct. Mater. 2008, 18, 2381–2389  2008 WILEY-VCH Verlfeasible with 0.05% TFA. In the following, we compared our
protocol for SnO2 to an optimized protocol for titania, as
reported previously by Sugiyama et al.[17a] The percentage of
peptides recovered in the elution fraction of peptides (relative
to an unprocessed sample) was determined for three different
experimental set-ups: SnO2 and 0.1% TFA as additive in the
loading solvent; TiO2 with 0.1% TFA, or 0.1% TFA and
300mgml1 LA as solvent. The results (shown in Fig. 6) reveal
that the recovery rates of nonphosphopeptides are comparably
low for SnO2 and TiO2 with lactic acid – indicating a sufficient
reduction in nonspecific binding – while in the case of TiO2
with TFA alone the selectivity was not satisfactory (e.g., 65%
nonspecific binding for NPP5). The comparable performance
of SnO2 using TFA alone with an optimized TiO2 method
demonstrates that the optimized protocol for SnO2 is able toag GmbH & Co. KGaA, Weinheim www.afm-journal.de 2385
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Table 3. Peptides and proteins identified from a tryptic digest of a-casein and fetuin with phosphopeptide enrichment using either SnO2 or TiO2, analysis by
nanoLC-MS/MS and subsequent database search using Mascot. Shown are the numbers of identifications from six repeat analyses.
Protein Peptide Identified by SnO2 enrichment[a] Identified by TiO2 enrichment[b]
aS1-casein YKVPQLEIVPNpSAEER 6 of 6 runs 6 of 6 runs
VPQLEIVPNpSAEER 5/6 5/6
HIQKEDVPSER 2/6 2/6
aS2-casein TVDMEpSTEVFTKK 4/6 4/6
NMAINPpSKENLCSTFCK 1/6 1/6
Fetuin HTFSGVASVEpSSSGEAFLIVGK 2/6 2/6
[a] Using 50% ACN/0.1% TFA as loading buffer. [b] Using 50% ACN/0.1% TFAþ 300mgml1 lactic acid as loading buffer.
2386compete with other established enrichment materials and
protocols, at least for model peptides. As a next step it was
necessary to prove whether our material and protocol was
applicable to more complex samples such as protein digests.2.3. Tryptic Protein Digests
a-casein and fetuin represent highly phosphorylated pro-
teins and are therefore often used as model proteins for
phosphopeptide enrichment studies. We analyzed a tryptic
digest of a mixture of a-casein (containing both aS1- and aS2-
forms) and fetuin after a phosphopeptide enrichment step
using the two optimized protocols for SnO2 (50% ACN and
0.1% TFA as loading buffer) and TiO2 (50% ACN/0.1%
TFAþ 300mgml1 LA), respectively. The elution fractions
recovered from the materials were analyzed by nanoflow LC-
MS/MS as described in detail in the Experimental section.
For evaluation of the results, we decided to rely on the
qualitative interpretation of database search results using the
Mascot search engine, as this reflects a typical ‘‘discovery-
mode’’ type of phosphopeptide profiling. Quantitative strate-
gies in complex samples need to rely on stable isotope labeling
or related approaches,[23] as (relative) quantitation based on
extracted ion chromatograms exclusively cannot be expected
to yield reliable results when comparing samples differing
enormously in their complexity such as a whole protein digest
and a phosphopeptide-enriched sample in the present case.Table 4. Peptides and proteins identified from a tryptic digest of the ten protein
nanoLC-MS/MS and subsequent database search using Mascot. Shown are
Protein[a] Peptide
Ovalbumin, chicken EVVGpSAEAGVDAASVSEER
ISQAVHAAHAEINEAGR
a1-acid glycoprotein 1, human EQLGEFYEALDCLR
Carbonic anhydrase, bovine AVVQDPALKPLALVYGEATSR
b-lactoglobulin, bovine TPEVDDEALEK
TPEVDDEALEKFDK
VYVEELKPTGDLEILLQK
Lactotransferrin, bovine LCALCAGDDQGLDK
Lysozyme C, chicken FESNFNTQATNR
NTDGSTDYGILQINSR
[a] No peptides were identified from the following proteins: bovine k-casein, a-
0.1% TFA as loading buffer. [c] Using 50% ACN/0.1% TFAþ 300mgml1 la
www.afm-journal.de  2008 WILEY-VCH Verlag GmbHAs Table 3 shows, the data obtained from the two materials
were highly comparable. One phosphorylation site from aS1-
casein was identified in all analyses (three parallel enrichment
procedures, two nanoLC-MS/MS runs per sample), in most
cases with two peptides, one of which contained a missed
cleavage site. A phosphopeptide from aS2-casein was identified
in four out of six runs, while a second phosphopeptide from this
casein variant and a phosphopeptide from fetuin were only
infrequently detected. This may be due to several reasons such
as low phosphorylation stoichiometry, poor spectral quality or
lower recovery from the enrichment procedure. For both the
stannia and the titania material, only one peptide (from aS1-
casein) was found to bind nonspecifically under the conditions
employed, and this peptide was identified in less than half of
the analyses. While a tryptic digest of these phosphoproteins is
expected to produce more than the phosphopeptides identified
here, the reason for the inability of identifying further
phosphopeptides may be the generally unfavorable fragmen-
tation properties, the reliance on identification by MS/MS, not
MS alone (thus requiring good spectral quality), and the low
ionization efficiency of these peptides.
After these encouraging results, a tryptic digest of a ten
protein mix was analyzed by nano-LC-MS/MS after phospho-
peptide enrichment by both SnO2 and TiO2. Ovalbumin
represented the only phosphorylated protein in the sample
(containing two annotated phosphorylation sites) and ideally
should be the only protein identifiable after the enrichment
step. The results for this sample are shown in Table 4. With themix with phosphopeptide enrichment using either SnO2 or TiO2, analysis by
the numbers of identifications from four repeat analyses.
Identified by SnO2 enrichment[b] Identified by TiO2 enrichment[c]
4 of 4 runs 2 of 4 runs
0/4 2/4
1/4 0/4
0/4 3/4
4/4 0/4
4/4 0/4
2/4 0/4
1/4 0/4
4/4 0/4
4/4 0/4
lactalbumin, equine myoglobin and human transferrin. [b] Using 50% ACN/
ctic acid as loading buffer.
& Co. KGaA, Weinheim Adv. Funct. Mater. 2008, 18, 2381–2389
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Figure 7. a) and b) Total ion chromatogram of a nanoLC-MS/MS run of the tryptic digest of the ten
protein mix (a) before and (b) after an enrichment step using SnO2 microspheres and 50% acetonitrile/
0.1% trifluoroacetic acid as loading buffer. c) shows the annotated MS/MS spectrum of the phospho-
peptide identified from ovalbumin (EVVGpSAEAGVDAASVSEEFR). Peptide identification was carried
out by Mascot as described in the Experimental section.optimized SnO2 protocol it was possible to identify ovalbumin
via one of its phosphopeptides in every single LC-MS/MS
analysis of duplicate runs from two separately processed
samples. As an example, Figure 7a and b depicts the MS2 total
ion chromatograms of a nanoLC-MS/MS analysis of the ten
protein mix before and after phosphopeptide enrichment with
stannia. It is apparent that a significant reduction of matrix
complexity was achieved, as the intensity of the most abundant
peak is reduced by a factor of 25 (note that an extended
gradient for the unprocessed sample was used to allow a more
accurate comparison of the results). The annotated MS/MS
spectrum of the phosphopeptide EVVGpSAEAGVDAASV-
SEEFR after the respective enrichment step is shown in
Figure 7c.
In the case of stannia, four other proteins (b-lactoglobulin
and lysozyme C in all four analyses, lactotransferrin and a1-
acid glycoprotein 1 in one analysis) were also identified with up
to two nonphosphopeptides. For enrichment with titania the
selectivity appeared to be better, because only in three cases
one unphosphorylated protein (carbonic anhydrase 2) wasAdv. Funct. Mater. 2008, 18, 2381–2389  2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheidentified. However, the identification
of ovalbumin via its phosphopeptides
succeeded in only two of four attempts,
indicating that the use of lactic acid as a
displacer in the loading solvent for the
titania material also causes significant
losses of phosphopeptides during load-
ing and washing. To demonstrate the
degree of enrichment, we analyzed the
ten protein digest also without an
enrichment step. In this experiment
all ten proteins could be identified, and
in the case of ovalbumin, no phospho-
peptides but eight unphosphorylated
peptides containing up to five acidic
amino acid residues per peptide were
identified, whereas in the enriched
sample only the phosphopeptide could
be identified. This is a further indicator
for the specificity of the phosphopep-
tide enrichment step using SnO2micro-
spheres.
By using the simple argumentation
that the total surface area of the
employed spheres in the enrichment
experiments is enormous compared to
what is needed to completely adsorb
the phosphopeptides (about 1 million
times larger), we conclude that the
surface area of the spheres is not the
decisive factor for the good perfor-
mance observed for the SnO2 material.
Furthermore, since we also have smal-
ler pores in the SnO2 replica spheres
compared to the commercial TiO2, it is
more likely that this is limiting ratherthan promoting the accessibility of the SnO2 surface to some
degree, because larger peptides entering the 5 nm pores is not
favored. Therefore, we can presume that the variations in the
phosphopeptide enrichment behavior observed between the
studied materials are mainly consequences of the surface
chemistry rather than the morphology.3. Conclusions
We have shown that porous tin oxide microspheres
represent a valuable new material for phosphopeptide
enrichment purposes. Using an optimized protocol, compar-
able selectivity to titania was achievable, with the advantage
that no solvent additives in high concentrations are necessary
to gain sufficient selectivity. This minimizes the risk of
problems with nanoscale HPLC columns and/or nanoelec-
trospray in the downstream analysis and should lead to a more
robust analytical platform for phosphoproteomic studies. Theim www.afm-journal.de 2387
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2388microspheres can be manufactured using readily available
starting materials, and their properties (thermal, physical, and
chemical stability) make them an interesting alternative to
presently used material. Further studies are currently ongoing
to test the performance of the SnO2 replicas on more complex
biological samples. Moreover, the flexibility of their prepara-
tion will allow the in-depth study of factors influencing the
phosphate group affinity that will help in the design of
improved metal oxide affinity materials.4. Experimental
Metal Oxide Materials: Porous tin oxide microspheres were
prepared according to the protocol of Sma˚tt et al. [18b], starting from
Daisogel silica particles (Daiso Co. Ltd., Osaka, Japan) with a particle
size of 10mm and 120 A˚ pore size. Briefly, the silica spheres were
impregnated with an excess amount of an aqueous SnCl2 solution
(1.8 gmL1, Riedel-de Hae¨n, Seelze, Germany). After an impregna-
tion time of 1 h, centrifugation was used to remove the excess precursor
solution. The samples were then directly heated at 150 8C (3 h) to
remove the solvent and further heated up to 250 8C (3h) and 550 8C
(5h) in order to decompose the precursor salt to SnO2. In a final step,
the silica portion was removed by leaching 2 times in aqueous NaOH
(2M) at 90 8C, and the obtained spheres were dried in vacuo. Prior to
use, the SnO2 material was treated with aqueous HCl (0.1 M) for 24 h
under reflux for activation, followed by drying in vacuo. Titania
(Sachtopore NP titanium dioxide, particle size 10mm/pore size 300 A˚)
and zirconia (ZirChrom-PHASE zirconium dioxide, particle size
10mm/pore size 300 A˚) were obtained from ZirChrom Separations,
Inc. (Anoka, MN, USA) and used as received.
Characterization of the SnO2 and Reference Spheres: The sphere
morphology was studied using SEM (Jeol JSM-6335F, Jeol Ltd.,
Japan). The surface area, mesopore dimensions and the mesopore
volumes were determined by nitrogen physisorption measurements at
77K (ASAP 2010, Micromeritics Co., Norcross, GA). The total
mesopore volume was taken at 0.98P/P0 and the BJH model
(desorption branch) was used for pore size calculations. Electrokinetic
titrations to obtain the IEP were performed on a Malvern ZetaSizer
Nano-ZS (Malvern Instruments Ltd.,Malvern, UK) coupled to aMPT-
2 titrator unit. The zeta potential was measured as a function of pH by
titrating with aqueous HCl (0.1M) at 25 8C. The data was monitored
and analyzed using the Malvern Dispersion Technology software v.
4.20.
Peptides and Proteins: Synthetic unphosphorylated peptides were
obtained from Bachem (Weil am Rhein, Germany), while phospho-
peptides were prepared by standard Fmoc solid phase chemistry and
kindly provided by K. Mechtler from the Institute of Molecular
Pathology (IMP, Vienna, Austria). All peptides used in the study are
listed in Table 1. Model proteins used in our experiments were
obtained from Sigma–Aldrich (Deisenhofen, Germany).
Tryptic digest of standard phosphoproteins: A total of onemilligram
of the respective proteins was dissolved in aqueous urea solution (8M).
Disulfide bonds were reduced using dithiothreitol (10mM, 55 8C,
60min) followed by alkylation of free thiol groups with iodoacetamide
(50mM, room temperature, 90min) according to standard procedures.
Samples were diluted 1 to 10 with aqueous NH4HCO3 (50mm), and
trypsin (proteomics grade, Sigma) was added at an enzyme-to-
substrate ratio of approximately 1:25. Samples were digested overnight
at 37 8C and purified by solid-phase extraction (C18 material) prior to
evaporation under a stream of nitrogen.
Enrichment of Phosphopeptides: In brief, the workflow is shown in
Figure 4. Different phosphorylated and nonphosphorylated peptides
(see Table 1) were used in a quantity of 300 ng (amounting to approx.www.afm-journal.de  2008 WILEY-VCH Verlag GmbH200 fmol) per peptide per sample for an enrichment experiment. In the
case of tryptic digests, 20mg of starting material for the digest of casein
and fetuin and 50mg for the ten protein digest were applied.
Approximately 4mg of oxide material (SnO2, TiO2, or ZrO2) was
weighed in 1.5 ml microcentrifuge tubes and equilibrated for 10min
with 100ml of the respective solvent (as noted in the Results and
Discussion section) prior to loading of the samples. After equilibration
the suspension was centrifuged and the supernatant was discarded.
Peptide samples diluted in loading solvent (100mL) were applied to the
oxide material and incubated for 30min, and after centrifugation and
removal of the supernatant the materials were washed twice for
10 minutes with loading buffer (100mL). When hydroxy acids were
used as additives the hydroxy acid was omitted in the second washing
step to avoid carry-over into the elution fraction. The supernatants of
the binding and two washing steps were pooled and stored for later MS
analysis. For elution of bound phosphopeptides, the material was
incubated twice with elution buffer (100mL of 50mM of (NH4)2HPO4
adjusted to pH 10.5 with NH4OH) for 10min and supernatants were
again pooled for analysis. All steps (equilibration, binding, washing,
eluting) were carried out on an IKA MS3 digital minishaker (IKA,
Staufen, Germany) to keep the metal oxides in suspension during the
procedure.
Pooled samples were dried in a nitrogen stream and redissolved in
water/acetonitrile/formic acid (95:5:0.5, v/v/v) prior to LC-MS analysis as
described below. All enrichment experiments were performed at least in
duplicate, and all collected fractions were analyzed twice by LC-MS.
LC-MS System: For the analysis and quantification of the standard
peptides after the enrichment procedure we used an Agilent 1200
HPLC system coupled with an Applied Biosystems 4000 Q TRAP
(triple quadrupole linear ion trap hybrid) mass spectrometer equipped
with a Turbo V electrospray ion source (Applied Biosystems, Foster
City, CA, USA). For gradient LC separation a Thermo BetaBasic-18
reversed phase column (150 2.1mm; particle size 3mm; Thermo
Scientific, Runcorn, UK) was used with a flow rate of 200mLmin1.
The mobile phases consisted of (A) 0.1% formic acid in water and (B)
0.1% formic acid in acetonitrile. A gradient elution, starting with 5% to
50% B in 30min, followed by 50% to 80% B in 5min, 80% B for 5min
and reequilibration of the column with 5% of solvent B for 10 minutes
was employed for reversed phase separation of the peptides. The mass
spectrometer was operated in positive enhancedMS scan (EMS) mode
where the third quadrupole is operated as a linear ion trap. The m/z-
rangewas set from 300 to 2000 with a scan rate of 4000 per second.Data
acquisition and analysis was performed with Analyst software, version
1.4.2 (Applied Biosystems).
For peptide quantification, an internal standard (300 ng of
bradykinin fragment 1–6, Table 1) was added to the sample after
the phosphopeptide enrichment procedure to correct for signal
variabilities. The recovery rates were calculated as a quotient of the
corrected peptide signal of the peptide in the elution fraction and the
corrected peptide signal of the corresponding peptide in an untreated
sample (100%, no enrichment).
Nanoflow LC-MS/MS System: Protein digests were analyzed using
an Agilent Nanoflow Proteomics Solution in data-dependent MS/MS
mode essentially as described previously [24]. An Agilent Zorbax 300
SB-C18 column (50mm 75mm i.d.) was used for all samples with the
exception of the unprocessed 10 protein mix, which was analyzed on a
150mm column to avoid undersampling due to the higher sample
complexity. Peak lists generated by the instrument software (LC/MSD
Trap software 4.2, BrukerDaltonik, Bremen, Germany) were exported
in Mascot-MGF format and searched against the UniProtKB/
SwissProt database (release 47.5, dated 19/07/05, 186882 entries) using
an in-house Mascot server running version 2.0.5 (Matrix Science Ltd.,
London, UK). Search parameters were set as follows: Taxono-
my¼ chordata (vertebrates and relatives), enzyme¼ trypsin, fixed
modifications¼ carbamidomethylation on Cys, variable modifica-
tions¼ phosphorylation on serine or threonine, peptide toleran-
ce¼1.5Da, MS/MS tolerance¼0.8Da, peptide charge¼ 2þ/3þ,
instrument¼ESI trap. Peptides were considered identified if they were& Co. KGaA, Weinheim Adv. Funct. Mater. 2008, 18, 2381–2389
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level contaminants) and the ions score reported by Mascot was at least
20.
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a b s t r a c t
Phosphopeptide enrichment based on metal oxide afﬁnity chromatography is one of the most pow-
erful tools for studying protein phosphorylation on a large scale. To complement existing metal oxide
sorbents, we have recently introduced tin dioxide as a promising alternative. The preparation of SnO2
microspheres by the nanocasting technique, using silica of different morphology as a template, offers a
strategy to prepare materials that vary in their particle size and their porosity. Here, we demonstrate howeywords:
hosphorylation
hosphopeptide enrichment
etal oxide afﬁnity chromatography
in dioxide
ass spectrometry
such stannia materials can be successfully generated and their properties ﬁne-tuned in order to obtain an
optimized phosphopeptide enrichment material. We combined data from liquid chromatography–mass
spectrometry experiments and physicochemical characterization, including nitrogen physisorption and
energy-dispersive X-ray spectroscopy (EDX), to explain the inﬂuence of the various experimental param-
eters.
© 2009 Elsevier B.V. All rights reserved.
anocasting
. Introduction
The central role of protein phosphorylation in biological sig-
aling processes has been the driving force for the development
nd advancement of methods for the characterization of this post-
ranslational modiﬁcation in biological samples. Recent years have
hown a notable increase in the number of analytical tools avail-
ble to study phosphorylation events on a large scale [1–5]. These
ethods for “phosphoproteomics” have complemented previously
vailable tools such as phosphospeciﬁc antibodies and immobi-
ized metal afﬁnity chromatography (IMAC) and include methods
ased on metal oxide afﬁnity chromatography (MOAC, see below),
on exchange chromatography [6–9] as well as methods involving
hemical modiﬁcation reactions [10,11].
MOAC has arguably been the most widely adopted strategy in
ecent years and has yielded very promising results. While the
fﬁnity of inorganic phosphates to oxides such as titanium diox-
des had been demonstrated earlier [12], TiO2 was introduced for
he purpose of phosphopeptide enrichment only in the begin-
∗ Corresponding author. Current address: Institute of Molecular Systems Biology,
TH Zurich, Wolfgang-Pauli-Strasse 16, 8093 Zurich, Switzerland.
ax: +41 44 633 26 98.
E-mail address: alexander.leitner@univie.ac.at (A. Leitner).
003-2670/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
oi:10.1016/j.aca.2009.01.063ning of this decade [13–15]. This was followed by reports that
other oxides are suitable for the same purpose as well, includ-
ing zirconium [16], aluminum [17], gallium [18], cerium [19], tin
[20] and niobium [21] oxides. Titania is currently the most widely
used oxide material and has been applied in a number of large
scale studies, allowing the identiﬁcation of up to thousands of
phosphorylation sites in complex biological samples. For exam-
ple, Mann and co-workers used two-dimensional phosphopeptide
enrichment based on strong cation exchange and titanium dioxide
fractionation to study signaling dynamics in HeLa cells upon epi-
dermal growth factor stimulation, identifying approximately 6600
phosphorylation sites in the study [22]. The use of two comple-
mentary fragmentation techniques, collision-induced dissociation
and electron transfer dissociation, in combination with TiO2-based
MOAC allowed the identiﬁcation of nearly 1500 phosphorylation
sites in human embryonic kidney 293T cells [23], as shown by
Molina et al. and Heck and co-workers developed a titania-based
on-line enrichment strategy and proﬁled 2152 phosphopeptides
from Drosophila melanogaster cell lysate [24]. Using both TiO2 and
ZrO2 material, and IMAC as complementary methods for enrich-
ment, Sugiyama et al. characterized 2172 phosphorylation sites in
Arabidopsis [25].
Despite the successful implementation of MOAC, it is evident
that there is little detailed knowledge available on the intricacies
of the binding mechanism of phosphopeptides to metal oxides.
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undamental studies carried out on small model compounds may
ot adequately reﬂect the binding behavior of polyfunctional
iomolecules. It iswell known that unphosphorylated peptides car-
ying acidic residues also bind to metal oxides to some degree,
nd this binding may be reduced by the addition of different addi-
ives/displacers in the solution used during the binding step (see
elow). While nonspeciﬁc binding of acidic peptides has been
ttributed to a bidendate binding of their carboxylic groups on
he surface of the metal oxide, this model does not offer a full
xplanation for the observed interactions. Presently, a more sys-
ematic study of the inﬂuence of different material properties of
OAC sorbents is limited by the availability of the respective mate-
ials, although there are different parameters that are expected to
ontribute to the enrichment process. For example, pore size dis-
ribution and total surface area of the particles will inﬂuence the
apacity of the material. Also, different MOAC materials may not
lways be chemically homogeneous as is evident from differences
n performance of titania materials from different manufacturers
26] or with different crystallinity [27].
Recently, we have evaluated porous tin dioxide (SnO2, stannia)
s an alternativematerial for phosphopeptide enrichment byMOAC
20]. We could not only demonstrate that stannia gives comparable
r even superior results than titaniawhenusedunder the samecon-
itions, but the material is also produced by a strategy that allows
onsiderable ﬂexibility inmaterial design. The so-called “nanocast-
ng” process [28,29] uses porous silica spheres as a template for the
eneration ofmetal oxide replicas in the pores of the silicamaterial.
hus, it offers a straightforward preparation of metal oxide spheres
f different particle size and type of porosity. Here, we take advan-
age of the ﬂexibility of the nanocasting process to prepare different
tannia materials and study the factors affecting the performance
f this novel phosphopeptide afﬁnity material.
. Experimental
.1. Preparation of porous tin dioxide microspheres by
anocasting
SnO2 materials were prepared according to the nanocasting
ethod described previously [30] from different silica templates.
hese included SiO2 spheres with different particle sizes (5, 10,
0m) and porosities (120, 200, 300, 1000Å nominal pore size).
ypically, the nanocasting process involves impregnation of the
orous silica spheres with SnCl2 solution, followed by decomposi-
ion of the salt to SnO2 by heat treatments in air, and ﬁnally removal
f the silica portion by leaching in either HF or NaOH solutions. An
verview of the different materials prepared and evaluated in this
tudy is given in Table 1.
able 1
verview of the materials used in this study.
ample code Starting material Number
impregn
nO2 120-5-1-NaOH Daisogel 5m, 120Å average pore size
(Daiso Co. Ltd., Osaka, Japan)
1
nO2 120-10-1-HF Daiso 10m, 120Å average pore size 1
nO2 120-10-1-HF HCl-treated Daiso 10m, 120Å average pore size 1
nO2 120-10-1-NaOH Daiso 10m, 120Å average pore size 1
nO2 120-10-1-NaOH HCl-treated Daiso 10m, 120Å average pore size 1
nO2 120-10-2-NaOH Daiso 10m, 120Å average pore size 2
nO2 120-10-3-NaOH Daiso 10m, 120Å average pore size 3
nO2 120-20-1-NaOH Daiso 20m, 120Å average pore size 1
nO2 200-5-2-NaOH Daiso 5m, 200Å average pore size 2
nO2 300-10-2-NaOH Kromasil 10m, 300Å average pore
size (Eka Chemicals, Bohus, Sweden)
2
nO2 1000-10-2-NaOH Daiso 10m, 1000Å average pore size 2ca Acta 638 (2009) 51–57
For hydrochloric acid activation, larger amounts (>500mg) of
tin dioxide materials were suspended in 0.1M aqueous HCl and
reﬂuxedovernight (approximately 16h)with overhead stirring. The
spheres were collected by ﬁltration, thoroughly washed with water
and dried in vacuo for up to two days at 60 ◦C. Alternatively, smaller
batches of material (∼100mg) were weighed in 1.5mL microcen-
trifuge tubes (Eppendorf Safe-Lock), 1.5mL 0.1M aqueous HCl was
added and the tightly sealed tubes were placed in an Eppendorf
Thermomixer set to 95 ◦C. After overnight shaking at 1400 rpm,
samples were thoroughly washed and dried as above.
2.2. Commercially available porous metal oxides
For comparison purposes, the followingmaterialswere used: GL
Sciences Titansphere TiO2 (10m particle size, 80Å nominal pore
size; MZ Analysentechnik, Mainz, Germany), Sachtopore NP TiO2
(10m/300Å; ZirChrom, Anoka, MN, USA) and ZirChrom-PHASE
ZrO2 (10m/300Å; ZirChrom).
2.3. Physicochemical characterization
The size and the morphology of the tin dioxide spheres were
studied using scanning electron microscopy (SEM) with a Jeol
JSM-6335F (Jeol Ltd., Tokyo, Japan)andprior to theanalysis the sam-
ples were sputtered with platinum. The surface areas, mesopore
dimensions and mesopore volumes were determined by nitrogen
physisorptionmeasurements at 77K (ASAP2010,Micromeritics Co.,
Norcross, GA, USA). The total mesopore volume was acquired at
0.98 P/P0, while the BJH model based on the desorption branch
was used in the pore size calculations. For the elemental analysis,
both a Link Inca 300 (Oxford Instruments, Abingdon, UK) energy-
dispersive X-ray spectroscopy (EDX) instrument and a Quantum
2000 (Physical Electronics, Chanhassen,MN, USA) X-ray photoelec-
tron spectroscopy (XPS) instrumentwere used. TheXPS instrument
was equipped with a monochromatic AlK X-ray source and oper-
ated at 25W with a spot diameter of 100m.
2.4. Phosphopeptide enrichment by metal oxide afﬁnity
chromatography
The enrichment procedure was performed essentially as
described previously [20]. Peptide mixtures (1g per peptide, see
Table 2) were dissolved in 100L of 50% CH3CN, 0.1% TFA in water
and added to microcentrifuge tubes containing 4.5±0.2mg metal
oxidebeads that hadbeenprewashedwith200L of the same solu-
tion. After incubation for 30min on the thermomixer (1400 rpm,
room temperature), the beads were settled by centrifugation and
the supernatant was recovered. The beads were then washed twice
of
ation steps
Leaching agent Average pore size
of SnO2 replica (Å)
Surface area of SnO2
replica (m2 g−1)
NaOH 50; 520 55.9
HF 54; 540 53.4
HF, HCl-treated 52; 620 46.4
NaOH 49; 530 55.9
NaOH, HCl-treated 48; 580 48.7
NaOH 51; 490 52.8
NaOH 52; 540 50.4
NaOH 52; 400 62.1
NaOH 100; 500 44.7
NaOH 500 (monomodal) 40.3
NaOH 530 (monomodal) 18.3
A. Leitner et al. / Analytica Chimi
Table 2
Overview of the synthetic peptides used in this study, and their typical retention
times in HPLC. Phosphorylated amino acid residues are highlighted in bold.
Sequence Mr tR (min)
Mix 1
WAGGDASGE 848.3 16.4
RNIAEIIKDI 1183.7 27.0
PTHIKWGD 952.5 19.3
EGVNDNEEGFFSAR 1569.7 23.8
NpSVEQGRRL 1137.5 16.2
SVENLPEAGIpTHEQR 1758.8 20.3
LIEDNEpYTAR 1302.5 17.3
QLGEPEKpSQDSSPVLpSELK 2230.0 24.1
Mix 2
WWGSGPSGSGGSGGGK (P0) 1419.6 21.7
WWGSGPSGSGGpSGGGK (P1) 1499.6 22.4
WWGSGPSGpSGGpSGGGK (P2) 1579.5 22.9
WWGSGPpSGpSGGpSGGGK (P3) 1659.5 22.8
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see primary particle aggregates which give rise to the interaggre-
gate porosity observed at ∼500Å typical for all samples. Generally
the smallest mode of pores is not detectable by SEM. However, in
the case of sample SnO2 1000-10-2-NaOH, which was replicatedWWGpSGPpSGpSGGpSGGGK (P4) 1739.5 21.8
nternal standard
DRVYIHPF 1045.5 23.6
ith 100L of the same solvent and the supernatants combined
ith the ﬁrst solution. Elution was performed by incubating the
eads two times for 15min with 100L of a solution containing
0mM (NH4)2HPO4, adjusted to pH 10.5 by addition of ammo-
ia solution (25% in water). Again, the supernatants from the two
lution steps were combined. All experiments were performed in
riplicate.
All collected fractions (binding/washing and elution) were then
vaporated to dryness on a SpeedVac vacuum concentrator (Ther-
oFisher Scientiﬁc, Waltham, MA, USA) and stored at −20 ◦C prior
o LC–MS analysis.
.5. Liquid chromatography–mass spectrometry
Samples were reconstituted in 200L of an aqueous solution
ontaining 5gmL−1 angiotensin II (Bachem) as internal standard.
0L each of this solution was used for three separate LC–MS anal-
ses.
Peptides were separated on an Agilent 1200 HPLC system
Agilent Technologies, Waldbronn, Germany) equipped with a
hermo BetaBasic-18 column (150mm×2.1mm) at a ﬂow rate
f 200Lmin−1 at 25 ◦C. Gradient elution was performed using
olvent A=0.1% formic acid in water and solvent B=0.1% formic
cid in acetonitrile and the following gradient table: 0–5min, 5%B;
–35min, 5–50%B; 35–40min, 50–80%B, followed by reequilibra-
ion at 5%B.
The eluent from HPLC was introduced into the TurboV elec-
rospray ion source of an Applied Biosystems 4000 Q TRAP triple
uadrupole linear ion trap instrument (Applied Biosystems, Foster
ity, CA, USA). Detection was performed in enhanced MS (linear
on trap) scan mode using the following settings: Scan range, m/z
00–1700 (Mix 1) or 500–900 (Mix 2); scan speed, 4000amus−1;
ositive ionization, voltage 4000V; declustering potential, 50V.
.6. Data analysis
For quantitative analysis, extracted ion chromatograms were
btained for the one or two most abundant charge states of every
eptide using a ±0.5 m/z window. Peak heights were used for fur-
her evaluation, as they were found to provide more reliable results
han peak areas in preliminary experiments (data not shown).
aterial characteristics were compared based on two parameters
eﬁned as follows: Speciﬁcity =peak height in the elution frac-
ion divided by combined peak heights in the binding/washing
nd elution fractions (ideally 100% for phosphopeptides and 0% forca Acta 638 (2009) 51–57 53
unphosphorylated controls), and Recovery =peak height in elution
fraction divided by peak height of an unprocessed control. Statisti-
cal signiﬁcances between materials were determined by one-way
analysis of variance (ANOVA) performed using Microsoft Excel.
3. Results and discussion
3.1. Design of the study
While the general suitability of porous stannia microspheres for
phosphopeptide enrichment has been described previously [20],
the manufacturing process of this material allows to study in detail
the inﬂuence of different material properties on performance. For
this purpose, a set of SnO2 spheres were prepared that differed in
the particle and pore size of the starting material (silica), the num-
ber of impregnation steps, the process used for leaching out the
silica (using hydroﬂuoric acid versus sodium hydroxide) and the
use of an additional acid treatment step of the ﬁnal material. For
example, in the SEM images in Fig. 1(a) and (b), silica spheres with
mean sizes of 5m and 10m have been used as templates for the
preparation of differently sized SnO2 spheres. In the insets clear dif-
ferences in the interior structure of the replica spheres depending
on the starting silica materials can be observed. In Fig. 1(a), one canFig. 1. Examples of SEM images of nanocast tin dioxide materials prepared from
different silica materials: (a) Sample SnO2 200-5-2-NaOH prepared from 5m sized
silica spheres (pore size: 200Å) and (b) sample SnO2 1000-10-2-NaOH prepared
from10mspheres (pore size: 1000Å). Insets showdetails of the textural properties
of the interior of the replica spheres. Scale bar for the insets equals 200nm.
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rom silica spheres with a pore size of 1000Å, it can be observed
inset of Fig. 1(b)).
Regardless of the starting material used, all replicas were pre-
ared successfully; details about the materials used in the present
tudy can be found in Table 1. With the exception of materials pre-
ared from silica with higher porosities, average pore sizes and
urface areas are very similar.
For practical applications in phosphoproteomics, two proper-
ies play a major role for the end user of the afﬁnity material,
amely speciﬁcity and recovery. The discrimination between phos-
hopeptides and unphosphorylated, but frequently highly acidic
eptides carrying several aspartic or glutamic acid residues remains
challenge for different phosphopeptide enrichment strategies.
he problem of nonspeciﬁc binding has been well documented for
MAC-based protocols and has been addressed by methyl esteriﬁ-
ation of the carboxyl groups [31]. While the effects have not been
s dramatic in the case of metal oxide afﬁnity chromatography,
ome type of ion exchange or acid-base interaction mechanism
ppears to play a role also in this case, resulting in the bind-
ng of unphosphorylated peptides. To overcome this, a number of
olvent additives have been proposed in the literature to reduce
onspeciﬁc interactions, these include dihydroxybenzoic acid [15],
hthalic acid [11], aliphatic hydroxy acids such as lactic acid [32],
lutamic acid [33] or its ammonium salt [34]. Previously, we have
hown that tin dioxide appears to exhibit intrinsically less nonspe-
iﬁc binding than titanium dioxide [20] so that these additives are
ot required in the enrichment protocol for mixtures of moderate
omplexity.
The second important issue is the recovery of phosphopep-
ides from different afﬁnity materials. Previous studies have shown
hat an experimental bias may exist towards the enrichment of
olyphosphorylated peptides. Obviously, their interaction with the
orbent is much stronger and can lead to two scenarios: multiply
hosphorylated peptides may be over represented when washing
onditions are relatively harsh (or the binding to thematerial inher-
ntlyweak) so that a considerablenumberof singlyphosphorylated
eptides are removed along with nonspeciﬁc binders. On the other
and, when mild elution conditions are used for desorption, recov-
ry of multiply phosphorylated peptides may be compromised.
ifferent elution conditions from metal oxides have been used in
he literature, andwehaveobtained themost satisfying resultswith
combinationofhighpHand theadditionof inorganicphosphate to
aximize the yield of phosphopeptides. However, intrinsic mate-
ial properties may still limit the achievable recoveries for a given
aterial.
In order to systematically evaluate tin dioxide as an MOAC sor-
ent, we chose a set of synthetic peptides listed in Table 2. Most of
he work described herein was carried out using Mix 1 containing
our singly or doubly phosphorylated model peptides along with
our unphosphorylated controls. Additional experiments were per-
ormed on a set of peptides with identical amino acid sequence
hat differed only in the number of phosphorylation sites, ranging
rom zero to four (Mix 2). We have previously demonstrated that
he general enrichment procedure works well also in more com-
lex samples [20], so the composition of the two sample mixtures
s ideal for a focused study on material-related effects.
LC–MS analysis was optimized to achieve highly reproducible
esults in order to allow minor differences between the materials
o be observed. Thus, we favored the use of conventional HPLC col-
mn diameters (2mm I.D.) because of the increased robustness in
erms of signal stability. Additionally, the peptide amounts used
or the enrichment experiments, in the range of several hundred
mols, reduce the effects of any external factors such as adsorption
n surfaces that may be considerable for analyte amounts several
rders of magnitude lower [35,36]. Initial experiments using stan-
ard mixtures revealed that the chosen set-up including detectionca Acta 638 (2009) 51–57
in the linear ion trap mode of the Q TRAP instrument allowed us
to obtain relative standard deviations of peak heights in the range
of ∼1% which was also the case throughout the further study. To
ensure reliability of the data, three experimental replicates (indi-
vidual enrichment procedures) were performed for all materials,
and bound and unbound fractions were each analyzed in triplicate
by LC–MS.
Typical retention times for all peptides are given in Table 2.
Interestingly, the retention times of Mix 2 do not correspond to
the widespread assumption that retention time in reversed-phase
chromatography decreases with an increase in phosphorylation:
actually, the doubly phosphorylated form of the peptide is most
strongly retained, while the unphosphorylated and the quadruply
phosphorylated form showed the least retention for the chro-
matographic system chosen. The retention behavior is most likely
inﬂuenced by different factors such as the mobile phase system
used, the activity of residual silanol groups on the stationary
phase and the presence of interactions within the peptide chain
(intramolecular ionpairing) that affect the interactionof hydropho-
bic regions with the stationary phase.
3.2. Material properties inﬂuencing phosphopeptide enrichment
speciﬁcity
We have previously observed that when tin dioxide replicas
were prepared using different leaching agents (sodium hydroxide
versus hydroﬂuoric acid), their speciﬁcity differed somewhat, and
NaOH-leached SnO2 appeared to have higher speciﬁcity towards
phosphopeptides. Moreover, we observed that when the spheres
were reﬂuxed overnight in diluted hydrochloric acid, an additional
increase in performance was obtained, although the reason for this
was not clear. In the present, systematic study, we were able to
conﬁrm these results. For this purpose, tin dioxide replicas were
prepared from a single startingmaterial, 10msilica particleswith
a nominal pore size of 120Å, and part of the spheres was treated
with either NaOH or HF to remove the silica portion. Additionally,
part of the NaOH- and HF-leached spheres was treated with 0.1M
HCl, as described in the Section 2. All four materials were evaluated
using the previously established protocol, and selected results are
shown in Fig. 2. From these data, it is evident that the amount of
nonspeciﬁc binding of unphosphorylated peptides noticeably dif-
fers between the differently prepared spheres, and it was found to
be lowest for the NaOH- and HCl-treated spheres.
For example, EGVNDNEEGFFSAR (Glu1-ﬁbrinopeptide B), exhib-
ited the strongest binding among the unphosphorylated peptides,
which is due to thehighly acidic character of thepeptide (four acidic
residues, pI = 4.00). For SnO2 particles that were not treated by HCl,
37% and 14% of the total amount were bound to the afﬁnity mate-
rial under the conditions chosen for the HF- and the NaOH-leached
spheres, respectively. This bindingwas reduced to values of 15% and
9% for the HCl-treated samples, showing a dramatic improvement
in speciﬁcity. At the same time, the amount of singly phosphory-
lated peptides that bound to SnO2 was also noticeably reduced,
which we attribute to the fact that phosphopeptides are also par-
tially bound via nonspeciﬁc interactions.
Thus, leaching by sodium hydroxide and further “activation”
using HCl afforded a material with substantially reduced non-
speciﬁc binding, although at the cost of phosphopeptide recovery
in the elution fraction. This is particularly relevant for the weak-
est binding phosphopeptide, NpSVEQGRRL. We propose that for
this peptide, strong intermolecular ion pairing occurs between the
phosphorylated serine residue located near theN-terminus and the
twostronglybasic arginine residuesnear theC-terminus. This could
be conﬁrmed by covalent modiﬁcation of the arginines with mal-
ondialdehyde according to a procedure previously developed by us
[37,38]. The reduced basicity of the modiﬁed Arg residues resulted
A. Leitner et al. / Analytica Chimica Acta 638 (2009) 51–57 55
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n improved binding of the phosphopeptide to the metal oxide:
he amount of unbound peptide decreased from ∼57% to ∼31%,
eﬂecting the weaker intramolecular ion pair formation. While the
resenceof twoarginine residues in apeptide is not typical for com-
lex sampleswhere trypsin ismost commonly used as theprotease,
his observation demonstrates that intramolecular ionic interac-
ions can interfere with the binding process in particular cases.
The effect of preparation conditions on the material properties
as further studied by EDX and XPS to estimate the remaining
mount of silicon after the leaching steps, and nitrogen physisorp-
ion to reveal any effects on the porosity of the materials. EDX data
rommaterials that had been exposed toNaOH for different periods
f time (12–96h) showed that after approximately 24h, a constant
evel of remaining Si is obtained at ∼0.75 at%, while shorter contact
ith the strong base resulted in more residual silica. XPS results
ig. 3. Inﬂuence of additional HCl treatment on the physicochemical properties of 10
black): 60 cm3 g−1, NaOH−HCl (red): 40 cm3 g−1, HF+HCl (green): 20 cm3 g−1, HF−HCl (b
f the references to color in this ﬁgure legend, the reader is referred to the web version oftreated tin dioxide materials for enrichment. Leaching was performed either with
al peptides are given for (from top to bottom) NaOH+HCl (black), NaOH−HCl (red),
ences to color in this ﬁgure legend, the reader is referred to the web version of the
showthe same tendency. (Note that theNaOH leaching solutionwas
changed every 24h in order to not saturate the solution.) The con-
stant level suggests that the remainder is not easily accessible for
dissolution and may therefore also play a minor role in generating
unspeciﬁc interactions. Interestingly, HCl treatment increased the
apparent amount of Si as determined by EDX to ∼1%, although the
difference to the untreated spheres was not statistically signiﬁcant.
We propose that this is the result of a removal of SnO2 aggregates
that are only weakly attached to the rigid core of the particle. This
assumption is again corroborated by XPS values and by nitrogen
physisorption data that show a relative increase in larger pores
upon HCl treatment (Fig. 3). Like for the Si content, the changes in
porosity are not expected to be the predominant cause for changes
in speciﬁcity, as pore sizes and surface areas do not inﬂuence the
performance to a large degree, as will be shown below. Instead,
m tin dioxide particles: (a) nitrogen physisorption isotherms (offsets: NaOH+HCl
lue): nooffset); (b) the correspondingBJHpore sizedistributions. (For interpretation
the article.).
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t seems more likely that the acid treatment results in chemical
hanges to the tin dioxide surface that affect the afﬁnity properties
f the material.
Other factors that could possibly inﬂuence the speciﬁcity of
he material were also investigated. Subjecting the materials
o repeated impregnation steps affords particles with increased
obustness by continuously increasing the wall thickness of the
nO2 replicas. This doesnot lead to adramatic reduction inpore vol-
meor surface areas of thematerial, as shown inTable 1, and should
herefore only have a minor inﬂuence on speciﬁcity. Accordingly,
o signiﬁcant differences were found for materials that had been
mpregnated once, twice, or three times. The multiply impregnated
pheres could be better suited for high-pressure applications.
In contrast, notable differences were observed in some cases
hen SnO2 particles were prepared from silica templates with dif-
erent pore sizes. Silica sphereswith nominal porosities of 120, 200,
00 and 1000Å were used for nanocasting. Table 1 shows that the
nO2 replica prepared from the 200Å shows a bimodal pore size
istribution similar to the spheres obtained from 120Å templates,
lthough with larger mesopores in the range of 100Å (compare
lso the data shown in Fig. 3). In contrast, the bimodal distribution
hanges to a monomodal one when silica of larger pore size is used,
s the two modes of pores merge into one.
When the afﬁnity towards phosphopeptides was compared,
mall to medium pore size silica (120–300Å) afforded material
ith similar properties, despite the change in pore size. The replica
f the 1000Å silica spheres gave the worst performance, as less
han 40% of the two phosphopeptides NpSVEQGRRL and SVENL-
EAGIpTHEQR were recovered in the elution fraction. The poor
inding efﬁciency is related to the dramatic reduction in available
urface (less thanhalf than for the 200 and300Å replicas), resulting
n reduced binding capacity. Thus, while it is generally feasible to
enerate nanocast porous spheres from such a wide pore material,
t comes at the cost of loading capacity.
Similarly, preparation of stannia materials of different particle
ize is easily achieved by varying the particle size of the silica. In
his study, spheres with average diameters of 5, 10 and 20m were
ompared. This aspect is of particular relevance for set-ups where
he particles are packed in capillaries or columns, as the use of
arger particles results in lowerback-pressures.We found that 5 and
0m particles showed almost identical afﬁnities, while the speci-
city of 20m replica was lower, resulting in increased binding
ig. 4. Speciﬁcity (a) and recovery (b) values for phosphopeptide Mix 2 using different me
re given for (from top to bottom) SnO2 (black), Sachtopore TiO2 (red), Titansphere TiO2 (
olor in this ﬁgure legend, the reader is referred to the web version of the article.).ca Acta 638 (2009) 51–57
of both phosphopeptides and unphosphorylated controls. Whether
this is a result of the somewhat higher surface area compared to
the smaller particles (see Table 1), cannot be said with certainty.
In summary, the major inﬂuencing factors that were apparent
are the “chemistry-related” preparation conditions, which not only
appear to inﬂuence the porosity of the material to some degree, but
also the surface of the material. Unfortunately, more detailed infor-
mation on surface properties is not easily obtainable from methods
available to us.
3.3. Comparison of nanocast tin dioxide material with titania and
zirconia sorbents: inﬂuence of the number of phosphorylation sites
The stannia material with the best performance as determined
above, i.e. spheres leached with NaOH and further treated with
HCl, was compared to commercially available oxides in terms of
the binding behavior towards mono- and polyphosphorylated pep-
tides. 10m particles were chosen for all oxides, and the same
enrichment protocolwas used for allmaterials (without using addi-
tives), as nonspeciﬁc binding of unphosphorylated peptides was
irrelevant in this study. This was corroborated by the fact that ZrO2
was the only material that showed any noticeable binding of the
unphosphorylated form of the peptide (∼2%). This is in line with
ourprevious observations that ZrO2 showshighernonspeciﬁcbind-
ing.
In contrast, signiﬁcant differences were apparent for the dif-
ferently phosphorylated forms, as shown in Fig. 4. SnO2 and ZrO2
showed much higher recoveries of the singly phosphorylated pep-
tide than the two titania materials – above 75% for stannia and
zirconia compared to only 13 and 33% for Sachtopore and Titan-
sphere, respectively – and similar results were obtained for the
doubly phosphorylated form. In contrast, the best recovery values
for the triply and quadruply phosphorylated peptidewere obtained
using the Titansphere TiO2 and the ZrO2 material. Quantitative
binding on all materials (100% speciﬁcity) was obtained for the
peptides carrying two to four phosphate groups so that any losses
can directly be attributed to incomplete elution from the materials.
(No reductions in signal intensities were observed when peptide
solutions were incubated without afﬁnity material under binding
and elution conditions, respectively, so that a signiﬁcant inﬂuence
of peptide degradation or adsorptive loss during the enrichment
procedure can be ruled out.)
tal oxides for enrichment. Values for individual peptides (for sequences, see Table 2)
green) and ZrO2 (blue). For details, see text. (For interpretation of the references to
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Clearly, additional experiments on rather complex samples are
ecessary to compare in more detail the afﬁnities of the stannia
aterial to other metal oxides, and are presently being carried out
sing samples of biological interest. However, judging from this set
f data, it appears that SnO2 allows for a high recovery of singly
nd doubly phosphorylated forms of the same peptide, while still
iving acceptable values for higher phosphorylated forms (>30%).
ecoveries of multiply phosphorylated peptides may be improved
y a further optimization of elution conditions, for example using
eagents proposed recently by Kyono et al. [39].
. Conclusion
While different porous metal oxides are increasingly used for
hosphopeptide enrichment purposes, little is known about the
actors inﬂuencing their performance. Commonly, structural varia-
ions of the afﬁnity material are limited by commercial availability
r the ﬂexibility of the manufacturing process. Using the nanocast-
ng technique, we have shown that a wide range of tin dioxide
aterials may be prepared, and the process should be equally
daptable to other oxides such as TiO2 or ZrO2. Differently porous
articles were found to give comparable performance (with the
xception of replicas from 1000Å material), which may be rele-
ant to particular experimental set-ups such as packed beds for
n-line enrichment columns. Interestingly, acid or base treatment
uring the preparation of the spheres was found to have the most
igniﬁcant inﬂuence. While this was connected at least to some
xtent to a change in the pore size distribution of the material, the
ecisive changes seem to take place on the surface of the mate-
ial. Further investigations in this direction are therefore necessary.
inally, experimentswith peptides differing in the number of phos-
horylation sites revealed that phosphopeptide enrichment using
he stannia material allows for the adequate representation of both
ingly and multiply phosphorylated peptides, which is important
or the analysis of biological samples.
Preliminary data froman ongoing study on the analysis ofwhole
ell lysateshavealreadydemonstrated that tindioxideafﬁnity chro-
atography is also applicable to this type of sample, as several
undred phosphopeptides were tentatively identiﬁed from HeLa
ysate. Results from this study will be reported in due course.
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Metal oxide affinity chromatography (MOAC) has become
a prominent method to enrich phosphopeptides prior to
their analysis by liquid chromatography-mass spectrom-
etry. To overcome limitations in material design, we have
previously reported the use of nanocasting as a means to
generate metal oxide spheres with tailored properties.
Here, we report on the application of two oxides, tin
dioxide (stannia) and titanium dioxide (titania), for the
analysis of the HeLa phosphoproteome. In combination
with nanoflow LC-MS/MS analysis on a linear ion trap-
Fourier transform ion cyclotron resonance instrument, we
identified 619 phosphopeptides using the new stannia
material, and 896 phosphopeptides using titania pre-
pared in house. We also compared the newly developed
materials to commercial titania material using an estab-
lished enrichment protocol. Both titania materials yielded
a comparable total number of phosphopeptides, but the
overlap of the two data sets was less than one-third.
Although fewer peptides were identified using stannia, the
complementarity of SnO2-based MOAC could be shown
as more than 140 phosphopeptides were exclusively
identified by this material.
The biological significance of protein phosphorylation has
stimulated the development and refinement of countless analytical
tools for profiling the “phosphoproteome”.1-5 Difficulties in
studying protein phosphorylation on a large scale are well
documented and have been addressed by improvements on all
levels of the proteomic workflow. For mass spectrometry-based
proteomics, this begins with the optimization of extraction
procedures for biological material (e.g., the addition of phos-
phatase inhibitors6) to ensure that the phosphorylation state is
accurately represented in the sample that is analyzed and ends
with the use of highly sensitive, fast scanning mass spectrometers
that employ improved fragmentation techniques to maximize the
sequence information from phosphopeptides.7,8 In between, new
enrichment and fractionation strategies have been developed in
recent years to complement the established techniques of im-
mobilized metal affinity chromatography (IMAC) and immunoaf-
finity precipitation. Among those, metal oxide affinity chromatog-
raphy (MOAC) takes advantage of the particular affinity of metal
oxides such as titanium dioxide to phosphate groups.9 Various
materials have been proposed although the majority of studies
were carried out using TiO2 as affinity material.10-12 In addition,
zirconium dioxide12-14 and, more recently, niobium pentoxide15
have been used in large-scale studies. Frequently, it has been
reported that metal oxides vary in their affinity to different groups
of phosphopeptides, e.g., mono- and multiply phosphorylated
forms. Therefore, several groups have reported the use of two
metal oxides and/or different enrichment techniques (MOAC and
IMAC in parallel) to allow for a more comprehensive representa-
tion of the phosphoproteome.16,17
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One obstacle in further improving MOAC as an enrichment
technique is the limitation in materials that are commercially
available for a systematic comparison. Titania and zirconia have
been used as stationary phases in HPLC,18,19 and materials with
small particle sizes are offered from several suppliers. For other
metal oxides, researchers need to rely on particles that have not
been specially optimized for chromatographic purposes. To
overcome these limitations, several groups have reported the
synthesis of metal oxide nanoparticles20,21 although controlling
the morphology of these particles is far from straightforward. On
the other hand, the concept of nanocasting22,23 offers more
freedom to prepare materials with desired particle and pore sizes.
This process relies on the formation of a “replica” in the pores of
a porous template particle such as a silica sphere by filling the
pores with a metal salt solution. Following this “impregnation”
step, metal oxides are formed in situ by evaporation of the solvent
and calcination in air.
We have recently shown that tin dioxide microspheres syn-
thesized this way can also serve as supports for MOAC24 and that
nanocasting allows the generation of a “library” of SnO2 materials
to be used for optimizing the material properties.25 Here, we
expand the nanocasting concept to the generation of titanium
dioxide microspheres suitable for MOAC. Both SnO2 and TiO2
materials were used to isolate phosphopeptides obtained from
a digest of soluble proteins from a HeLa cell lysate. This cell
line is a commonly used model system for phosphoproteomic
studies, and different groups have reported the enrichment of
HeLa phosphopeptides.12,26-28 In our case, we were able to
identify 600 to 900 phosphopeptides from less than 100 µg of HeLa
proteins per run, depending on the material. We compare the
performance of the nanocast material to a commercial titania
sorbent (Sachtopore NP, Sachtleben Chemie, Germany). Although
nonspecific binding was found to be higher with our in-house
materials, we could demonstrate that the nanocast spheres
perform well for complex biological samples and possess comple-
mentary affinity.
EXPERIMENTAL SECTION
Synthesis and Characterization of SnO2 and TiO2 Micro-
spheres. Nanocast tin dioxide microspheres were prepared as
described previously.24 Ten micrometer silica spheres (120 Å,
Daiso, Osaka, Japan) were used as templates and were impreg-
nated with an aqueous solution of 1.8 g mL-1 SnCl2. After
removing excess solution by centrifugation, the wet samples
were heat treated at 150 °C (3 h), 250 °C (3 h), and 550 °C (5
h) with heating ramps of 1 K min-1 between the different steps.
For the preparation of titanium dioxide spheres, a modified
method previously described by Lee et al.29 was employed. In
this case, 5 µm silica spheres (120 Å, Shiseido Co. Ltd., Tokyo,
Japan) were impregnated with an excess solution of 50% (v/v)
titanium isopropoxide (g97.0%, Aldrich) in ethanol (99.5%).
After stirring the suspension for 20 h, the excess precursor
solution was discarded from the sample using centrifugation
and finally ethanol was evaporated in a vacuum oven. Subse-
quently, a mixture of ethanol/water (1:1 volume ratio) was
added to the dried sample, upon which the sol-gel reaction
of the titanium precursor was initiated. In order to ensure
mechanically stable replica spheres, the impregnation/sol-gel
steps were repeated once. Finally, the composite spheres were
calcined at 550 °C to obtain crystalline anatase. The silica
template was removed from both materials by two sequential
treatments in 2 M NaOH at 90 °C. The obtained metal oxide
particles were then refluxed in 0.1 M aqueous HCl, as this was
previously found to increase specificity of the enrichment
process.25
The materials were characterized using scanning electron
microscopy, SEM (Jeol JSM-6335F, Jeol Ltd., Tokyo, Japan),
nitrogen physisorption (ASAP 2010, Micromeritics Co., Norcross,
GA), energy-dispersive X-ray spectroscopy (Link Inca, Oxford
Instruments, Abingdon, UK), X-ray diffraction (XRD, X’pert X-ray
diffractometer, Philips PANalytical, Almelo, The Netherlands), and
electro-kinetic titrations (Malvern ZetaSizer Nano-ZS, Malvern
Instruments Ltd., Malvern, UK).
Preparation of HeLa Protein Sample. HeLa cell lysate was
prepared as described in Poser et al.30 Dried HeLa proteins (1
mg) were resuspended in 8 M urea/500 mM NH4HCO3, reduced
using dithiothreitol (DTT, 50 µg per mg protein, 30 min, 56
°C), and alkylated by iodoacetamide (250 µg per mg protein,
30 min, room temperature). Alkylation was stopped by adding
an excess of 250 µg of DTT. Enzymatic digestion was first
carried out by diluting the samples to 6 M urea, adding lysyl
endopeptidase (mass spectrometry grade, Wako Chemicals,
Neuss, Germany) at an enzyme-to-substrate ratio of 1:50, and
incubating at 30 °C for 2 h. The sample was then diluted to 0.8
M urea and digested using trypsin (proteomics grade, Sigma-
Aldrich, Vienna, Austria) by adding two 16.5 µg aliquots initially
and after 2 h, respectively (final enzyme:substrate ratio 1:33).
Tryptic digestion was carried out overnight at 37 °C.
The protein digest was acidified using trifluoroacetic acid
(TFA) and purified by solid-phase extraction using C18 cartridges
(Phenomenex, Torrance, CA). The SPE eluate was evaporated
to dryness and stored at -20 °C until further use.
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Phosphopeptide Enrichment. Phosphopeptides were en-
riched by MOAC according to two different protocols separately
optimized for SnO2 and TiO2. In addition to the nanocast metal
oxides synthesized in-house, Sachtopore NP TiO2 (10 µm, 300
Å, Sachtleben Chemie, Duisburg, Germany) was used as
reference material. All steps were carried out at room temper-
ature in a thermomixer, and the MOAC material was settled
by centrifugation after each step.
Tin Dioxide Enrichment. Aliquots (200 µg) of digest were
redissolved in 100 µL of loading buffer (LB, 50% acetonitrile/0.1%
TFA). Five milligrams of stannia material was preincubated in LB
for 10 min, and afterward the supernatant was discharged. HeLa
sample was added and incubated for 30 min at room temperature.
After enrichment, the supernatant was discarded and beads were
washed twice with 100 µL of LB for 10 min. Finally 2 × 100 µL of
a 50 mM (NH4)2HPO4 solution (pH 10.5, adjusted with am-
monium hydroxide) was used for the elution of bound peptides.
Titanium Dioxide Enrichment. Phosphopeptide enrichment
using titanium dioxide was performed as above with the following
exceptions: 50% acetonitrile/0.1% TFA containing 300 mg mL-1
lactic acid was used as buffer for pretreatment, incubation, and
the first washing step. For the second washing step, 50%
acetonitrile/0.1% TFA was used. All eluates were acidified to a
pH of 4 to 5 with TFA and stored at -20 °C prior to analysis.
NanoLC-MS Analysis. LC-MS/MS analyses were carried
out on an Ultimate 3000 nanoLC system (Dionex, Amsterdam,
The Netherlands) connected to a LTQ FT Ultra mass spectrometer
(Thermo Scientific, Bremen, Germany) equipped with a Proxeon
nanospray source (Proxeon, Odense, Denmark). MOAC eluate
(90 µL, corresponding to ∼90 µg of starting material) were loaded
onto a trap column (Dionex PepMap C18, 5 mm × 300 µm ID, 5
µm particles, 100 Å pore size) at a flow rate of 25 µL min-1 using
0.1% TFA as mobile phase. After 40 min, the trap column was
switched in line with the analytical column (Dionex PepMap
C18, 250 mm × 75 µm ID, 3 µm, 100 Å). Peptides were eluted
using a flow rate of 275 nL min-1, and a ternary gradient
described in detail in Mitulovic et al.31 was used with the
following mobile phases: A (water/acetonitrile/formic acid, 95/
5/0.1, v/v/v), B (water/acetonitrile/formic acid, 70/30/0.08,
v/v/v), and C (water/acetonitrile/trifluoroethanol/formic acid,
10/80/10/0.08, v/v/v/v). The total run time was 240 min.
The LTQ FT was operated in data-dependent mode using a
full scan in the ICR cell (m/z range 400-1800, nominal resolution
of 100 000 at m/z 400, ICR target value 500 000) followed by MS/
MS scans of the five most abundant ions in the linear ion trap.
MS/MS spectra (normalized collision energy, 35%; activation value
q, 0.25; activation time, 30 ms; isolation width, ±3 Da) were
acquired in the multistage activation mode, where subsequent
activation was performed on fragment ions resulting from the
neutral loss of -98, -49, or -32.6 m/z. Precursor ions selected
for fragmentation (charge state 2 and higher) were put on a
dynamic exclusion list for 180 s. Monoisotopic precursor selection
was enabled.
Data Analysis. Xcalibur .raw files were searched against the
human subset of the IPI database (www.ebi.ac.uk/IPI/, version
3.55 (dated 12 Feb 09, 75 554 entries)) using the SEQUEST search
option of Proteome Discoverer (version 1.1, ThermoScientific).
Search parameters were set as follows: enzyme name, trypsin
(full); maximum missed cleavage sites, 2; precursor mass toler-
ance, 5 ppm; fragment mass tolerance, 0.5 Da; static modifications,
carbamidomethyl-Cys; dynamic modifications, oxidation on Met
and phosphorylation on Ser/Thr/Tyr. The maximum number of
identical modifications per peptide was set to three, and the
number of maximal modifications per peptide was set to four.
The output was filtered to a false discovery rate of 1% based on
the built-in decoy search functionality of the software.
The resulting peptide identifications from three technical
replicates were combined, and a nonredundant list of peptide IDs
was generated. The peptide counts reported here are based on
the following conventions: An identical amino acid sequence
differing only in Met oxidation (present/not present) is counted
as one. Phosphopeptides differing only in the number of phos-
phorylation sites (0, 1, 2, 3, 4) are counted as different peptides.
Peptides with identical numbers of phosphorylation sites, but
different localization of phosphate group (as assigned by SE-
QUEST), were also counted as different peptides.
A list of all phosphopeptide identifications is given in the
Supporting Information (Tables S1-S3). The complete data set
will be deposited in the IMP Vienna SpectrumDB database
accessible at http://www.imp.ac.at/research/protein-chemistry/
labhomepage/spectrumdb/?expname)Nanocast%20MOAC. Se-
lected peak areas were determined by manual integration in
Xcalibur.
Analysis of Peptide Properties. Isoelectric points of both
phospho- and nonphosphopeptides were calculated using the
program pICalculator,32 version 1.0. The pK settings “optimized”
(for unphosphorylated amino acids) and “default” (for phospho-
amino acids) were used. Amino acid distributions were calculated
by PROMPT,33 version 0.9.6, downloaded from http://www.
geneinfo.eu/prompt/downloads.php. Proportional Venn diagrams
were created by Venn Diagram Plotter, version 1.3.3103, available
from http://ncrr.pnl.gov/software/.
Caution: Corrosive substances such as tin chloride, titanium
isopropoxide, and concentrated acids and bases should be handled
with care and in a well ventilated fume hood. No further special
precautions apply.
RESULTS
Preparation of Nanocast Metal Oxide Materials for Phos-
phopeptide Enrichment. A more thorough structural investiga-
tion of the SnO2 replica as well as the commercial Sachtopore
TiO2 spheres has been reported previously.24 However, the
main properties of these materials are listed in Table 1 for
comparison with the new nanocast TiO2 spheres. On the basis
of our previous experience with tin dioxide spheres,24,25,34 we
prepared nanocast titanium dioxide material according to a similar
procedure (see Experimental Section). Both MOAC materials
were prepared from 120 Å pore size silica and treated with diluted
hydrochloric acid prior to use. This “activation” procedure has
been found beneficial for the specificity of the stannia material,25
presumably due to changes in surface chemistry.
(31) Mitulovic, G.; Stingl, C.; Steinmacher, I.; Hudecz, O.; Hutchins, J. R. A.;
Peters, J.-M.; Mechtler, K. Anal. Chem. 2009, 81, 5955–5960.
(32) Gauci, S.; van Breukelen, B.; Lemeer, S. M.; Krijgsveld, J.; Heck, A. J. R.
Proteomics 2008, 8, 4898–4906.
(33) Schmidt, T.; Frishman, D. BMC Bioinf. 2006, 7, 331 (article number).
(34) Sma˚tt, J.-H.; Schu¨wer, N.; Ja¨rn, M.; Lindner, W.; Linde´n, M. Microporous
Mesoporous Mater. 2008, 112, 308–318.
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SEM characterization of the nanocast titania microspheres in
relation to the starting silica template is shown in Figure 1. This
comparison indicates that we are able to fully replicate the sphere
structure on a macroscopic length scale as was shown earlier for
the stannia materials.24,25,34 Even if we have shown that the
morphology does not play a crucial role in phosphopeptide
enrichment performance of stannia spheres,25 it is important to
be able to control the size and shape of the particles for further
adaptations of these materials in column applications. Simply using
silica spheres with different morphology as templates, we have
the possibility to control the structure of the replica.
Nitrogen physisorption was carried out to reveal the textural
properties on a nanometer length scale and the results are listed
in Table 1 as well as shown in the Supporting Information (Figure
S1). While the nanocast SnO2 and the Sachtopore TiO2 spheres
show comparable properties with regard to the specific surface
area and mesopore volume (25-50 m2 g-1 and 0.19 cm3 g-1,
respectively), it is essential to point out that the nanocast TiO2
displays an almost 10 times higher surface area (250 m2 g-1)
and more than 4 times higher pore volume (0.85 cm3 g-1). In
addition to this, the nanocast TiO2 exhibits a sharp pore size
distribution around 17 nm. The reason for the higher surface
area compared to the stannia replica spheres is that titania is
forming a more true replica of the silica mesopore structure
on the nanometer length scale, which was also shown previ-
ously for nanocast zirconia spheres.34
As we observed previously for the SnO2 materials, the surface
chemistry of the MOAC materials plays a larger role for the
enrichment efficiency of phosphopeptides than the structural
properties do.25 Using X-ray diffraction (XRD), we are able to
determine the crystalline form and estimate the crystal size
(using the Scherrer equation) of the different MOAC materials,
and the results are shown in Figure S2 in the Supporting
Information. For the nanocast SnO2 spheres, we can only
observe the cassiterite crystalline phase with approximately 19
nm crystallite domains. Furthermore, the XRD patterns ob-
tained for the two different TiO2 materials can both be assigned
to the anatase form. However, there is a clear difference in
the domain size of the crystallites as the Sachtopore material
displays fairly large domains (∼35 nm), while the nanocast TiO2
spheres are nanocrystalline with a crystallite size of about 7
nm. Moreover, a larger portion of the nanocast titania particles
seems to be amorphous, because a broad hump can be
observed in the range of 10-20° 2θ.
Energy-dispersive X-ray spectroscopy (EDX) was used to
determine the remaining amounts of silica in the two replica
materials after the etching step. It was clear that the silica part
could be more easily removed from the tin dioxide spheres
compared to the titania spheres (∼1% and ∼3% remaining Si,
respectively). A probable reason for this behavior is that the
impregnated titania phase is in more intimate contact with the
silica template (better wetting of the surface), and thus, there is
a larger probability for the oxides to form a chemically stable
mixed oxide at the interface.
Because of the differences in the amount of residual silica in
the materials, we also studied the electro-kinetic behavior using
zeta potential titrations in order to determine the isoelectric point
(pI) of the different MOAC materials (listed in Table 1). The
stannia material clearly displayed the lowest pI value at about 4.1,
while for the Sachtopore TiO2 spheres the pI was higher (∼5.0).
Interestingly, the pI of the nanocast TiO2 was slightly lower
compared to the commercial TiO2 (∼4.7), which one would
expect for adding Si atoms in the TiO2 structure. The small pI
shift in addition to the smaller crystallite size could at least
partially explain the differences in the enrichment behavior that
we observe for both titania materials described below.
Analysis of the HeLa Phosphoproteome by Tin Dioxide
and Titanium Dioxide MOAC. Methodology [Figure 2]. The
three metal oxide materials, nanocast SnO2 and TiO2 and
commercial TiO2, were used to enrich phosphopeptides from
a HeLa cell lysate. To provide a fair comparison between the
materials, separately optimized protocols were used for stannia
and titania, respectively. Enrichment with tin dioxide was
carried out using 50% acetonitrile and 0.1% TFA during binding
and washing steps, while for titanium dioxide, binding and
initial washing was carried out in the presence of 300 mg mL-1
lactic acid to reduce nonspecific binding. The latter protocol,
following a procedure initially introduced by Sugiyama et al.,12
provides in our hands the best compromise between recovery
and nonspecific binding for titania, and no other protocols were
evaluated as part of this study. Phosphopeptides bound to the
metal oxides were eluted by an inorganic phosphate solution
adjusted to pH 10.5, ensuring efficient elution resulting from
the pH shift and the competition of the phosphate anions for
binding sites on the oxides.
Table 1. Textural Properties for the Different Particles Determined by Nitrogen Physisorption and Electro-Kinetic
Titrations
surface areaa [m2 g-1] pore volumeb [cm3 g-1] pore diameterc [nm] crystallite sized [nm] isoelectric pointe [pH]
Nanocast SnO2 55.9 0.188 5.0; 50.8 18.8 4.1
Nanocast TiO2 246.1 0.844 16.9 7.0 4.7
Sachtopore TiO2 23.5 0.193 32.1 35.2 5.0
a Determined using the BET model. b Determined from the adsorption branch at P/P0 ) 0.98. c Determined using the BJH model from the
desorption branch. d Approximated from the XRD data using the Scherrer equation. e Values obtained using electro-kinetic titrations starting from
the native pH of the metal oxides to a pH of about 2.
Figure 1. SEM images of (a) the SiO2 template together with the
novel TiO2 replica (b) spheres used in the enrichment protocol.
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MOAC eluates were subsequently analyzed by reversed-phase
HPLC-MS/MS on a linear ion trap-FTICR hybrid mass spec-
trometer. Because of the facile neutral loss of the phosphate group
(in the form of H3PO4) from many phosphoserine and phos-
phothreonine peptides that can compromise spectral quality,35
we employed multistage activation36 for sequencing. This
technique, which activates both the precursor ion and product
ions resulting from neutral loss of H3PO4 without an intermit-
tent isolation step, shows better performance compared to a
MS2/MS3 strategy and facilitates data analysis, as also recently
confirmed by Ulintz et al.37 Following a database search using
SEQUEST against the human subset of the IPI database and
a decoy database approach, peptide identifications were filtered
to a false discovery rate of less than 1% for every individual
LC-MS/MS run.
Number of Phosphopeptides. Figure 3 gives an overview of the
performance of the three MOAC materials. Combining the results
of three technical replicates (separate MOAC enrichment followed
by a single LC-MS/MS run), more than 600 phosphopeptides
were confidently identified from each material in at least one
LC-MS/MS analysis (Figure 3a). Average numbers per individual
run ranged from ∼330 to 570 for the different materials. Using
the two titania materials, a larger number of phosphopeptides
could be identified compared to stannia, and enrichment by the
Sachtopore material yielded roughly 10% more identifications than
the in-house made material (1010 vs 896). When grouping the
phosphopeptides according to the number of phosphorylation sites
(Figure 3b), we found that 71% of the peptides identified from
the Sachtopore samples were singly phosphorylated, while the
number was higher for the two nanocast materials (82% and 84%,
respectively). The majority of the remaining peptides were
diphosphorylated (>85% for all materials), although triply and (few)
quadruply phosphorylated peptides were also identified by all
materials.
Ishihama and co-workers previously reported specificities of
>90% in the elution fractions of Titansphere TiO2-MOAC using
lactic acid as modifier.14 We could corroborate these results
for the Sachtopore material, where we achieved 94% specificity.
In contrast, the amount of nonspecific binding was higher for
the nanocast materials: Specificities of 67% and 60% were
obtained for titania and stannia, respectively. These results are,
however, comparable to reported values obtained for zirconia-
based MOAC, and it is important to consider that no additional
additive was used for the stannia material. This confirms our
previous observation made using model peptides that stannia
possesses a significantly higher intrinsic specificity for phos-
phopeptides than titania,24 which has also been recently
confirmed by Zhang and co-workers using magnetic tin dioxide-
coated particles.38
Overlaps in the Data Sets. Every sample obtained from MOAC
was analyzed using a single dimension chromatographic separa-
tion followed by tandem MS. In order to examine the reproduc-
ibility of the enrichment strategy, MOAC was carried out in
triplicate. Figure 4a shows the overlap in phosphopeptide identi-
fications of the three materials used for this study. Less than one-
third of the phosphopeptides were identified in all three replicate
analyses, with the overlap being the highest for the nanocast
titania material. In at least two runs, 40-50% of the peptides were
detected. In both cases, the overlap was lowest for the tin dioxide
material. The (small) difference to the titania materials may be
caused not only by the material properties but also by slight
variations in instrument performance over time. In general, the
values obtained reflect the enormous complexity of the phospho-
peptide sample which would require a more comprehensive
(multidimensional) separation strategy for in-depth characteriza-
tion.
However, it is still of interest to confirm the overlap in
phosphopeptide IDs between the different metal oxide materials.
Figure 4b shows the overlap for all peptides identified in at least
one run per material. Only 297 phosphopeptides (18.6% of the total
pool) were identified with all three materials. Compared to the
Sachtopore data set, the nanocast materials contributed 586
additional identifications, of which 363 were from nanocast titania
and 144 from nanocast stannia (79 were found in both). Despite
(35) Boersema, P. J.; Mohammed, S.; Heck, A. J. R. J. Mass Spectrom. 2009,
44, 861–878.
(36) Schroeder, M. J.; Shabanowitz, J.; Schwartz, J. C.; Hunt, D. F.; Coon, J. J.
Anal. Chem. 2004, 76, 3590–3598.
(37) Ulintz, P. J.; Yocum, A. K.; Bodenmiller, B.; Aebersold, R.; Andrews, P. C.;
Nesvizhskii, A. I. J. Proteome Res. 2009, 8, 887–899.
(38) Qi, D.; Lu, J.; Deng, C.; Zhang, X. J. Phys. Chem. C 2009, 113, 15854–
15861.
Figure 2. Analytical strategy for the enrichment of HeLa phospho-
peptides by metal oxide affinity chromatography.
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the low degree of overlap between the two materials, predicted
isoelectric points of the phosphopeptides and distribution accord-
ing to phosphorylated amino acids were very comparable (see
Figure S3 in Supporting Information).
At first glance, this might suggest that there is no significant
difference in the affinities of the different materials. However, a
more detailed analysis of the data reveals additional qualitative
and quantitative differences. For example, when only the subset
of phosphopeptides is considered that is identified in all three
technical replicates for a given material (n ) 392), only a small
fraction of the peptides (56) were identified three times with all
three metal oxides. However, 74 phosphopeptides (37 for Sach-
topore TiO2, 35 for nanocast TiO2, and 2 for nanocast SnO2)
were identified in all replicates of one material, but not a single
time with any other material.
More importantly, a comparison of peak areas of selected
identifications revealed that relative amounts of phosphopeptides
differed significantly between the materials, sometimes even by
a factor of 10. In contrast, reproducibility between technical
replicates was very good on the basis of signal intensities. Selected
examples are shown in Figure 5, which also provide evidence that
SnO2 shows clear quantitative differences in affinity for a subset
of peptides. Note that quantitative differences in affinity do not
always correspond to differences in identification. Frequently,
a given peptide was still identified although it was present at
levels of less than 10% compared to the better performing
material. However, it is obvious that with decreased sample
amounts the differences in identification would become more
apparent.
Characterizing Nonspecific Binding. As mentioned above, the
nanocast materials showed a larger amount of nonspecific binding
when compared with the commercial material. Thus, we examined
the lists of nonspecifically bound unphosphorylated peptides to
find out whether any differences in the physicochemical properties
of these peptides exist. Figure 6a compares the distribution of
isoelectric points among the three sets of peptides. It is evident
that a clear majority of peptides that nonspecifically bind to stannia
are strongly acidic, with a pI < 5. It is very likely that this is a
consequence of the enrichment protocol that does not use any
additional modifier, in contrast to the titania protocol. In previous
work on stannia-based MOAC, we could not find any additive that
improved the specificity without significantly compromising
recoveries. However, the amount of nonspecific binding is still at
a level that should not cause problems for phosphopeptide
identification, as more than half of the identified peptides were
phosphorylated. Interestingly, despite the higher numbers of
unphosphorylated peptides identified using the nanocast titania
material, differences in the pI distributions between the two sets
of peptides were small, with a slightly larger contribution of more
acidic peptides for the nanocast material. Therefore, a higher
degree of nonspecific binding may at least in part be explained
by the much larger surface area of the replica material, resulting
in more binding sites per milligram of material. As the same
amount of material by weight was used, nonspecific binding may
be reduced if smaller amounts proportional to the surface areas
are used in this case.
As a second parameter that affects nonspecific binding, we
looked for differences in amino acid distribution among the
nonphosphopeptides (Figure 6b). As could be expected, the
stannia data set contained elevated levels of aspartic and glutamic
acid, although both titania materials also showed increased levels
of these two residues relative to the average amino acid composi-
Figure 3. Comparison of phosphopeptides identified by the three metal oxide materials. (a) Total number of phosphopeptides identified (in at
least one of three replicates) and (b) distribution according to the number of phosphorylation sites per peptide.
Figure 4. Overlaps (in %) in the phosphopeptide identifications from the three metal oxide materials. (a) Overlap of phosphopeptide identifications
in different technical replicates. (b) Overlap of phosphopeptides (identified at least in one of three replicates) for the three metal oxide materials.
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tion of the SwissProt database (version 57.6, 28/07/09) taken as
a reference. Other notable differences to SwissProt for all three
materials were also observed, with reduced levels of Phe, Ile, Leu,
Met, and Tyr. While overall differences between the two titania
materials were again rather small, enormous differences in
histidine content are noticeable when comparing tin dioxide and
titanium dioxide: The average His content in SwissProt is 2.3%,
identical to the number in the SnO2 data set. The corresponding
numbers for Sachtopore and nanocast titania are 10.2 and 8.4%,
amounting to a 4-fold increase in relative His content. In fact,
in the Sachtopore data set, 73% of the unphosphorylated
peptides contain at least one His residue and 48% contain two
or more. Although there have been some reports about the
histidine affinity of titanium dioxide,39,40 it has not been
discussed in the context of proteomic research. Tin dioxide, in
contrast, does not appear to bind His peptides preferentially.
DISCUSSION
The results presented above provide convincing evidence that
nanocast metal oxide materials are suitable for application to
complex biological samples such as whole cell lysates. However,
in the case of the TiO2 material, nonspecific binding still is
higher than for a well established commercial chromatographic
material. Further studies to address this issue are ongoing in
our laboratories, although even the presently achievable
specificities provide samples that are highly enriched for
phosphopeptides and commonly available instruments with
high sequencing speeds are able to deal with the slightly
elevated number of peptides present. In fact, the largest number
of phosphopeptides identified in any single run (636) as part
of this study was achieved using the nanocast titania. The
aspect of nonspecific binding would be even less of a concern
in combination with other chromatographic or electrophoretic
separation methods in a two-dimensional setup.
Importantly, the use of tin dioxide has resulted in the
identification of additional phosphopeptides not covered by the
titania materials, and even the two titania materials differ in their
(39) Dickerson, M. B.; Jones, S. E.; Cai, Y.; Ahmad, G.; Naik, R. R.; Kro¨ger, N.;
Sandhage, K. H. Chem. Mater. 2008, 20, 1578–1584.
(40) Ko¨ppen, S.; Bronkalla, O.; Langel, W. J. Phys. Chem. C 2008, 112, 13600–
13606.
Figure 5. Examples for different affinity of phosphopeptides to tin dioxide and titanium dioxide. Peak areas given are averages of three technical
replicates, error bars represent one standard deviation.
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specificities. This not only confirms previous data from studies
in which different metal oxides have been used (Ti and Zr, Ti
and Nb) but also increases the number of MOAC sorbents
available to enhance the coverage of the phosphoproteome.
Further improvements in the design of nanocast metal oxides
will focus on the optimization of surface chemistry which is still
not fully explored and is potentially very dependent on the
synthesis conditions. Improving the specificity of the materials
may also be achieved by refinement of the enrichment protocol,
in particular the binding and washing steps. Finally, the concept
is expandable to other metal oxides of interest that have not yet
been widely used, such as the recently described hafnium41 or
tantalum42 oxides. A detailed comparison of such materials is only
possible when different metal oxides are prepared in highly similar
procedures, thereby reducing the influence of parameters such
as particle and pore size.
In summary, we have used two metal oxide affinity materials
prepared by the nanocasting technique to analyze the phospho-
proteome of HeLa cells. Both materials significantly enriched for
phosphopeptides and provided complementary coverage of the
phosphoproteome. The final data set obtained from the nanocast
materials alone (provided in the Supporting Information) contains
1137 phosphopeptides.
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unphosphorylated peptides bound to the three metal oxide materials.
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Manuscript 1 
A Chemically Cleavable Linker for Immobilizing Bait 
Compounds in a Target Protein Pull-down Concept  
Abstract 
A novel linker chemistry based on a malondialdehyde - indole condensation reaction has 
been developed for the affinity-independent elution of targeted protein pull downs. Recently 
developed in our lab for tagging of tryptophan residues on proteins or peptides, the concept 
was extended for the design of a chemically cleavable linker system. In our setup a specific 
kinase inhibitor (bosutinib) was coupled to agarose and acrylamide beads respectively via 
the new linker system and a protein pull down experiment of possible interaction partners of 
a K562 whole cell lysate was performed. After purification, the linker can be cleaved from the 
beads by incubation with 50mM pyrrolidine. The system is especially compatible with 
targeted protein pull downs because during cleavage step no protein hydrolys is or any 
degradation of amino acid side-chains was induced. From the pull-down experiment, key 
targets of bosutinib such as the tyrosine kinase, Btk, were identified. 
 
Introduction 
For many drugs which are in pharmaceutical development or already in clinical use, their 
main targets and other possible interaction partners are still unknown. To facilitate further 
advances in drug effectiveness but also to get a better overview of possible side effects, all 
interacting proteins should ideally be known. In the field of chemical proteomics, proteins are 
selectively enriched by affinity chromatography for further analysis by 2D-gelelectrophoresis 
and/or liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). With the 
help of organic chemistry probes can be coupled to beads via certain linker chemistry to 
further purify targeted proteins. Thereby it is possible to purify targets from matrix 
components which may otherwise interfere with downstream analysis. However, in case of 
targeted protein pull downs, elution of enriched proteins in their native form can be difficult, 
since most conventional elution protocols are based on the use of denaturing components 
like detergents, low pH, or high salt concentrations for elution. Recently new affinity 
independent elution methods which do not affect the bioaffinity interaction were introduced 
[1-5]. Linkers can be cleaved enzymatically  by cleaving a DNA-linker with nuclease [3] 
introduced by Santala et al., photochemically [5], or chemically by using an azobenzene 
linker which can be cleeaved by reduction with sodium dithionite [1, 4]. 
Here, we use a malondialdehyde-indole derivative as linker which can be chemically cleaved 
by incubation with pyrrolidine or hydrazine. This chemistry, using malondialdehyde bound to 
the indole nitrogen was previously used in our lab for the reversible and selective tagging of 
tryphophan residues on peptides or proteins [6, 7].   
 
Experimental 
Synthesis 
The indole linker 3 ((E)-2-(1-(3-oxoprop-1-enyl)-1H-indol-3-yl)acetic acid, IAA-MDA) was 
designed to display two functional groups on opposite ends for coupling to the support  and 
the drug (“bait”), respectively, and a chemically cleavable group in the middle of the linker 
moiety (scheme 1, a).  
A condensation reaction of malondialdehyde (MDA) with 3-indolyl-acetic acid (IAA) 1 under 
strongly acidic condition [7],  primarily described by Teuber et al.in 1964 [8],was used 
(scheme 1, a).  As the first step, malondialdehyde (MDA) was applied in its commercial 
available form as tetramethoxypropane (TMP) 2, which is converted to MDA in situ during 
reaction. The newly formed derivative contains a chemically cleavable group at the indole 
nitrogen which is linked to an activated - unsaturated aldehyde group for coupling onto 
beads. Structure of the synthesis product was confirmed by mass spectrometry and NMR 
spectroscopy (see supplemental data). The reaction conditions had to be controlled 
accurately (not more than 2h reaction time, controlled temperature) to avoid polymerisation 
of the derivative, due to the high activity of the resulting acroleine type group. The reactive 
carbonyl group typically reacts with amine or hydrazide nitrogens to form Schiff base type 
products.  
For affinity chromatography purpose, we used the Pierce Carbolink Coupling Gel, an 
agarose gel which contains hydrazide functionalities (coverage approximately 10 µmol/ml 
gel). Additional coupling experiments were carried out on hydrazide activated acrylamide 
beads for comparison of coupling and purification performance. Both materials performed in 
comparable manner. For simplicity only data gained by use of agarose beads is quoted. With 
the use of 10 mM aniline as catalyst [9] the reaction time could be reduced to two hours and 
the reaction was performed in slightly acidic environment (solvent buffered to pH 4.5)  
(scheme 1, b). During the reaction, the beads turned yellowish due to binding of the colored 
IAA-MDA derivate.  
The coupling efficacy was around 50% as determined by liquid chromatography – mass 
spectrometry (LC-MS) in multiple reaction monitoring mode detection of the cleavage product 
3-indolyl-acetic acid (IAA) after cleavage with 355mM pyrrolidine (complete cleavage). After 
coupling, remaining hydrazide groups had to be saturated to avoid cross reactions in 
following steps. Therefore we used a 30x molar excess of N-acetoxysuccinimide in order to 
achieve complete saturation of remaining hydrazide groups (scheme 1, c). Completeness of 
saturation was demonstrated by trying to re-bind the derivative to already saturated beads. 
No coloring of beads, like it is normally the case upon binding of the derivative, could be 
detected upon twentyfold excess of N-acetylsuccinimide, and after treatment with pyrrolidine, 
no IAA could be detected by LC-MS analysis. A result of the saturation process was the 
competitive displacement of readily bound IAA from beads (up to 50%).  
From this point, the beads were ready for the attachment of the desired affinity target. The 
free carboxylic residue of the linker was coupled to amino groups on affinity targets, using 4-
(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM) as coupling 
reagent [10]. The coupling reaction with DMT-MM is a one step reaction, so carboxylic 
residues on the bait have to be protected first. Additional, only free amino groups in their 
non-ionized form are accessible for the reaction.  
To prove the effectiveness of the reaction, we chose methyl 2-amino-3-(4-
hydroxyphenyl)propanoate (tyrosine methyl ester)  for coupling (scheme 1, d). As solvent, 
methanol was found to be the best candidate because it ensured good coupling efficiency 
without a collapse of the agarose beads. The binding efficiency was determined to be 50%, 
again evaluated by quantitative LC-MS (see supplemental data). As a reference for 
quantitation a 3-indolylacetic acid- tyrosine methyl ester conjugate 4 was used, which was 
synthesized in house. The coverage of baits could be varied by changing in the amount of 
IDA-MDA used for the initiation reaction. Consequently the protocol allows an easy control of 
the total loading of baits on the beads. 
 For specific linker cleavage 50mM pyrrolidine was used and a 0.1M Tris buffer system did 
not seem to interfere with the cleavage chemistry. The use of pyrrolidine was further tested 
to clarify whether or not the reagent causes protein precipitation on the beads or causes any 
protein degradation. Therefore beads were incubated overnight with a mixture of four 
proteins that were dissolved in 0,1M Tris buffer or 50mM pyrrolidine solution either (see 
supplemental data). The supernatant and possible remaining proteins from beads, once 
directly after incubation and once after three washing steps with 0.1M Tris buffer (beads 
were boiled in Lämmli buffer for elution) of both samples were analysed by 1D SDS-PAGE 
with silver staining. The two samples behaved similarly. In case of pyrrolidine, a small 
amount of protein could be detected after 3 washing steps, indicating a slight precipitating 
effect of pyrrolidine (see supplemental data). To prove the long term stability of the system, 
beads linked with the derivative alone, or linker coupled to bait were stored for 3 weeks in 
water containing 0.02% sodium azide at 4°C, respectively. After 3 weeks, no changes in the 
coupling rate could be detected for both samples.  
 Biological application 
As a biological application we used the tyrosine kinase inhibitor bosutinib (SKI-606) [11] for 
enrichment of possible direct and indirect interactors from a K562 cell lysate. Bosutinib is an 
ATP-competitive third generation kinase inhibitor for the treatment of chronic myeloid 
leukemia (CML) [12], which is currently in phase III of clinical trials. Former investigations 
revealed SRC and ABL kinases as the main interactors of bosutinib, but also a lot of other 
affinity targets could be found [12-14]. The drug in its amino functionalized form (scheme 2) 
was kindly provided by the Center of Molecular Medicine, Austria (CeMM). The applicability 
of this functionalized form of bosutinib for targeted protein pulldowns was shown in a recent 
publication from Superti-Furga’s group [13]. A coupling rate of 50% could be achieved with 
DMT-MM as coupling agent. Ready-made beads had an overall coverage of 0.7 µmol of 
bosutinib per ml beads suspension. The cleavage product (IAA-MDA-c-bosutinb) resulting 
from elution by pyrrolidine was found and confirmed by MS (see supplemental data). The 
efficacy of the c-bosutinb coupling reaction was calculated by the amount of remaining IAA 
after cleavage with pyrrolidine compared to an uncoupled control.  
 
Affinity Purification 
Protein pull down experiments were performed at the Center of Molecular Medicine on a 
K562 cell lysate according to a protocol from Rix et al. [15] with the exception that instead of 
eluting interactors by boiling with Lämmli buffer, elution was performed with 100mM 
pyrrolidine and incubation for 3h at 4°C. The higher amount of pyrrolidine (100mM instead of 
50mM in previous experiments) was chosen to compensate for higher sample complexity 
and the lower incubation temperature (4 °C instead of RT in previous experiments). This step 
was at this point not optimized with regards to concentration needed to carry out a complete 
cleavage. 
 
  
Immunoblot analysis 
Immunoblot analysis was performed by 1D SDS-PAGE separation of the eluates (an elution 
by boiling beads with Lämmli buffer was used for comparison). A monoclonal anti BTK 
antibody was used for detection. The tyrosine kinase BTK is one of the main interactors of 
Bosutinib. The immunoblot is shown in figure 1, demonstrating the enrichment of BTK by 
affinity purification. Hence, the applicability of the purification protocol using indole linker 
beads could be successfully demonstrated (line C). In terms of efficacy a stronger signal 
could be achieved using the indole-beads compared to the reference (line D). This strong 
enrichment of BTK  suggests that even lower concentrations of pyrrolidine might be used for 
cleavage if desired. 
 
Liquid chromatography mass spectrometry 
Along with the immunoblot analysis a LC-MS/MS protein identification of the pull-down was 
realized on a LTQ-Orbitrap XL mass spectrometer to identify specific interaction partners and 
to determine the degree of unspecific binding. Prior to LC-MS, 2D gel electrophoresis with 
tryptic in gel digestion of separated proteins was performed. For procedure information the 
reader is referred to the work of K. Bennett [15] and collegues.  
Target purification using the indole linker system allowed the identification of 32 targets of 
bosutinib (Table 1). Main interactors like SRC, ABL, BTK or TEC were successfully identified 
but also newly found targets like CAMK2G could be identified [16] (Table 1). However, also a 
high degree of unspecific bound proteins were  found (see supplemental data). Agarose and 
acrylamid gels behaved similarly, whereby the latter showed a higher degree of unspecific 
binding. 
  
Conclusion 
A new linker chemistry, based on a reversible reaction of malondialdehyde with the indolyl 
group of 3-indolyl-acetic acid was demonstrated for an affinity chromatography concept in 
form of a pull-down protocol. The linker was coupled to hydrazide functionalized agarose 
beads via an -unsaturated aldehyde group, and baits can be coupled to the linker via an 
amide groups with DMT-MM as coupling agent. A protein pull down was successfully 
performed using bosutinib as bait for purifying interaction partners of a K562 cell lysate. 
Efficient purification of the main target BTK was shown by immunoblot analysis. All main 
interactors could be identified by LC-MS/MS analysis. To further reduce unspecific binding of 
unwanted proteins the binding, washing and elution protocol may be further improved. The 
reduction of the pyrrolidine concentration used during cleavage seems particularly 
reasonable due to the high enrichment efficiacy achieved for the bosutinib target Btk when 
using 100mM pyrrolidine, compared to the purification using a noncleavable linker.  
  
 Scheme 1. Linker synthesis. (a) Synthesis of the cleavable linker building block. Reagents and 
conditions: Tenfold excess of tetramethoxypropane added dropwise to 3-indolyl-actetic acid in 80% 
TFA, 1h RT, 40% yield. (b) Coupling of linker to hydrazide functionalized agarose gel. Reagents and 
conditions: 50% acetonit rile/50% 100mM ammonium acetate pH 4.5, 10mM aniline as catalyst, 2h RT, 
50% recovery rate. (c ) Saturation of remaining hydrazide groups. Reagents and conditions: 30x molar 
excess of N-acetoxy succinimide in 50% acetonitrile/50% 50mM sodium phosphate pH 7.8 as buffer,  
2h RT. (d-e) Coupling and release of affinity probe. Reagents and conditions : (d) MeOH, four fold 
excess of TyrOMe and 40x excess of DMT-MM for 1.4µmol linker groups per ml agarose beads, 3h 
RT; (e) 50mM pyrrolidine, 2h RT, 50% coupling efficiacy (determined with LC-MS/MS, see 
supplemental data).  
Scheme 2. Coupling of c-bosutinib to linker. Reagents and Conditions: (a) Amino functionalized 
bosutinb was converted from HCl salt into free amino from by conversion with 3x excess of DIPEA, 
MeOH, 1h RT; (b) 10 times excess of DMT-MM to bosutinib was used, MeOH, 3h RT, slight agitation 
of beads, 50% coupling efficiacy. (c) pyrrolidine cleavage.   
 
  
Table 1. List of direct interactors of bosutinib identified by affinity chromatography using the indole 
linker system (coupled to agarose- and acrylamide beads) and LC-MS/MS protein identification (LTQ-
Orbitrap XL mass spectrometer). Complete list of identifications see supplemental data.  
 
  
IPI Ac Entrez Ac Gene symbol
peptide 
counts - 
acrylamide 
beads
peptide 
counts - 
agarose 
beads
IPI00296337 5591 PRKDC, ISOFORM 1 OF DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT. 189 116
IPI00031410 2475 FRAP1, FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN. 65 45
IPI00029132 695 BTK, TYROSINE-PROTEIN KINASE BTK. 32 34
IPI00013212 1445 CSK, TYROSINE-PROTEIN KINASE CSK. 20 21
IPI00413961 5747 PTK2, PTK2 PROTEIN TYROSINE KINASE 2 ISOFORM B. 8 15
IPI00293613 29110 TBK1, SERINE/THREONINE-PROTEIN KINASE TBK1. 9 14
IPI00003783 5605 MAP2K2, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2. 9 11
IPI00003479 5594 MAPK1, MITOGEN-ACTIVATED PROTEIN KINASE 1. 10 8
IPI00219604 5604 MAP2K1, DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1. 8 8
IPI00787531 2580 GAK, SIMILAR TO CYCLIN G-ASSOCIATED KINASE. 5 8
IPI00216378 818 CAMK2G, CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA ISOFORM 1. 5 7
IPI00827625 817 CAMK2D, ISOFORM DELTA 11 OF CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II DELTA CHAIN. 2 7
IPI00000878 7006 TEC, TYROSINE-PROTEIN KINASE TEC. 6 6
IPI00234463 1453 CSNK1D, ISOFORM 2 OF CASEIN KINASE I ISOFORM DELTA. 8 5
IPI00883914 5571 PRKAG1, AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC GAMMA-1 SUBUNIT ISOFORM 2. 7 5
IPI00029263 2241 FER, PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER. 3 5
IPI00377174 816 CAMK2B, CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 4. 2 5
IPI00029643 51776 NA, ISOFORM 2 OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT. 5 5
IPI00872474 4067 LYN, LYN PROTEIN (FRAGMENT). 0 4
IPI00873480 4216 MAP3K4, UNCHARACTERIZED PROTEIN MAP3K4. 0 4
IPI00848174 NA NA, SIMILAR TO CASEIN KINASE I ISOFORM DELTA. 14 4
IPI00411818 25989 ULK3, UNC-51-LIKE KINASE 3. 8 3
IPI00742900 5595 MAPK3, MITOGEN-ACTIVATED PROTEIN KINASE 3 ISOFORM 2. 4 3
IPI00513803 10746 MAP3K2, MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2. 2 3
IPI00183400 1452 CSNK1A1, CASEIN KINASE I ISOFORM ALPHA. 3 2
IPI00410287 5562 PRKAA1, PROTEIN KINASE, AMP-ACTIVATED, ALPHA 1 CATALYTIC SUBUNIT ISOFORM 2. 2 2
IPI00006752 9448 MAP4K4, ISOFORM 1 OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4. 2 2
IPI00472717 3654 IRAK1, ISOFORM 2 OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1. 0 2
IPI00217437 146057 TTBK2, TAU-TUBULIN KINASE. 0 2
IPI00328867 6714 SRC, OTTHUMP00000030931. 0 2
bcrabl NA NA, Gene_Symbol=BCR-ABL fusion protein 0 2
IPI00412057 55589 BMP2K, ISOFORM 2 OF BMP-2-INDUCIBLE PROTEIN KINASE. 3 0
IPI00029196 5588 PRKCQ, ISOFORM 1 OF PROTEIN KINASE C THETA TYPE. 2 0
IPI00002857 1432 MAPK14, MITOGEN-ACTIVATED PROTEIN KINASE 14 ISOFORM 2. 2 0
IPI00384765 9088 PKMYT1, MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE. 2 0
 __ 
Figure 1. Immunoblot analysis of pull down experiment on K562 cell lysate. The bait was 
immobilized C-Bosutinib. Primary antibody (AB): monoclonal anti-BTK (Santa Cruz Biotechnology, 
Santa Cruz, CA); Secondary AB: Alexa Fluor 680 goat anti-mouse. Lines: (A) protein marker, (B) total 
cell lysate, (C) elution with 100mM pyrrolidine, (D) elution by boiling with Lämmli buffer.  
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